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"If we begin with certainties, we shall end in doubts; but if we begin with doubts, 
and are patient with them, we shall end with certainties" 
 
                                           
Sir Francis Bacon, 1605 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ter nagedachtenis aan mijn ouders 
 List of abbreviations 
 
BP Back Propagation 
CC Clinical Condition 
CEJ Cemento-Enamel Junction 
CJA Clinical Judgment Analysis 
CRF Clinical and Radiographic Findings 
DRF Dental Risk Factor 
EPT Electric Pulp Test 
EV  Expected Value 
Gy Gray 
ICD International Classification of Diseases 
JANNET Judgment Analysis via Neural NETwork 
LR Likelihood Ratio 
MDDS Model for Dental Decision Support 
MRRF Malignancy Related Risk Factor 
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OV Outcome Value 
PATFACT Patient's Dental IQ 
PE Probability Estimation 
PNN Probabilistic Neural Network 
RD Radiation Dose 
ROC-curve Receiver Operating Characteristic curve 
SCC Squamous Cell Carcinoma 
SD Standard Deviation 
ST Strategic Teeth 
 
 
Numeric convention 
 
In this thesis, we will follow the English system of using the dot {.} for decimals and the 
comma {,} to indicate thousands.
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Introduction  
 
Overview 
 
Patients with head and neck cancer have to cope not only with a life-threatening 
disease but also with the prospect of adverse effects of cancer therapies, frequently 
affecting the mouth and jaws.(1,2) This is especially true if high-dose radiation therapy to 
the oral and maxillofacial structures is part of the overall treatment regimen.(3) To reduce 
oral sequelae, extensive dental preventive and treatment measures before, during, and 
after cancer therapy are mandatory. (4,1,5)  
In view of the risk that accompanies high-dose irradiation, special attention to 
preradiation dental planning appears critical. Each case must be managed individually on 
the basis of the patient's needs, the status of the tumor, and the risk known to exist for 
dental heath in irradiated tissues; a single-formula approach for all patients is contra-
indicated.(6)  
Evidence-based medicine is an approach to clinical decision-making in which the 
clinician uses the best evidence available to decide upon the intervention that suits an 
individual patient best.(7) This can be a challenging and complex task. The key to control 
is the implementation of 'good clinical decision-making'. For that reason, decision 
support systems to aid clinicians in reaching optimal decisions have become increasingly 
important.  As described by Muir Gray,(7) 'good clinical decision making' plus 'good 
(decision support) systems' result in 'good clinical outcomes'. In accordance with this 
view, the main subject of this thesis is to develop and test a decision support system, in 
order to enhance dental decision-making in patients with head and neck cancer. 
  
 
Head and neck cancer (8,9) 
 
Epidemiological data indicate that there are an estimated 40,000 - 60,000 newly 
reported cases of head and neck cancer in the Unites States every year.(10,11) The annual 
incidence is approximately 17 per 100,000.(8) This represents approximately 5% of all 
newly diagnosed cancers occurring in the United States per year. Worldwide, an 
estimated 400,000 - 500,000 new cases of head and neck cancer occur.(12,13) This ranks 
head and neck cancer as the sixth most common cancer.  
Squamous-cell carcinoma (SCC) is the most common malignant neoplasm of the 
mucous membranes of the upper aero-digestive tract and accounts for more than 90% of 
newly diagnosed head and neck malignancies. In the Netherlands, cited by Slootweg and 
Richardson,(9) in 1994, 2034 new cases were registered out of approximately 63,500 new 
malignancies in a population of 15.4 million inhabitants.(14)  
Primary tumors are specified by site of occurrence. About 38% percent of head and 
neck carcinomas occur in the larynx, 32% in the oral cavity, 20% in the pharynx, 4% in 
the major salivary glands, and 6% in the remaining head and neck sites.(14,15) However, it 
should be noted that significant geographic variations in the occurrence of head and neck 
cancer have been documented. For example, the highest incidence rates of oral cavity 
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and pharyngeal cancer are reported for South Asia, whereas the highest incidence rates 
for laryngeal cancer are found in Southern Europe.(16) The incidence of SCC is two to 
three times higher in men than in women. Laryngeal cancer has an even higher incidence 
in men. The male-female ratio is 5:1.(9) However, the incidence in women continues to 
rise, probably because of the increasing number of female smokers. 
The overall age-adjusted head and neck cancer death rates have remained unchanged 
over the past 30 years.(10) The 5-year survival rates average about 40-50% (10,14) and vary 
from about 40% for nasopharyngeal carcinomas, through 50-60% for oral and 
pharyngeal carcinomas, up to 67-70% for laryngeal and salivary gland carcinomas. The 
annual age-adjusted death rate in the United States due to SCC of the head and neck is 
estimated at 13,000 cases per year.(8) Based on the overall mortality rates reported by 
Visser et al.,(14) in the Netherlands, this number is estimated at 1340 patients per year. It 
was estimated that worldwide in the year 2000, approximately 286,000 patients died as 
result of oral and oropharynx cancers.(12) 
Tobacco use is the major risk factor for development of SCC of the oral cavity, 
oropharynx, and larynx. As a second important etiological factor, alcohol appears to 
potentiate the effect of tobacco. Excessive use of both tobacco and alcohol increases the 
risk of oral cancer by a factor of 15, compared with individuals who use neither. The 
effect of tobacco and alcohol is time- and dose-dependent. Other suggested etiological 
factors include genetic predisposition, dietary factors, betel nut use, viral infections, poor 
oral hygiene, and mechanical irritation from teeth or dentures. Occupational exposure to 
asbestos, wood dust, or certain vapors or metals increases the risk for development of 
sino-nasal carcinomas.(17,18) 
The choice of head and neck cancer treatment depends on the anatomic site and 
extent of the tumor, and on histological factors. Final treatment decisions taken by the 
multidisciplinary cancer team are influenced by a number patient factors, including age, 
medical condition, compliance, and possible continuation of smoking and drinking, and 
the relative morbidity of the various treatment options. The treatment regimen consists 
primarily of surgery and radiation, either alone or in combination. Generally, tumors of 
limited size can be treated with equal effectiveness by either radiation therapy or 
surgery. Combination therapy is the preferred modality for advanced tumors. The 
approach should be directed toward the elimination of the cancer while preserving 
function and quality of life. The surgical approach therefore requires not only ablative 
but also reconstructive procedures. The possibility or presence of neck metastasis 
requires surgical management with a neck dissection. Adjuvant radiation therapy is 
mostly used as post-surgical treatment. This treatment decision is usually based on 
histological parameters.  Chemotherapy has been of little benefit to patients with head 
and neck cancer and cannot yet be considered to be part of the standard treatment 
regimen. However, chemotherapy may be given as palliative treatment to patients with 
bulky, unresectable tumors, locally recurrent disease, or distant metastases.(19) cited by (9)  
 
 
 
 
                                                                                                                                        CHAPTER 1 
4 
Oral sequelae (1,2) 
 
Radiotherapy to the head and neck region, which includes oral and maxillofacial 
structures and salivary glands, may result in serious side effects. The short-term effects 
are mucositis, loss of taste and smell, secondary or 'opportunistic' infections, and reduced 
salivary function. The long-term effects include persistence of reduced salivary function, 
radiation caries, progression of pre-existing periodontal disease, limited mouth opening 
(trismus), soft-tissue breakdown and failure to heal, and radiation bone injury, which in 
its severest form develops as osteoradionecrosis. As a secondary effect, patients with 
head and neck cancer experience significant tooth loss, prior to and following 
radiotherapy. In pediatric patients, radiotherapy may also cause developmental dental 
and maxillofacial abnormalities.  
Mucositis may appear in the second week after the start of radiotherapy. Initially, the 
affected mucous membranes appear reddened and edematous as a result of hyperemia. 
The mucosa may then become ulcerated and covered with a fibrinous exudate.(6,20-23) The 
lips, cheeks, soft palate, and floor of the mouth are at greater risk of mucositis. 
Discomfort and a burning sensation are commonly present. Mucositis worsens if 
smoking is continued.(24)  Pain varies considerably in severity and may be intensified by 
certain foods. In addition, the patient may develop problems in swallowing and speaking. 
Severe symptoms usually dissipate within 6 weeks following completion of 
radiotherapy, but reactions may be prolonged and late mucosal reactions may even 
develop.(25) 
Alteration and loss of taste may be noticed as early as 2 weeks after initiation of 
radiotherapy (6,26) The rate and extent of taste loss are related to the radiation dose 
delivered to the area involving taste receptors. After 3 weeks of therapy, it takes 500 to 
8000 times normal concentrations of taste stimulant to evoke normal taste responses.(2) 
Taste function usually returns to normal 2 to 4 months following completion of therapy. 
Oral mucosal alterations resulting from irradiation create a favorable environment 
for the growth of microorganisms.(27) Secondary or 'opportunistic' infections are 
therefore common. While Candidiasis (Candida albicans) is most common, any 
bacterial, mycotic, or viral organism may cause infections. Candida infection usually 
presents as painless, pearly white, raised flecks or patches that adhere firmly to the 
underlying mucous membrane.  
Oral dryness or 'xerostomia' is one of the most common complaints.(20,28) Saliva is 
often reduced in volume and is more viscous. The overall diminished salivary flow and 
the lack of lubricating mucin account for this oral dryness. Further, the remaining 
salivary secretions become more acidic, thus promoting decay of the remaining teeth. 
Radiation xerostomia is rapid in onset and is usually persistent. Some of the oral 
sequelae of head and neck radiation already mentioned, such as mucosal alterations and 
soft tissue infections,(29) taste loss, and radiation caries, have been linked to lack of 
normal salivation.(6) 
Rapid demineralization and breakdown of tooth structure often occur following 
radiotherapy(6,20) and may start as early as 12 weeks after treatment. The teeth need not 
be directly in the field of radiation. Dental demineralization may also occur when the 
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major salivary glands are included in the field of radiation. An inadequate supply of 
saliva deprives the tooth structure of calcium and phosphate ions, resulting in 
demineralization.(30) Even patients who may not have complaints of oral dryness may 
have changes in saliva composition. Not only is the saliva more viscous, with a reduced 
pH-buffering capacity, its antibacterial properties are also diminished.(29) This results in a 
highly cariogenic oral microflora, which, coupled with poor oral hygiene and dietary 
changes, leads to heavy dental plaque formation. The microbial, chemical, 
immunological, and dietary changes(31-33) add up to an enormous increase in incidence of 
dental caries.(34,35) The usual pattern is one of circumferentially progressive caries, and 
widespread caries is often seen (Fig 1.1 and 1.2). Exposed root surfaces are especially 
susceptible to caries.  
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The periodontium also is sensitive to the effects of radiation at high doses, leading to 
widening of the periodontal space. The periodontal ligament's specific network of fibers 
becomes disoriented and thickened.(36-39) Cementum demonstrates changes similar to 
those seen in bone. Reports of increased periodontal disease activity are sparse, but 
progressive destruction of the periodontium following radiation treatment is a realistic 
outcome and(20,40-42) is a major cause of postradiation tooth loss.(42)  
Trismus characterized by spasms and/or fibrosis of the muscles of mastication and 
by injury to the temporomandibular joint may develop when these tissues are in the field 
of radiation.(43-46) Consequently, mouth opening can be severely limited (trismus) and 
oral function seriously impaired. Trismus may become evident during radiotherapy but is 
usually manifested 3 to 6 months after treatment.  
Oral cavity soft-tissue breakdown, failure to heal, and bone necrosis may develop 
because tissues in the field of radiation become hypovascular, hypoxic, and 
hypocellular.(47-49) Bone necrosis or 'osteoradionecrosis' (ORN) may develop 
spontaneously or may be induced by trauma. Trauma often results from tooth extraction, 
invasive periodontal procedures, or the use of poorly fitting prosthodontic 
appliances.(42,50-57) ORN occurs in  approximately 2% to 10% of those exposed to high 
radiation doses;(58-60) the majority of  patients may present with milder forms of radiation 
tissue injury.(52,54,58,61-64) Patients are most vulnerable to ORN in the first two years after 
irradiation,(52,55,58,65-68) although this complication can occur any time thereafter.(64,69) 
There is general agreement that the lower jaw is much more susceptible to ORN than the 
upper jaw.(60) Clinically, the necrotic bone is denuded, (Fig 1.3, 1.4, and 1.5) greenish 
gray, suppurative, foul smelling, and painful at rest, at night, and especially during 
chewing.(49,51,53,54,56,59-61,66,70,71) Possible consequences are pathologic fracture, 
intraoral/extraoral fistulation, and local/systemic infection.(55,60,72-76) 
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Children undergoing radiotherapy may experience significant changes or 
abnormalities in the growth and development of dental and maxillofacial structures. 
These alterations include blunted roots, incomplete calcification, delayed or arrested 
tooth development, asymmetrical facial growth, and abnormal occlusal relationships.(77-
79)  
 
Pretherapy oral screening 
 
To reduce oral sequelae, extensive dental preventive and treatment measures before, 
during, and after cancer therapy are mandatory.(1,4,5) Implicit in the preventive approach 
is pretherapy oral screening to identify and eliminate dental risk factors.(5) The current 
standards for dental care before radiotherapy include extraction of teeth with significant 
bone loss, extensive caries, and/or extensive periapical lesions. In addition, partially 
impacted or incompletely erupted teeth and residual root tips not fully covered by bone 
and/or showing radiolucency to x-rays should be removed.(3,5,6,80,81)  The essential 
elements of the pretherapy oral screening are outlined in Chapter 2. 
Important factors in the dental management of these patients include among others, 
the following considerations:(6)  
(1) Anticipated radiation field and dose;  
(2) Pre-therapy dental status, dental hygiene, and retention of teeth that will be exposed 
to high-dose irradiation;  
(3) Patient motivation ('dental IQ') and ability to comply with preventive measures. 
Persons with head and neck cancer have a higher incidence of dental and oral 
pathology than the general population. Particularly elderly persons and persons of lower 
socioeconomic status form a substantial proportion of patients with head and neck 
cancer.(15,82) The prevalence and incidence of dental disease in these groups are high, and 
compliance with dental care recommendations is usually poor (44,83-88) For example, 
Lockhart and Clark(89) conclude on the basis of clinical examinations of 75 dentulous 
head and neck cancer patients that almost all (95%) of them needed some form of dental 
treatment. However, in spite of strong urging from members of the cancer team, only a 
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small proportion of the patients (19%) were compliant in seeking dental care for their 
treatment needs. This pattern of non-compliance for dental treatment in head and neck 
cancer patients has been reported by several other investigators.(90-94) 
Although several studies strongly support the efficacy of the pretherapy oral 
screening,(80,95,96) evidence-based clinical guidelines(97-99) to aid clinicians in deciding 
which options for dental intervention best suit these patients are not yet widely available. 
In view of the risks that result from high-dose irradiation, special attention to 
preradiation dental planning appears critical. Each case must be managed individually; a 
single-formula approach for all patients is contra-indicated.(6) Dental management can 
thus be a challenging and complex task. The key to control may be the implementation 
of a dental decision-support system, derived from an evidence-based approach. 
 
 
Evidence-based approach 
 
Evidence-based medicine is an approach to clinical judgment and decision-making 
in which the clinician uses the best evidence available to decide upon the intervention 
that suits an individual patient best.(7) This approach involves evaluating rigorously the 
effectiveness of health-care interventions, disseminating the results of these evaluations, 
and using these findings to determine clinical practice.(100) Good clinicians use both 
personal clinical expertise and the best available external evidence, and neither alone is 
enough. External clinical evidence can inform, but can never replace individual 
expertise. Evidence-based medicine is therefore not an obligatory 'cookbook' 
approach.(101)  
One of the basics of evidence-based practice is the implementation of  'good clinical 
decision-making'. This could explain why decision support systems that aid clinicians in 
reaching optimal decisions have become increasingly important.  As stated by Muir 
Gray,(7)  
 
 
 
 
 
 
Decision strategies 
 
Optimal decision-making calls for a strategy that is appropriate to the situation. 
Thompson,(102) cited by Keuning,(103) explains that two basic situational factors influence 
the choice of decision strategy: 
(1) Insights into the structure of the problem (cause-effect relations);  
(2) Preferences regarding possible outcomes. 
A matrix summary distinguishes four different strategies (Fig 1.6). 
 
 
good clinical decision making  +  good (decision support) systems   
= 
good clinical outcomes 
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            Figure 1.6 
 
(1) Computational strategy: good insight into the decision problem and certainty 
with regard to causation and outcome preferences imply adoption of a computational 
strategy for decision-making. For example, the technique of 'folding back and averaging 
out' a decision tree, further explained in Chapter 2, provides such a solution.  However, 
in many instances, the levels of certainty concerning underlying decision factors and 
outcomes are reduced. In these cases, higher levels of certainty or 'belief' cannot easily 
be derived by experimentation, for example by a randomized controlled clinical trial.  
A Baysian approach,(104-107) briefly introduced in Appendix 1, provides a 
mathematical rule explaining the methodology of changing existing beliefs in the light of 
new clinical data or evidence. In other words, it allows clinicians to combine new data 
with their existing knowledge and expertise. Baysian methods have become the primary 
tool for decision support systems that acknowledge uncertainty.(106,108,109) These systems 
will be briefly introduced in Chapter 6. 
(2) Judgmental strategy: when outcome preferences are clear but cause-effect 
relationships are uncertain, a judgmental strategy for decision-making is required. With 
such problems, the decision makers, given lack of clear insight into the decision 
problem, fall back entirely on their judgmental abilities. Judgment analysis,(110) more 
fully explained in Chapters 3 and 4, provides methods for capturing, comparing, and 
aggregating decision and judgment policies of individuals. 
(3) Compromise strategy: if those involved in the decision problem (e.g. patient and 
clinician) have a clear understanding of the problem but have different concerns, a 
compromise strategy is required. For example, the patient's main concern may be the 
maintaining of oral function by preservation of teeth, whereas the main concern of the 
dental clinician may be the elimination of risk factors by means of extracting remaining 
teeth, to prevent adverse outcomes. In this controversial situation the compromise 
strategy will be required, involving consideration and negotiation, during which both 
parties will have to shift their positions to a certain extent, leading to an acceptable 
solution and 'informed consent'.  
(4) Gambling strategy: when there is no insight into the decision problem and no 
consent with regard to the preferences or goals, a solution can only be reached by 
gambling. In medicine and dentistry, this approach does not belong to standards of  'good 
clinical practice' and can lead to serious professional misconduct.  
 
 
Certainty of 
beliefs about 
cause-effect Judgmental 
Computational Compromise 
Gambling 
Yes No 
Yes 
No 
Clear preferences regarding 
possible outcomes 
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Objectives 
 
In view of the risk that accompanies high-dose (> 55 Gy) head and neck irradiation, 
and in accordance with the evidence-based approach that underlies the health-care 
paradigm of this new millennium,(7,111)  the main subject of this thesis is to develop and 
test a decision support system, in order to enhance dental decision-making in patients 
with head and neck cancer. More specifically, studies were conducted to: 
(1) Identify the decision dilemma and perform a clinical decision analysis (base-case 
analysis); 
(2) Analyze the judgment policies of clinicians familiar with and experienced in 
preradiation dental screening; 
(3) Propose a method for judgment analysis, to identify the characteristics of individual 
judgment policies of dental clinicians with respect to the prophylactic extraction of 
teeth; 
(4) Assess which factors included in the base-case decision analysis are most strongly 
associated with tooth loss in patients with head and neck cancer; 
(5) Develop and test 'SCREDENT', a system for dental decision support in patients 
with head and neck cancer. 
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Outline 
 
The outline of this thesis is displayed in Fig 1.7.  
 
Chapter 1 presents a general introduction to the problem domain and a statement of the 
objectives.  
Chapter 2 offers a clinical decision analysis, comprising four basic steps: 
(1) Identification and analysis of the decision dilemma, and construction of a decision 
tree; 
(2) Analysis of the decision tree, using the method of 'folding back and averaging out'; 
(3) Presentation of the optimal decision alternatives; 
(4) Probabilistic sensitivity analysis, using second-order Monte Carlo simulations.  
Chapter 3 involves an international survey using a judgment analysis questionnaire to 
capture the decision policies of clinicians familiar with and experienced in preradiation 
dental screening. As all policies were aggregated together, this is a 'between-clinicians' 
analysis. 
Chapter 4 proposes JANNET, a new tool for Judgment Analysis, using a probabilistic 
neural network (PNN). JANNET can be used when the assumptions underlying multiple 
regression analysis (the main method for judgment analysis) are not met. JANNET is 
used to analyze the decision policies of individual clinicians. Therefore, this is a 'within-
clinician' analysis. 
In Chapter 5, a cohort study to search for clinical evidence is presented. This study was 
designed to investigate the association of tooth loss with dental status, dental risk factors 
(DRFs), and radiotherapy-related factors in a sample of patients with head and neck 
cancer. It involves a retrospective and follow-up study of 209 head and neck cancer 
patients in the Netherlands who received a dental evaluation prior to radiotherapy. 
Patients who met the inclusion criteria were subsequently evaluated after a follow-up 
period of 1-5 years (median 3 years) in order to establish the end points.  
In Chapter 6, the results from Chapters 2-5 are used to construct and test SCREDENT, a 
system for dental decision support in patients with head and neck cancer.  
To validate the decision support system, it is used to analyze the dental treatment 
planning in an additional sample of 30 patients who were treated in the University 
Medical Center Utrecht.  
In Chapter 7, a summary, general discussion, and conclusions are provided. 
A summary and conclusions in Dutch are given in Chapter 8. 
In Appendix 1, the Bayesian Approach is briefly introduced, and an explicatory example 
is given. In Appendix 2, the SCREDENT form and guidelines are presented and 
Appendix 3  provides the SCREDENT "getting started" document. 
 
 
                                                                                                                                        CHAPTER 1 
12 
 
 
        
       Figure 1.7 
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Abstract 
 
Objective 
The proposed model was designed to function as a tool for the development and 
testing of evidence-based guidelines for the pretherapy oral screening and dental 
management of patients with head and neck cancer. 
 
Study Design 
Methods of clinical decision analysis were used to analyze the decision dilemma and 
construct a decision algorithm and decision tree. The robustness of the model was tested 
by means of a probabilistic sensitivity analysis with second-order Monte Carlo 
simulations (n = 10.000). 
 
Results 
Clinical criteria for evaluating dental pathologic conditions and malignancy- and 
patient-related conditions were transformed in probability estimates. The tradeoffs 
between the benefits and drawbacks of dental intervention were integrated into the 
model to identify the optimal option for dental intervention. The calculation process of 
'folding back and averaging out' the decision tree enabled the identification of the 
optimal options for dental intervention in four different pretherapy risk conditions. 
 
Conclusions 
A priori testing of the proposed model with 95% confidence intervals suggests that it 
has great potential for solving clinical dilemmas associated with pretherapy dental 
decision-making. In addition, it seems a useful tool for the development of evidence-
based clinical guidelines. A posteriori clinical testing should further validate the model 
before assimilation into clinical practice takes place. 
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Introduction 
 
Patients with advanced head and neck cancer have to cope not only with a life-
threatening disease but also with the prospect of adverse effects of cancer therapies.(1)  
This is experienced as extremely traumatic.(2-4) The wide spectrum of adverse effects in 
particular influences the entire mouth and jaws,(5-9) resulting in severe impairment of oral 
function.(3,10-12) This seriously affects both the tolerance of treatment and the quality of 
life.(13)  
Numerous reports indicate that in addition to the cancer therapy itself, preexisting 
dental disease, tooth extraction, and dental treatment are major risk factors for oral 
complications.(7,9,14-19)  To prevent oral complications and to improve patient outcomes, 
extensive preventive and treatment measures before, during, and after cancer therapy are 
necessary.(7,20-22) This is especially true if radiation therapy is part of the overall head and 
neck cancer treatment regimen.   
Implicit in the preventive approach is pretherapy oral screening to identify and to 
eliminate dental risk factors (DRFs; see Table 2.2, page 25). Elimination of DRFs is 
possible through dental treatment or tooth extraction. To be safe, a minimum interval of 
14 days' healing time between tooth extraction and the onset of radiation reactions is 
recommended (radiation reaction established at 10 to 12 days after initiation of external 
beam radiation).(21) Criteria for the extraction of teeth before radiation therapy include 
the following:(7,21,23) 
• moderate to advanced periodontal disease, 
• extensive periapical lesions of roots, 
• extensive tooth decay, 
• partially impacted or incompletely erupted teeth,  
• residual root tips not fully covered by  bone and/or showing  translucency to x-rays. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a  Modified after Jansma et al,(7)  and Stevenson-Moore and Epstein.(21)  
 
 
Table 2.1  Essential  elements of pretherapy oral screeninga 
History Medical history, dental history, dental complaints 
Consultation Family dentist, oncologist, surgeon, consultant radiotherapy  
Cancer- and cancer therapy-
related factors 
Clinical staging and location, cure or palliation; type of therapy; mode, dose, and 
field of radiotherapy, immediacy of treatment 
Patient related factors Age; patient’s preferences; dental awareness; level of oral hygiene 
Clinical examination 
  Extraoral: 
 
  Intraoral: 
 
Examination of head and neck: soft tissue examination; swellings, mouth opening 
 
Examination of oral mucosa and alveolar process; periodontal examination; 
evaluation of dentition, dentures 
Radiographic examination Panoramic radiograph, intraoral radiographs when indicated: detection of foci 
(periapical infections, periodontal disease, unerupted or partially erupted teeth, 
residual root tips, cysts) 
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Although several studies strongly support the efficacy of pretherapy oral screening, 
evidence-based clinical guidelines(24-26)  to aid clinicians in deciding which option for 
dental  intervention suits these patient best are not yet widely available. Current 
standards for dental care prior to radiation therapy and chemotherapy were developed at 
a Consensus Development Conference on Oral Complications of Cancer Therapies(23) 
and were published as a NCI monograph.(20) In our view, these  standards are primarily 
based on clinical experience, show great diversity,(7)  and are formulated in broad terms.  
Because the clinical situation is often complex and the available information on the 
primary disease ambiguous, we believe that the process of pretherapy dental decision 
making needs to be more adequately structured.  It also includes the need to determine 
more precisely which dental conditions are indicative risk factors and of significant 
importance in the process of pre-cancer therapy dental decision-making. This is essential 
because a substantial proportion of patients with head and neck cancer consists of the 
elderly and those of lower socio-economic status.(27,28) The prevalence and incidence of 
dental disease in these groups are high,(22,29-34) which makes the pretherapy management 
of DRFs mandatory.  
In this article we propose and a-priori test a Model for pretherapy Dental Decision 
Support (MDDS). The proposed model is based on the accepted standards for pretherapy 
dental intervention.(20)  A protocol based on the work of Jansma et al.(7)  and a review and  
comment by Stevenson-Moore and Epstein(21,23)  have served as sources of more current 
information. The MDDS is designed to function as a tool for the development and testing 
of evidence-based clinical guidelines for the pretherapy oral screening and dental 
management of patients with head and neck cancer. Evidence-based decision support is a 
rapidly expanding approach in which clinicians use the best evidence available, in 
consultation with the patient, to decide which option suits the patient best.(35) 
 
 
Methods 
 
The proposed MDDS was constructed using techniques of clinical decision support. 
Overviews of these methods and examples are given by Paulker and Kassirer,(36)  
McCreery and Truelove,(37,38)  and Petitti.(39)   (An explanation of how to perform a 
decision analysis goes beyond the scope of this article; For better understanding of the 
practical issues we refer to a series of articles on this topic.(40-44)) 
The decision-analytic approach includes a number of basic steps:(39,41-45) 
(1) Identify and analyze the decision dilemma and construct a baseline decision 
algorithm (a set of decision-making steps) and decision tree (a graphical display of 
the logical sequence of the decision problem (see Fig 2.2, page 29), explained more 
fully below); 
(2) Calculate the Expected Value (EV) of each decision alternative; 
(3) Choose the optimal decision alternative; 
(4) Perform sensitivity analyses. 
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The robustness of the model was tested by means of a probabilistic sensitivity 
analysis using second-order Monte Carlo simulations.(46)  (We refer to an article  by 
Doubilet et al.(47) for an excellent overview and illustration of this method.)   
A personal computer and software for clinical decision analysis, SMLTREE version 
2.9+ (copyright Hollenberg, JP, Roslyn, NY, 1985-1993), were used to construct the tree 
and to perform the analyses. The tree was printed using SMLTREE’s graphic interface. 
 
 
Results 
 
The decision dilemma 
 
The assumption that pretherapy decision making in patients with head and neck 
cancer is challenging, often involving clinical dilemmas, is based on three specific 
considerations. 
The first of these considerations is that the current standards for pretherapy dental 
intervention (7,20,21,23) primarily involve only gross dental pathology of teeth that must be 
extracted. They do not cover the area of  "moderate" dental disease, for which alternative 
dental treatment options exit.  For example, what type of intervention is indicated for 
teeth with pocket depths of 4-6 mm: no treatment, periodontal treatment, or tooth 
extraction? Is such a condition a significant DRF if these teeth will be exposed to the 
radiation used to treat the cancer? Is continuing dental management following radiation 
therapy of “moderate” dental disease a realistic possibility? Current literature gives no 
unequivocal answers to these questions. For example, a series of clinical cases presented 
by Epstein et al.(48) demonstrates that in carefully selected cases  periodontal 
management is successful even after high-dose radiation therapy.  However, Lockhard 
and Clark(22) conclude on the basis of clinical examinations of one hundred thirty-one 
head and neck cancer patients that 81%  (59) of the dentulous patients who needed some 
form of dental intervention did not seek the indicated treatment. In these cases it is clear 
that unacceptable risks for cancer therapy complications will remain. Perhaps a more 
radical approach involving tooth extraction is more appropriate in these cases of low 
attitudes toward dental health.  
For the purpose of the proposed MDDS presented here, we introduce the dental risk 
factor. DRFs are examined and identified at the level of each individual tooth and can be 
eliminated by dental intervention: either tooth extraction or dental treatment (including 
oral surgery, e.g. root resection). Clinical prediction rules(49) based on clinical and 
radiographic findings of dental disease were used to  rank a dental condition as "high" or 
"moderate" risk. Table 2.2 gives the results of this ranking procedure. The definition of a 
DRF is: "dental disease unrelated to cancer or cancer therapy that directly and/or 
indirectly increases the risk for oral complications of cancer therapy." The term indirect 
implies that pre-existing dental disease increases the likelihood of post-cancer therapy 
tooth extractions or extensive dental treatment, which are major causes of trauma-
induced complications  (e.g. the onset of osteoradionecrosis following tooth extraction at 
an irradiated site).(50,51)   
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Not only do the criteria for tooth extraction cited above address only gross dental 
pathology, they are also formulated in rather broad, undefined terms. For example, teeth 
with “extensive periapicale lesions” should be extracted.(21) However, a descriptive term 
such as extensive is imprecise and subjective. Furthermore, the assessment of the 
endodontic condition of a tooth is not made exclusively on a single criterion such as 
periapicale condition; rather it is multi-criterial.(52,53)  
The second consideration underlying the assumption that pretherapy decision-
making in patients with head and neck cancer is challenging is based on 
recommendations by Stevenson-Moore and Epstein,(21,23)  Beumer et al.,(9) and Jolly.(54)  
The planning of tooth extraction and dental treatment prior to radiation therapy should 
also consider factors related to cancer, cancer therapy, and medical conditions. This 
recommendation is not evident in the current guidelines for pretherapy dental 
intervention. We therefore introduce the malignancy-related risk factor (MRRF): 
defined as "nondental risk factor, related to cancer, cancer therapy, and the medical 
condition, that increases the risk of oral complications." MRRFs are examined and 
identified at organ (head and neck) and patient level. MRRFs cannot be eliminated by 
dental intervention. The MRRF scores appear in Table 2.3 and Fig 2.1. 
The third consideration underlying the assumption that pretherapy dental decision-
making frequently involves dilemmas is that optimal patient care also depends on 
thoughtful analysis of the tradeoffs between the benefits and drawbacks of clinical 
actions.(8,55-57) Can the ends justify the means? How effective is the pretherapy removal 
of questionable teeth in reducing the incidence of oral complications? Does this affect 
oral functioning?  What are the adverse effects of pretherapy tooth extraction?  What is 
the “optimal” oral outcome of the pretherapy dental interventions?  To answer these 
questions, the various oral outcomes of the pretherapy dental interventions should be 
identified and assessed. The measuring of the outcome of intervention is a basic 
component of expected value decision making.(40-44,46,58)   We used a category-scaling 
method,(59) differentiating between strategic and non-strategic teeth, to assign values to 
the outcomes of dental intervention. The procedure is as follows: the best outcome is 
given a value of 1, the worst outcome a value of 0. Direct scaling is used to assign values 
to all intermediate outcomes. They are then ranked in order of preference between the 
best and worst outcome. Outcome Values (Ovs) below O.3 are labeled "negative," thus 
undesirable. Table 2.4 summarizes the hierarchy of the OV’s.  
On the basis of the three considerations discussed above, the dental decision dilemma is 
identified as follows: Which pretherapy action --tooth extraction or dental treatment to 
eliminate DRFs-- leads to the optimal oral outcome, with respect to the MRRFs  that are 
present?   
The decision problem is structured in the next steps of the decision analysis. 
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Table 2.2       Dental Conditions to assign Dental Risk Factor (DRF) Score 
Clinical and Radiographic Findings (CRF)a Weighting  
Periodontal disease   
Probing depth / Proximal bone lossb:     3 to 6 mm Medium  
Probing depth / Proximal bone loss:      > 6mm  High 
Gingival recession:                                3 to 6 mm Medium  
Gingival recession:                                 > 6 mm  High 
Bleeding upon probing Medium  
Spontaneous gingival bleeding  High 
Furcation involvement / Bone loss in furcation area  High 
Mobility  <  1-2 mm side to side Medium  
Mobility  >  2 mm side to side and/or 1 mm vertical  High 
PULPAL DISEASE AND PERIAPICAL LESIONS   
Abnormal response to testsc,  no previous endodontic treatment,  no rarefying osteitisd Medium  
Abnormal response to tests, no previous endodontic treatment, rarefying osteitis  High 
Swellings and/or sinus tracts  High 
Rarefying osteitis, < 3mm, with adequate root canal fillinge, without  (percussion) pain Low/Medium  
Rarefying osteitis, < 3mm, with inadequate root canal fillinge, with (percussion) pain  High 
Rarefying osteitis, > 3 mm  High 
Condensing osteitis f/hypercementosisg with normal reactions to tests Low  
Condensing osteitis with abnormal reactions to tests Medium  
Internal/external root resorption  High 
EXTENSIVE CARIES   
Primary caries < 2/3 of the clinical crown Medium  
Primary caries > 2/3 of the clinical crown/pulpal involvement  High 
Defective restorationh with secondary cariesi, no pulpal involvement Medium  
Root caries  < 1/2 of root circumference, no pulpal involvement Medium  
Root caries  > 1/2 of root circumference  High 
NON FUNCTIONAL TEETH   
Partially impacted  (incompletely erupted) teeth or permucosal residual roots  High 
Residual root tips not fully covered by alveolar bone and /or   showing periodontal ligament or 
radiolucency  High 
Fully impacted teeth,without follicle enlargement and fully covered by bone Low  
Fully impacted teeth, with follicle enlargement and/or not fully covered by bone,  High 
ORAL HYGIENE, DENTAL AWARENESS, CO-OPERATION   
Low level of oral hygiene, low dental awareness, lack of cooperation  High 
 
a Identified at tooth level, which means tooth-related.  
b Radiographic standard for interpretation of bone proximal bone loss is that the alveolar crestal bone must be greater than 3 
mm from the CEJ.69 
c Pulp sensitivity: cold, heat, electric (EPT) and percussion tests. 
d Rarefying osteitis: radiolucent periapical bone destruction communicating with the periodontal ligament space via a 
discontinuity in the lamina dura.70 
e Criteria for  assessment of root canal obturation: The prepared and filled canal should  contain the original canal and should 
be filled completely (0.5-2 mm from radiographic apex). No space between canal filling and canal wall should be seen. No 
canal space should be visible beyond the end point of the root canal filling. The whole canal system/ all roots  should be 
obturated (Consensus Report European Society of Endodontology) 53 
f Hypersclerotic trabeculi in the bone adjacent to the periapical region and communicating with the periodontal ligament 
space.70 
g Distortion of the apical third of the tooth root characterized by increased width while the periodontal ligament space and 
lamina dura remain unaltered.70 
h Restorations are defective if any of the following conditions are present: marginal discrepancies >0.5 mm, part of the 
restoration missing, bulk fracture, or marginal staining of composites suggesting leakage.71 
i True radiographic secondary (i.e., recurrent) caries and/or residual caries.71 
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Table 2.2 continued 
 
Interpretation of  Weightings to assign the Dental Risk Factor  (DRF) Score: 
• If one or more  CRFs have a High  Weighting,  then DRF is High; 
• If three or more  CRFs  have a  Medium  weighting , then DRF score is High; 
• If one or two CRFs have a Medium  weighting and no CRF has a High   weighting, then DRF score is 
Medium; 
• If no CRF has a High or Medium  weighting, then DRF score is low. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1.  Flowchart for interpretation of clinical condition (CC) weightings (see Table 2.3) to assign 
MRRF score.  
 
 
Table 2.3       Clinical  Conditions to assign Malignancy Related Risk Factor (MRRF) Score 
Clinical  Conditions ( CC) Weighting 
Radiation Therapy   
 40 < RD  < 55  
 
Field  includes >50 %  of  major salivary 
glands Medium  
 40 < RD  < 55 Field  includes teeth in  upper/lower jaw Medium  
 RD > 55  Field  includes teeth in lower jaw  High 
 RD > 55 Field  includes teeth in upper jaw  High 
 Interstitial radiation therapy, teeth adjacent to radiating implant  High 
Chemotherapy  High 
Teeth in close proximity to tumor  High 
Immediacy of radiotherapy:  < 14 days  High 
 
RD: radiation dose 
Interpretation of Weightings to assign the Malignancy Related Risk Factor (MRRF) Score: 
• If one or more Clinical Conditions (CCs)  have a High weighting, then MRRF score is "High"; 
• If three or more  CCs  have a  Medium weighting , then MRRF score is "High"; 
• If one or two CCs have a Medium weighting, and no CC has a High weighting, then MRRF score is 
"Medium"; 
• If no CC has a High or Medium weighting, then MRRF score is "Low". 
yes 
yes 
yes 
yes 
no 
no 
no 
START 
ONE OR MORE CC HIGH ? 
THREE OR MORE CC MED.? 
ONE OR TWO CC MED.? 
NO CC HIGH OR MED.? 
MRRF is Low 
MRRF is High MRRF is Medium 
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Table 2.4   Hierarchical values of  Oral Outcomes: Outcome Values (OV) 
Clinical description Outcome Value OVb 
POSITIVE OUTCOME    
Functional tooth / strategic, healthy 1.0 
Functional tooth/ strategic, following treatment of medium DRF condition/ MRRF meda 0.9 
Functional tooth/ strategic, following treatment of medium DRF condition/ MRRF higha 0.8 
Functional tooth/ strategic, following treatment of high DRF condition/ MRRF high/med 0.7 
Non-functional tooth/non- strategic, following treatment of medium DRF condition/ 
MRRF meda 
0.6 
Non-functional tooth/non- strategic, following treatment of high/med DRF condition/ 
MRRF higha 
0.5 
Healthy, edentate segment of processus alveolaris 0.3 
NEGATIVE OUTCOME, ORAL COMPLICATION  
Osteoradionecrosis or other serious oral complication 0.0 
 
a The oral outcomes of dental intervention are classified using a hierarchical scale: Strategic Teeth (ST) have OV 
Values from 1.0 – 0.7. Non-Strategic Teeth (N-ST) have  Outcome Values of 0.6 or 0.5 . 
b The MRRFs have influence on OV: if MRRF is high, a tooth has a greater probability for post-therapy dental /oral 
complications (e.g. radiation caries) and therefore the OV is  somewhat lower. The same is true for the DRF scores. 
A tooth following treatment of a high DRF condition has a greater probability for dental/oral complications than a 
tooth following treatment of a medium DRF condition. This difference is reflected in the OV.  
 
 
Baseline decision algorithm 
 
A baseline decision algorithm is a set of step-by-step instructions for solving a 
problem. In this model for MDDS they are as follows: 
(1) Perform pretherapy oral screening and gather essential information (see Table 2.1). 
(2) Assign DRF scores (see Table 2.2). 
(3) Assign MRRF scores (see Table 2.3). 
(4) Evaluate the extent to which patient's level of oral hygiene and cooperation can be 
favorably  influenced, if necessary, and take action to do so (immediately, in future, 
or both). 
(5) Identify the alternatives for dental intervention (either tooth extraction or dental 
treatment); 
(6) Do a Probability Estimation (PE) --estimate the probability of each chance event-- 
and assign values to the various outcomes of each decision alternative. Positive and 
negative outcomes are differentiated. The positive outcomes are categorized as 
"outcome/strategic" if the tooth in question contributes significantly to oral 
functioning, and "outcome/non-strategic" if the tooth can be considered as non-
strategic (the Outcome Values are summarized in Table 2.4); 
(7) Calculate the Expected Values (EV) using the process of  "folding back and 
averaging out," which is briefly explained below;  
                                                                                                                                        CHAPTER 2 
28 
(8) Choose the alternative with the highest EV as the preferred course of action ("best 
option") to eliminate DRF; repeat this procedure until all decisions to eliminate all 
DRFs are taken; 
(9) Carefully consider and judge patients' wishes, expectations, and attitudes towards 
dental treatment and dental health,(54)  inasmuch as these are an essential part of the 
clinical decision-making. Determine whether all decisions to eliminate the DRFs are 
applicable to the patient: if so, then make a treatment plan; if not, then reconsider 
patient preferences and/or modify decisions for dental intervention until all decisions 
are applicable, and then make a plan to carry them out;  
(10) Evaluate clinical outcomes over time and take additional measures if required.(7)  
 
 
Decision tree 
 
A decision tree is a schematic representation of the decision problem in a logical and 
temporal sequence. By convention, a decision tree is built from left to right, with 
decision nodes represented by squares and chance nodes by circles. The outcomes are 
specified in boxes at the "tips" of the branches, on the right. The branching of the 
decision tree for the model presented in this article is given in Fig 2.2.  Only "high" and 
"moderate" risk factors are included. "Low" risk conditions were left out because they 
are not critical in this process of decision-making. Including only relevant aspects leads 
to an increased responsiveness of the model.(60,61)   
The model's decision tree is made up of the following elements: 
• eight decision nodes --points in the decision tree at which several clinical judgments 
(high or medium risk) or choices (the decision alternatives- tooth extraction or dental 
treatment) are made. 
• eight chance nodes, at which chance (probability) determines which outcome state 
will occur (a positive outcome is and a negative is not desired). We have used 
Probability Estimations to rank these chances (probabilities) by order of magnitude; 
Ovs --health states that occur as result of each dental intervention. As explained above 
and summarized in Table 2.4, hierarchical rankings (OVs) are assigned to the outcomes.  
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5 positive; PE 0.80 
MRRF high 
DRF high 
1 extract 
2 treat 
1 positive;  PE 0.80 
1 negative; PE 0.20 
OV 0.0 
OV 0.3 
2 positive;  PE 0.20 
2 negative; PE 0.80 
OV 0.0 
OV ST  0.7 / OV N-ST  0.5 
MRRF medium 
3 extract 
4 treat 
3 positive;  PE 0.90
3 negative; PE 0.10 
OV 0.0 
OV 0.3 
4 positive; PE 0.50 
4 negative; PE 0.50 
OV 0.0 
OV ST  0.7 / OV N-ST  0.5 
5 negative; PE 0.20 
OV 0.0 
OV 0.3 
6 positive; PE 0.60 
6 negative; PE 0.40 
OV 0.0 
OV ST  0.8 / OV N-ST  0.5 
5 extract 
6 treat 
7 extract 
7 positive; PE 0.90 
7 negative; PE 0.10 
OV 0.0 
OV 0.3 
8 treat 
8 positive;  PE 0.75 
8 negative; PE 0.25 
OV 0.0 
OV ST  0.9 / OV N-ST  0.6 
DRF medium 
MRRF high 
MRRF medium 
Figure 2.2  Graphical representation of decision tree: black square = decision node; 
black circle = chance node; ST, strategic tooth; N-ST, nonstrategic tooth. Values in 
boxes represent values of outcome of dental intervention. Table 2.4 summarizes 
hierarchy of Outcome Values (OVs) 
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Expected values and optimal decision alternatives 
 
A calculation process called "folding back and averaging out" analyzes the decision 
tree. The process starts at the tips of the branches (Outcome Values). The Outcome 
Value (OV) is multiplied by the Probability Estimation (PE) of that outcome. This 
calculation is repeated for all outcomes emanating from the decision node being 
evaluated. The values are added together, rendering the Expected Value of the decision 
alternative. For example, the Expected Values of the decision alternatives branching out 
from the first decision node (DRF high/ MRRF high) are (as seen in Table 2.5): 
Strategic tooth: 
• EV (extract)= (0.3 x 0.80) + (0 x 0.20) = 0.24 (= optimal decision alternative) 
• EV (treat) = (0.7 x 0.20) + (0 x 0.80) = 0.14 
Non-strategic tooth: 
• EV (extract)= (0.3 x 0.80) + (0 x 0.20) = 0.24 (= optimal decision alternative) 
• EV (treat) = (0.5 x 0.20) + (0 x 0.80) = 0.10 
The decision alternatives with the highest EV are the "optimal" decision alternatives. 
The EVs of all decision alternatives are given in the column labeled "EV", and the "best 
options" in the column "Choose" in Table 2.5.  
 
Table 2.5      The decision tree displayed  as a spreadsheet 
Risk Condition Outcome Value (OV )b    
Expected 
 Value (EV)e 
DRF 
score 
MRRF 
score 
Decision 
Alternative Outcome 
PEa 
 
ST N-ST ST   N-ST 
Choose: 
 
Pos. 
Neg. 
0.80 
0.20 
0.3 
0 
0.3 
0 0.24 0.24      Extract  
     Treat Pos. 
Neg. 
0.20 
0.80 
0.7 
0 
0.5 
0 0.14 0.10 
If STc: extract 
If N-STd: extract 
Pos. 
Neg. 
0.90 
0.10 
0.3 
.0 
0.3 
0 0.27 0.27 
 
 
 
High 
 
 
High 
 
 
Medium 
 
     Extract 
 
     Treat Pos. 
Neg. 
0.50 
0.50 
0.7 
0 
0.5 
0 0.35 0.25 
If ST: treat 
If N-ST: extract ≈ treat 
Pos. 
Neg. 
0.80 
0.20 
0.3 
0 
0.3 
0 0.24 0.24      Extract  
     Treat Pos. 
Neg. 
0.60 
0.40 
0.8 
0 
0.5 
0 0.48 0.30 
If ST: treat 
If N-ST: treat 
Pos. 
Neg. 
0.90 
0.10 
0.3 
0 
0.3 
0 0.27 0.27 
 
 
 
 
Medium 
 
 
High 
 
 
 
Medium       Extract 
 
      Treat Pos. 
Neg. 
0.75 
0.25 
0.9 
0 
0.6 
0 0.67 0.45 
If ST: treat 
If N-ST: treat 
 
ST: if the tooth in question is a strategic tooth; N-ST, if the tooth in question is a nonstrategic tooth; Pos. positive; 
Neg. negative 
a Reflects probability of  such an event  after tooth extraction or dental treatment. Positive and negative outcomes 
are differentiated --e.g., probability of a positive outcome of tooth extraction, if DRF and MRRF are high, is  0.80. 
This means that tooth extraction has an 80% chance of a positive, desired outcome (no osteoradionecrosis) and a 
complementary 20% chance of  (1 – 0.80 = 0.20) of a negative outcome (osteoradionecrosis). For example, the 
chance of  0.2 is based on data from literature.50   
bA hierarchic value is assigned to each outcome; this is explained in text and summarized in Table 2.4.  
e Result of the calculation process of the “folding back and averaging out” the decision tree. 
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Probabilistic sensitivity analysis 
 
The baseline estimates of probabilities (PEs) and of OVs were quantified through the 
use of direct  ranking methods. This implies a degree of uncertainty and susceptibility  to 
biases. Because the analysis of the model is done with  these "estimates" it is called a 
base-case analysis.(58)  In the Discussion, its limitations and strengths are outlined. 
A sensitivity analysis (58)  is carried out to see whether uncertainties in the estimates 
affect the robustness of the MDDS. If the optimal choices for dental intervention of the 
MDDS are sensitive to variation of the baseline estimates (PEs and OVs), then the 
potential use of the MDDS as a tool to develop clinical guidelines is limited. Further data 
collection  is necessary in order to make accurate estimations. On the other hand, if the 
optimal choices are not influenced by variation of the baseline estimates, the model is 
considered to be robust and useful.  
For the purpose of varying the baseline estimates, we assume that each PE and OV 
possesses a probability distribution and that these distributions are logistic-normal 
distributions, determined by their means and upper (97.5 %) and lower (2.5%) limits(47)  
(see Table 2.6).  After multiple simulations (n =10.000) in which each PE and OV is 
randomly assigned a value taken from its distribution, the following is calculated: mean 
EV, standard deviation of the EVs, frequency with which each decision alternative is 
optimal, and 95% confidence intervals. The results of the probabilistic sensitivity 
analyses, using the second-order Monte Carlo simulations explained above, appear in 
Table 2.7. 
 
Table 2.6    Data used in Probabilistic Sensitivity Analyses 
PE  Valueb 
 
Outcome  Value OV a Risk Condition 
 Strategic Tooth Non-Strategic Tooth. 
DRF score   MRRF score 
Decision 
Alternative Outcome
a 
2.5 
% 
50 
% 
97.5
% 
2.5 
% 
50 
% 
97.5 
% 
2.5 
% 
50 
% 
97.5 
% 
Pos. 0.65 0.80 0.90 0.19 0.29 0.42 0.19 0.29 0.42    Extract 
   Treat Pos. 0.10 0.19 0.34 0.60 0.70 0.79 0.40 0.50 0.60 
Pos. 0.74 0.91 0.97 0.19 0.29 0.42 0.19 0.29 0.42 
      
 
    High 
     High 
 
     Medium    Extract 
   Treat Pos. 0.39 0.50 0.60 0.60 0.70 0.79 0.39 0.50 0.60 
Pos. 0.65 0.80 0.90 0.19 0.29 0.42 0.19 0.29 0.42    Extract 
   Treat Pos. 0.49 0.60 0.69 0.70 0.80 0.87 0.39 0.50 0.60 
Pos. 0.80 0.90 0.96 0.19 0.29 0.42 0.19 0.29 0.42 
     Medium 
      
     High 
 
     Medium 
   Extract 
   Treat Pos. 0.60 0.75 0.86 0.80 0.90 0.95 0.50 0.60 0.69 
 
ST, Tooth in question is a strategic tooth; N-ST, tooth in question is a nonstrategic tooth; Pos, positive; Neg, negative. 
a Negative outcome conditions need not be described inasmuch as their probability distributions are complementary to 
the distributions of the positive outcomes (sum of the PE values of Pos and Neg is 1) and the OV of Neg. are zero by 
default. 
b Distributions of PEs and OVs are assumed to be logistic-normal distributions, determined by their means and  upper or 
lower limits of  their 95% confidence ranges.47 After multiple simulations (n =10.000) in which each PE and OV is 
randomly assigned a value taken from its distribution (the shaded columns), the following is calculated: mean and 
standard deviation of EV, frequency with which each decision alternative is best, and the 95% confidence intervals of 
these frequencies. These data appear in Table 2.7. 
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Table 2.7   Results of  probabilistic sensitivity analyses with second-order Monte Carlo       
simulations (n= 10.000 ) a 
 DECISION ALTERNATIVE  
Decision node 
 
ST Extract ST Treat N-ST Extract N-ST Treat 
Mean EV b 0.24 0.14 0.24 0.10 
SD of EV 0.05 0.04 0.05 0.03 
Frequency “Best” c 94% 6 % 98% 2 %  
DRF High / MRRF High 
95% Confidence Interval d 93.5-94.5% 5.5-6.6% 97.7-98.3% 1.7-2.3% 
Mean EV 0.27 0.35 0.27 0.25 
SD of EV 0.05 0.04 0.05 0.03 
Frequency “Best” 12 % 88% 61% 39% 
DRF High / MRRF Med 
95% Confidence Interval 11.4-12.6% 87.4-88.6% 60.1-61.9% 38.1-39.9% 
Mean EV 0.24 0.48 0.24 0.30 
SD of EV 0.05 0.06 0.05 0.04 
Frequency “Best” 1% 99% 17% 83% 
DRF Med /MRRF High 
95% Confidence Interval 0.8-1.2% 98.8-99.2% 16.3-17.7% 82.3-83.7% 
Mean EV 0.27 0.67 0.27 0.44 
SD of EV 0.05 0.07 0.05 0.06 
Frequency “Best” 1 % 99 % 2% 98% 
DRF Med / MRRF Med 
95% Confidence Interval 0.8-1.2% 98.8-99.2% 1.7-2.3% 97.7-98.3% 
 
SD, Standard Deviation. 
a In each simulation a PE and OV are randomly assigned a value taken from their distribution (see Table 2.6). The 
following is calculated (these headings appear in column 2): mean EV, SD of EV, frequency with which each 
decision alternative is “best” (calculated using the "folding back and averaging out" as explained in text), and the 
95% confidence intervals.47 The results appear in  rows to the right of entries in column 2. Simulations (n=10.000) 
were performed for both conditions:  if tooth in question is strategic (ST) and non-strategic (N-ST).  In total 2 x 
10.000 = 20.000 calculations were made for each of the four risk conditions. 
b Mean Expected Values (EV) correspond with the baseline EVs (Table 2.5) 
c Frequencies of “Best “ Decision Alternatives are binomially distributed. 
d Using standard techniques for normal approximation to the binomial distribution, the 95 % confidence interval is 
approximately as follows:   p  ± 1.96 x (p x 1-p/n) where p= frequency of "Best" and n= number of simulations 
(n=100 by default). 
 
 
Discussion 
 
We used clinical decision analysis to design a MDDS in patients with head and neck 
cancer in order to solve decision dilemmas associated with pretherapy dental screening. 
Current management guidelines address only gross dental pathology, are formulated in 
rather broad terms, do not fully consider malignancy-related risk factors, and do not 
analyze the tradeoffs between the benefits and drawbacks of pretherapy dental 
interventions. 
The MDDS presented here uses a decision tree to separate the decision dilemma into 
three components: DRFs, MRRFs, and OVs.  The components differ with respect to their 
"dimension" or the "domain" to which each belongs. The DRFs are of primary interest 
and are tooth-related. They are described in terms of clinical criteria and can be 
eliminated by dental intervention. The MRRFs, however, are disease-related and cannot 
be influenced through pretherapy dental management.  The Outcome Values (OVs) 
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belong to the domain of oral functioning(57) and have a strong impact on the quality of 
life.(62) We have differentiated between strategic and nonstrategic teeth because of the 
implications for oral function. 
The decision-analytic approach is qualitative because it uses precisely defined 
clinical criteria instead of broadly described dental pathologic conditions. The oral 
outcomes of the dental intervention are incorporated into the model. In addition, the 
approach is also quantitative: the clinical criteria and conditions are transformed into PEs 
and OVs. The calculation process called  "folding back and averaging out" enables 
identification of the optimal option for dental intervention. 
The model identifies four different pretherapy risk conditions, represented by the 
four decision nodes in Fig 2.2.  Table 2.5 summarizes all decision results of the MDDS. 
The MDDS gives clear answers to the decision problem in three of the four risk 
conditions. Only when the DRF score is high, the MRRF score is medium, and the tooth 
in question is nonstrategic  does the MDDS fail to indicate the "optimal"  pretherapy 
action. ("If N-ST: extract ≈ treat," in the column labeled Choose in Table 2.5).  Under 
this risk condition the "optimal" decision apparently depends more strongly on 
complementary decision factors such as clinical possibilities and costs, timing of the 
dental intervention, and follow-up period necessary to evaluate clinical success or 
failure. However, if under this risk condition (DRF high/MRRF medium) the tooth in 
question is strategic, dental treatment is the optimal option. Here the effectiveness of the 
MDDS in analyzing the tradeoffs between the benefits and drawbacks of the dental 
intervention is evident.  In this case the benefit of maintaining of oral function by 
retaining a strategic tooth (through dental treatment) weighs more heavily than does the 
benefit of preventing of oral complications when extracting the tooth; it is thus 
worthwhile to take the risk. It should be emphasized that retaining strategic teeth in order 
to maintain or to improve oral function is extremely important for these patients because 
of the significant consequences for the quality of life.(1,8,57,63-65) 
As explained earlier, instead of objective data, PEs and estimated OVs were used in 
this model for dental decision-making, and it is therefore called a base-case analysis. 
According to Weinstein and Fineberg,(58) this does not prevent the model from producing 
pragmatic conclusions. They point out that clinical decisions must after all be made. 
Without clinical decision analysis, a clinician also uses subjective judgments of 
uncertain events. These judgments are not always "structured" in great detail and are not 
easily incorporated into the intuitive process of mental decision-making.(58,66) Using 
clinical decision analysis permits a more logical approach. It divides the decision-
making process into manageable components. Most important, the approach is 
quantitative,(46,58,67) and is intended to aid clinicians in deciding what they should do 
under a given set of circumstances. In addition, it allows sensitivity analyses to be 
carried out. All this will result in decisions that are more consistent with the underlying 
uncertainties and outcome values. Moreover, clinical decision-making will also reveal 
those areas in which further clinical research would be most valuable.(58) However, an 
important limitation of using a "base-case analysis" comes from the built-in judgment 
biases(68) and the instability over time of the estimations through changing circumstances 
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--e.g. changes in cancer therapy and patient compliance(3) and changes in prognosis of 
disease control.   
For the purpose of a priori testing of the model, we preformed probabilistic 
sensitivity analyses. We used second order Monte Carlo simulations(47) with 95% 
confidence intervals. As explained earlier, we used estimations based on the literature 
and our clinical experience to assign values to probabilities and outcomes. It must be 
pointed out here that instead of absolute values we used hierarchical rankings. For 
example, a sound tooth has a higher OV than an endodontically treated tooth, and a tooth 
extraction (ie, an edentulous site) is better than a strong chance of osteoradionecrosis. 
Given a high MMRF, the probability of a negative outcome is greater when retaining a 
tooth with a high DRF than when such a tooth is extracted. The probabilistic sensitivity 
analysis was performed to allow exploration of the dependence of the optimal decisions 
on the change of the apparent rankings.  
The results of the probabilistic sensitivity analysis indicate that, in general the 
conclusions of the model are robust. The frequencies and confidence intervals for the  
"optimal" interventions are summarized in Table 2.7. It should be emphasized that the 
robustness applies particularly to the structure or "internal logic" and "coherence"(66) of 
the model as well as to the ranking or "interrelation" of the baseline data.  The robustness 
is somewhat lower in three risk conditions: (1) DRF high /MRRF medium for strategic 
teeth, and (2) DRF high /MRRF medium for nonstrategic teeth, and (3) DRF 
medium/MRRF high for nonstrategic teeth. In these cases there remains some 
uncertainty as to what the optimal decisions are. We have already discussed the 
importance of the modifying decision factors when DRF is high, MRRF medium, and 
teeth are non-strategic (i.e. situation 2). In the remaining two risk conditions--(1) DRF 
high/MRRF medium for strategic teeth, and (3) DRF medium/MRRF high for  non-
strategic teeth-- the probabilistic sensitivity analyses reveal that the MDDS will result in 
the opposite option for dental intervention in approximately 10% to 20% of all 
simulations. It appears that the subjective estimates used in these areas should be 
assessed more exactly. It is clear that clinical research in these areas is most useful.  
Our overall conclusion is that the MDDS is a useful tool for the development and 
analysis of clinical guidelines. Building the model has helped us to gain more 
understanding of the decision dilemmas involved, and using the concept of EV decision-
making has given us more insight into how risks and outcomes of dental intervention 
affect the process of clinical decision-making.  We believe that the MDDS has great 
potential to assist clinicians in dealing with pretherapy dental decisions in patients with 
head and neck cancer. However, we would strongly emphasize that the principal role of 
the clinician in choosing the optimal strategy for dental intervention is of paramount 
importance.  
Evaluation of the clinical effectiveness of the model as an aid for clinicians should 
be carried out with scientific rigor before assimilation into clinical practice can take 
place. Clinical testing of the model should result in objective data that will make an a 
posteriori validation possible. A representation of the MDDS in the format of a 2X2 
contingency table (Table 2.8) permits the comparison and analysis of clinical data from 
retrospective or prospective clinical studies in this area. This format is especially useful 
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if a Chi-Square statistical evaluation of the relationship between the DRFs and MRRFs is 
to be carried out. 
 
 
 
 
 
 
 
 
 
 
 
 
a Best decision depends on modifying decision factors: consistency of plan, time required for 
evaluation of dental treatment, patient's preferences, costs, etc. 
 
 At present we are conducting an international, multi-center clinical study in order to 
further validate the MDDS. In addition, the validity of the clinical and dental criteria and 
of the Malignancy Related and Dental Risk Factors Scores is being tested using "clinical 
judgment analysis" of the opinions of clinicians.(66) For that purpose an international 
consensus project has been set up at a number of locations in the United States of 
America, Australia, and Europe.  
 
 
We thank Dr. Joop A.J. Faber of the Utrecht University Biostatistic Department, and Elizabeth 
Krijgsman-Roueche, language editor, for advice and assistance in the preparation of the manuscript.  
 
Table 2.8  Results of the Dental Decision Making model displayed as a 2X2 
contingency table 
DRF High                            DRF Medium 
MRRF Strategic Non-Strategic Strategic Non-Strategic 
High Extract Extract  Dental treatment Dental treatment 
Medium Dental treatment Extract ≈ Dental treatment a  Dental treatment Dental treatment 
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Abstract 
 
Objective  
The first objective of this international survey was to study how dental- and 
radiotherapy-related risk factors influence clinicians' preradiation dental decision- 
making in patients with head and neck cancer, and to evaluate clinicians’ degree of 
certainty in making such decisions. A further objective was to examine the correlation of 
clinicians' policies with the policy based on a model for dental decision support 
(MDDS), presented in an earlier article. 
 
Study design  
A consensus questionnaire was mailed to 54 oral-maxillofacial surgeons and 
hospital-based dentists at a number of international locations. The responses were 
aggregated and anonymously analyzed through use of a multiple regression procedure.  
 
Results 
Forty-four clinicians returned the questionnaire (response rate of 81%). Nine 
clinicians (20%) were using printed clinical guidelines for preradiation dental screening. 
Eighty-eight percent of clinicians’ preradiation decisions and 49% of their certainty 
could be explained  by  the studied  risk factors.  Not all risk factors were significant at   
p < 0.001. Clinicians’ policies showed high correlation (0.85) with the policy based on 
the model for dental decision support.    
 
Conclusions   
The findings support our previous assumption that policies in this field seem to be 
primarily based on clinical experience and opinions rather than on evidence-based 
clinical guidelines. We conclude that the clinical usefulness and validity of the model for 
dental decision support should now be tested and that it could also serve as a training 
tool.  
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Introduction 
 
Preradiation dental decision making in head and neck cancer patients for the purpose 
of identifying and eliminating risk factors for the oral complications of cancer therapies 
is often challenging.(1) In our view, current management guidelines(2-4) address only gross 
dental pathoses, are formulated in rather broad terms, and do not fully assess the trade-
offs between the benefits and drawbacks of preradiation dental extractions.  
To contribute to the development of guidelines for preradiation dental screening, we 
proposed a model for dental decision support (MDDS) in this field.(1)  The MDDS was 
designed to help solve decision dilemmas and to develop evidence-based clinical 
guidelines for preradiation dental screening. Its robustness and coherence(5) were a-priori 
tested, using the method of probabilistic sensitivity analysis.(6) Our overall conclusion 
was that the proposed MDDS is useful as a tool for the development and analysis of 
clinical guidelines.  
In order to further validate the MDDS we set up an international survey to analyze 
the policies of clinicians. The first objective of the survey was to study how variations in 
dental- and radiotherapy-related risk factors influence clinicians’ preradiation dental 
decision-making. More specifically, is a decision for preradiation dental extraction 
affected by:  
(1) the dental condition of teeth (moderate versus gross dental pathosis)  and/or 
(2) the functionality of a tooth (strategic versus nonstrategic) and/or 
(3) the location of teeth (upper versus lower jaw)  and/or 
(4) the radiation dose on the teeth (40 - 55 Gray vs > 55 Gray) ? 
 Do these 4 risk conditions influence the degree of certainty the clinician has in the 
decision? The second objective of the survey was to examine the matching of the 
policies of the clinicians with the policy based on the proposed MDDS. A correlation 
analysis was used to accomplish this second objective. 
 
 
Material and methods 
 
A judgment analysis questionnaire was mailed to 54 oral-maxillofacial surgeons and 
hospital-based dentists at a number of locations in North America, Australia, and 
Europe. Their names and addresses were obtained by contacting the secretaries of their 
professional organizations. The secretaries were asked to select those clinicians who 
were expected to be familiar with(7) and experienced in the domain of preradiation dental 
decision making. 
The questionnaire was constructed, using specific design considerations described by 
Cooksey,(5) from 48 simulated paper cases in a fractional factorial design.(8,9)  This type of 
design  allows the comparison of a number of (risk) conditions or factors.  It should be 
noted that not all relevant decision factors, such as patient’s previous dental performance 
or timing considerations, could be included in the questionnaire. The importance of these 
factors has been discussed previously.(1) The questionnaire addresses those cases in 
which decision making was expected to be critical. Cases in which past dental 
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performance and possibilities for dental care are minimal, for example, usually lead to 
partial or full mouth clearance, as previously explained.(1)  These "obvious cases" were 
left out in order to improve the responsiveness of the questionnaire.(10;11)  Six replicated 
cases were included to permit analysis of the reliability of the responses, using 
Cronbach’s alpha.  
The clinicians were informed of the objectives of the survey and assured of its 
confidentiality and anonymity. They were queried concerning their professional 
qualifications and clinical posts, and asked whether they were involved in the 
preradiation dental screening of patients with head and neck cancer. In addition, the 
clinicians were asked to estimate the average number of new patients with head and neck 
cancer per year in their hospital or institute and to return printed guidelines for 
preradiation dental screening if any were available. They were also invited to make 
written comments on the questionnaire.  
The paper cases were presented to the clinicians in the format of verbal categories 
derived from the aforementioned MDDS, which had not yet been published. Fig 3.1 
displays edited examples of the questionnaire format. Clinicians were asked to choose 
the optimal option for dental intervention.  In addition, they were instructed to express 
the degree of certainty in the appropriateness of their decision on a visual analogue scale 
(from a 100% gamble to 100 % certainty). The paper cases were presented in a particular 
order to avoid response bias --e.g. clinicians’ tendency to repeat the same score 
patterns.(12)  
 
Dental conditions Radiotherapy conditions Pre-therapy dental intervention 
Strategic tooth                Non-strategic tooth 
Example of judgment case 
Periodontal pocket 10 mm 
Furcation involvement 
Tooth in lower jaw 
 
Radiation dose > 55 Gray 
Field includes lower jaw 
 
tooth extraction   
dental treatment 
    or no-action 
 
tooth extraction   
dental treatment 
    or no-action 
 
Instructions: 
Please choose ‘optimal’ option for dental intervention 
How certain are you of your choice? 
Please mark Visual Analogue Scale 
 
 
 
100% gamble                                  100% certain 
Case 1 
Periodontal pocket 6-7 mm 
Furcation involvement 
Tooth in lower jaw 
 
Radiation dose > 55 Gray 
Field includes lower jaw 
 
tooth extraction   
dental treatment 
    or no-action 
 
tooth extraction   
dental treatment 
    or no-action 
   
 
100% gamble                                    100% certain 
 
Case 2 
Periodontal pocket 6-7 mm 
Furcation involvement 
Tooth in upper jaw 
 
 
Radiation dose > 55 Gray 
Field includes upper jaw 
 
 
tooth extraction   
dental treatment 
    or no-action 
 
 
tooth extraction   
dental treatment 
    or no-action 
   
 
100% gamble                                    100% certain 
Figure 3.1  Questionnaire format (sample).  
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We first analyzed the questionnaire through use of descriptive statistics. No attempt 
was made to compare the results originating from each international location. 
Responding clinicians were treated as a single group. The first analysis resulted in the 
aggregated totals for extraction versus treatment and no-action of each paper case and 
the mean rates and SDs of clinicians’ certainty in making the decisions. The categorical 
independent variables (IV’s), summarized in the first column of Tables 3.1 and 3.2, were 
transformed into discrete dummy variables through use of a dummy-coding scheme.(13)  
A standard multiple regression procedure was then used to analyze the relationships 
between the dependent variables and the independent variables, a process that resulted in 
two regression models.  The unstandardized regression coefficients were transformed to 
relative regression coefficients, which are an indication of the relative importance of the 
independent variables.(5,14) The underlying assumptions of both the multiple regression 
models were tested using normal probability plots and "residual-predicted" 
scatterplots.(5,14,15) 
A personal computer and a software package for statistical analysis (SPPS 8.0 with 
Advanced Statistic option, SPSS Inc, Chicago, Ill) were used for the analyses. 
 
 
 
 
Table 3.1 Parameters of standard multiple regression analysis: 
dependent variable = EXTR    
 
 
Independent Variable 
 
Regression 
coefficient 
Relative 
regression 
coefficient 
 Significance 
 level P.  
less than .… 
Constant  -22.698 21 % .001   
DP  21.774 20 % .001 
DE  23.019 21 % .001 
DI  20.598 19 % .001 
RTX   9.211 10 % .001 
JAW  3.632 3 % .100 
STRAT  -6.361 6 % .005 
 
R = .935 (p <.001),  R Squared = .874;  
EXTR, extraction decision; DP, periodontal condition; DE, endodontic condition;  
DI, impacted teeth; RTX, radiation dose; JAW, location of tooth;  
STRAT, functionality of tooth. 
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Table 3.2   Parameters of standard multiple regression analysis:  
dependent variable = CERTAIN    
 
 
Independent Variable 
 
Regression 
coefficient 
Relative 
regression 
coefficient 
 Significance 
 level P. 
 less than .… 
Constant  80.953 88 % .001   
DP  1.038 2 % .909 
DE  -.614 0 % .659 
DI  -2.067 3 % .226 
RTX  4.022 4 % .001 
JAW  .282 0 % .836 
STRAT  -2.762 3 % .041 
                  
                  R = .694 (p <.001),  R Squared = .482; 
CERTAIN, Clinicians' level of certainty.  
(For other abbreviations, see footnote to Table 3.1) 
 
 
Results 
 
Forty-four clinicians returned the questionnaire and provided usable data for 
analysis. This is a response rate of 81%. All participants, oral-maxillofacial surgeons    
(n = 21; 48%) or hospital-based dentists (n = 23; 52%); all stated that they were familiar 
with and experienced in preradiation dental screening of patients with head and neck 
cancer. In all, the clinicians represent in total 30 general or specialized hospitals or 
cancer institutions. The total estimated number of new patients with head and neck 
cancer per year for all institutions was 6,500.  The median number of new patients per 
hospital or institute was 100 patients (range, 15 - 900). 
Nine clinicians (20%), representing 3 hospitals/institutions (one in North America 
and the other two in Europe) reported that they were using printed clinical guidelines for 
preradiation dental screening.  Comments written on the questionnaires revealed that 
clinicians find judgment and decision making with respect to paper cases to be rather 
constraining. Some clinicians pointed out that lack of comprehensive clinical 
information affected their judgment performance, leading to less certainty in the 
decisions.  However, this did not prevent a number of these participants from making 
very supportive comments on the project. Some clinicians emphasized that their 
decision-making in clinical practice was largely influenced by patients' previous dental 
performance and by socio-economic considerations. They regretted that these factors 
were not included in the questionnaire.  
Descriptive statistics produced frequencies of dental extraction decisions over the 
paper cases and mean rates of clinicians’ certainty.  A summary of these results appears 
in Tables 3.3 and 3.4. The reliability index based on Cronbach's alpha was .81.  The 
multiple regression analyses produced 2 models that included all independent variables. 
Inspection of the normal probability plots and "residual/predicted" scatterplots revealed 
no major violations of the regression assumptions. Tables 3.1 and 3.2 display the 
                                                                                                                                        CHAPTER 3 
45 
unstandardized regression coefficients, and constants, the relative regression coefficients, 
and the R and R2 for each regression model.  The regression coefficient of the extraction 
decision (EXTR) and the clinicians' level of certainty (CERTAIN) were R = .94 and R = 
.69, respectively; both differed significantly from zero (P < .001). With the exception of 
the independent variable location of tooth (JAW), all independent variables contributed 
significantly to the explanation of EXTR. CERTAIN could be significantly explained 
only by the independent variable radiation dose (RTX), with P < .001. The contribution 
of the other independent variables was not significant at a .001 probability level. (see 
Table 3.2). In all, on the basis of the values of R2, 88% of clinicians' preradiation 
decisions and 49% of their certainty could be explained by variations in dental-related 
and radiotherapy-related risk factors.  
The extent to which the policies of the clinicians correlate with the MDDS-based 
policy is high. A correlation coefficient of 0.85 was found.  
 
 
Table 3.3 Frequencies of preradiation dental extractions versus treatment/no-action and mean 
clinicians’ certainty 
Pre-radiation Dental Intervention  
 
Dental Condition,  
tooth in radiation field 
 
 
Radiation 
dose 
 
Radiation 
field 
includes 
… 
Extraction/ 
no-treatment 
totals1 
Mean 
certainty 
(%) 
 
SD 
(%) 
Fully impacted tooth (e.g. third molar) without 
follicle enlargement and fully covered by bone 
>55 Gy Lower 
jaw 
11/32 81 20 
Fully impacted tooth (e.g. third molar) with 
follicle enlargement and not fully covered by 
bone 
>55 Gy Lower 
jaw 
35/9 84 24 
Fully impacted tooth (e.g. third molar) with 
follicle enlargement and not fully covered by 
bone 
40 - 55 Gy Lower 
jaw 
 
31/13 82 24 
Incompletely erupted tooth (e.g. third molar) >55 Gy Lower 
jaw 
42/2 90 19 
 
1 Options for dental intervention include: extraction, (surgical) removal of tooth, no-treatment, tooth is left in situ. 
2 Mean of clinicians’ certainty of the appropriateness of their decision, measured on a visual analogue scale: 0% 
certain = 100% gamble, 100% certain = 0% gamble. 
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1 Options for dental intervention include: extraction (surgical) removal of tooth; treatment: dental treatment (including e.g. surgical 
endodontics).  
2 Mean  of clinicians’ certainty in the appropriateness of their decision, measured on a visual analogue scale, 0% certain = 100% 
gamble; 100% certain = 0% gamble. 
3 No dental treatment other than prophylaxes is required in this particular case. 
4 Rarefying osteitis: radiolucent periapical bone destruction communicating with the periodontal ligament space via a discontinuity in 
the lamina dura. 
5 Condensing osteitis: hypersclerotic trabeculi in the bone adjacent to the periapical region and communicating with the periodontal 
ligament space and having a distinct border. 
6 Restorations are defective if any of the following conditions are present: marginal discrepancies > 0.5 mm, part of the restoration 
missing, bulk fracture, or marginal staining of composites suggesting leakage.  
 
 
Table 3.4  Frequencies  of  preradiation dental extractions versus treatment and means of clinicians' 
certainty 
 Preradiation dental intervention 
 Strategic tooth Non-strategic tooth 
 
Dental condition of tooth in 
radiation field 
 
Radiation 
dose 
Radiation 
field 
includes .. 
Extraction/ 
treatment 
totals1 
Mean 
certainty2 
(%) 
 
SD 
(%) 
Extraction/ 
treatment 
totals 
Mean 
certainty 
(%) 
 
SD 
(%) 
No periodontal pocket,  
sulcus depth: 1-3 mm.3 
>55 Gy Lower jaw 0/ 44 93 15 0/ 44 95 9 
Periodontal pocket 3-5 mm 
bleeding upon probing 
> 55Gy 
 
Lower jaw 6/ 38 85 17 8/ 36 89 14 
Periodontal pocket 6-7 mm, 
furcation involvement 
>55 Gy Upper jaw 
Lower jaw 
31/ 13 
44/ 0 
84 
90 
25 
21 
40/ 4 
44/ 0 
94 
95 
13 
13 
Periodontal pocket 6-7 mm, 
furcation involvement 
40-55 Gy Lower jaw  
 
33/ 11 81 23 38/ 6 90 14 
Periodontal pocket 3-5 mm, 
bleeding upon probing, poor 
overall dental health 
None 
 
Either jaw 1/ 43 83 21 7/ 37 81 22 
Periodontal pocket 6-7 mm, 
furcation involvement, 
poor overall dental health 
None Either jaw  
 
14/ 30 81 20 26/ 18 80 16 
Periodontal pocket 6-7 mm, 
furcation involvement, 
tooth adjacent to radiating 
implants 
Interstitial  
 
Lower jaw 39/ 5 88 15 41/ 3 92 11 
Rarefying osteitis 4  
O < 3mm)  
no root canal filling,  
percussion pain  
>55 Gy Upper jaw 
Lower jaw 
12/ 32 
20/ 24 
85 
84 
17 
19 
23/ 21 
31/ 13 
81 
85 
24 
19 
Rarefying osteitis  
(O > 3mm)  
inadequate root canal 
filling5, percussion pain 
>55 Gy Upper jaw 
Lower jaw 
 
30/ 14 
40/ 4 
86 
86 
19 
23 
41/ 3 
42/ 2 
91 
95 
16 
10 
Rarefying osteitis  
(O > 3mm)  
no root canal filling,  
abnormal response to pulp 
sensitivity tests  
>55 Gy 
 
Lower jaw 26/ 18   
 
82 21 34/ 10   88 17 
Condensing osteitis5, no 
root canal filling, abnormal 
response to pulp sensitivity 
tests 
>55 Gy 
 
Lower jaw 19/ 25   82 18 28/ 16   86 16 
Defective restoration6 with 
secondary caries, no pulpal 
involvement 
>55 Gy Lower jaw 
 
2/ 42   89 14 9/ 35   90 16 
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Discussion 
 
This international survey, using a judgment analysis questionnaire, showed not only 
great similarities in the preradiation dental extraction policies of 44 clinicians but also a 
high correlation with the MDDS. In addition, the clinicians had a rather high overall 
degree of certainty (mean, 86.3 %, SD, 18.6%) in the appropriateness of their decisions, 
which was significantly correlated only with the radiation dose on teeth.  
As cues for clinicians' extraction decisions, dental conditions (independent variables: 
periodontal condition, endodontic conditions, and impacted teeth) which altogether had a 
relative importance of 62% (Table 3.1), were far more important than RTX, which had a 
relative importance of 10%, and tooth functionality, which had a relative importance of 
6%. The similarity in clinicians' policies is lower in the case of moderate dental pathosis 
(e.g. teeth with periodontal pockets of 3-5 mm and bleeding upon probing), condensing 
osteitis, or fully impacted third molars in the lower jaw  (Tables 3.3, and 3.4, Fig 3.2). 
Tooth location (upper versus lower jaw) did not significantly contribute to the decision-
making.  
This survey thus shows that given optimal conditions such as favorable past dental 
performance and possibilities for dental care, clinicians' pretherapy dental decision 
making is mainly influenced by dental conditions. Yet clinicians' degree of certainty in 
the appropriateness of their decisions is significantly influenced only by the radiation 
dose on teeth and not by dental conditions or tooth functionality. All this could support 
our previous assumption(1) that clinical policies in this field seem to be based primarily 
on clinical experience and opinions and not on evidence-based clinical guidelines. This 
conclusion is strengthened by our discovery of the limited use of printed guidelines.  
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Figure 3.2.  Mean levels of clinicians' consensus for all 3 dental risk 
conditions (vertical lines represent SDs). Consensus was calculated 
by dividing majority of clinicians of each paper case by total number 
of clinicians (n = 44). 1.00, 100% consensus; 0.50, no consensus (i.e.  
50% of clinicians favored one type of intervention and 50% favored 
the other type). 
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Because the responding clinicians are involved in the multidisciplinary care of 
nearly 6,500 new head and neck cancer patients per year, we believe that the results of 
this survey are not only important for further validation of the MDDS, but are also 
noteworthy for clinical practice.  
As a factor that influenced clinicians' extraction decisions, periodontal condition had 
a relative importance of 20%. All clinicians agreed on preradiation extraction of strategic 
and non-strategic teeth in the lower jaw with periodontal pocket depth of 6 mm and more 
and with root furcation involvement if they were within the planned radiation field of 
more than 55 Gy. This consensus corresponds with current management guidelines.(2-4) 
When non-strategic teeth with advanced periodontal disease were located in the upper 
jaw within a planned radiation field of more than 55 Gray, 40 clinicians (91%) judged 
that extraction was the optimal strategy; 31 clinicians (70 %)  would  extract strategic 
teeth under these conditions. In comparison with the lower jaw  (with respect to which 
100 % of the respondents favor the extraction of strategic and non-strategic teeth) the 
upper jaw is obviously associated with less concern among a minority of clinicians that 
teeth with severe periodontal disease in the upper jaw may cause serious oral 
complications such as osteoradionecrosis (ORN), either directly or following post-
radiation extraction. From the periodontal epidemiologic and management points of 
view, teeth in the upper jaw with pockets larger than 6 mm and with furcation 
involvement are not of less concern than teeth in the lower jaw.(16-19)  Periodontal care of 
such advanced conditions is time-consuming and requires optimal patient compliance.(20-
24) Many epidemiological surveys have demonstrated that severe periodontitis exists in a 
very small proportion of the population and that patients in the lower socio-economic 
and educational groups are at significantly greater risk for severe periodontitis.(25) A 
substantial proportion of patients with head and neck cancer belong to these risk 
groups.(26;27) Inasmuch as non-compliance and low interest in oral health are frequently 
encountered in patients with head and neck cancer,(28-31) the MDDS complies with the 
view of most clinicians and advises pre-therapy extraction of  teeth with advanced 
periodontitis, if they are within a planned radiation field over 55 Gy, regardless of 
whether they are in upper or lower jaw.  
Before a radiation dose of over 55 Gy is received, should nonvital teeth exhibiting 
rarefying osteitis and percussion pain be extracted or endodontically treated, surgical 
endodontics included? (The question assumes that practical and economic considerations 
allow such a choice).  Almost three fourths of the clinicians (73 %) were in favor of 
endodontic treatment of strategic teeth in the upper jaw if the periapical lesion was less 
than 3 mm in diameter. If a strategic tooth with such an endodontic condition was 
located in the lower jaw, the percentage dropped to 54%. If the lesion exceeded 3 mm in 
diameter, 41 % of the respondents were in favor of endodontic treatment of a strategic 
tooth in the lower jaw, whereas if the tooth had in addition an inadequate root canal 
filling, a vast majority --91%-- was in favor of extraction. Thus, the decisions were 
influenced by the diameter of the periapical lesion and by whether endodontic treatment 
was a primary treatment or involved retreatment. Clinicians' policies in this area coincide 
with current approaches for endodontic therapy(32;33)  in which success rates between  
70% and 95%  have been reported.(33-35) Whether these success rates can also be achieved 
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in cases in which an endodontically treated tooth will subsequently receive radiation 
could not be deduced with confidence from the literature. According to Kielbassa et 
al.,(36) several studies have shown that success for endodontic treatments carried out after 
radiation is not severely impaired by previous radiation therapy; prospective clinical 
surveys providing evidence-based information would be very helpful in determining 
whether this is also true for endodontic (re)treatments, endodontic surgery included, 
carried out before radiation therapy. 
Tooth functionality had a relative importance of only 6% in clinicians' extraction 
decisions. Maintaining of oral function by retaining strategic teeth was apparently less 
important than minimizing the risk of oral complications by extracting strategic teeth. 
The MDDS is based on the principle that optimal patient care also depends on thoughtful 
analysis of the tradeoffs between the benefits and the drawbacks of clinical actions.(37-40) 
The model shows that, in selected cases and under certain risk conditions, it is 
worthwhile with regard to better patient outcomes to accept some degree of  risk of an 
adverse outcome.(1) However, abundant evidence from judgment analysis studies 
suggests that the aversion to "risky choices" does not depend only on the mathematic 
weighting of probabilities and outcome values, on which method the MDDS is mainly 
based; decision-makers also use "clinical wisdom" and a number of simplifying 
operations called heuristics, which can lead to biases in judgments and decisions.(41) 
Nonetheless, we believe that opinion-based and experience-based decision-making is an 
essential part of the clinical thought process and that the clinician's role in reaching the 
optimal decision is of paramount importance.(1) In our survey, this is confirmed by the 
high correlation found between the policies of the responding clinicians and the MDDS. 
This finding might impair the supplementary usefulness of evidence-based decision- 
making in clinical practice. Some opponents of an evidence-based approach state that 
certain clinical decisions are made for practical and economic reasons, not because of 
evidence-based ideals. According to Muir Gray,(42) however, an evidence-based 
approach initiates strategies to increase the good-to-harm ratio of therapies and promotes 
innovations in clinical practice, resulting in an increase of the effectiveness of health 
care. 
Some caution must be taken in generalizing the outcomes of this survey. Again, 
some judgment analysis studies using paper cases have demonstrated limitations on how 
well judgment analysis can model real-life clinical settings. According to Wigton,(43) the 
simulated cases contain only a fraction of the variables presented in a real-life clinical 
setting. Furthermore, factorial designs as used in this survey present the variables in the 
simulated cases as categoric, whereas in the clinical setting they are mostly continuous; 
as a consequence, judgments could be biased. However, according to Kirwan et al.(44;45) 
and Rovner et al.,(46) judgments made using paper cases have been shown to agree 
closely with judgments made on real patients. It is therefore reasonable to assume that 
paper policies can accurately model actual clinical practice policies. (It should be 
remembered that this survey addressed "ideal" cases without considering real-life 
economic and practical constraints.) 
Results of our international survey indicate that the responding clinicians and the 
MDDS are both less certain under moderate dental risk conditions where in addition 
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other decisional considerations are significant. We expect that further development of 
the MDDS could give more insight into this particular area of judgment and decision-
making, in which the clinical effectiveness of the accepted guidelines could perhaps be 
improved. In addition, the MDDS could be further developed as a training tool for 
inexperienced residents. We have modified the MDDS and are currently conducting a 
multicenter cohort study in order to test whether the concept is valid and workable in a 
clinical setting and could be useful as a training tool.   
 
 
We thank Elizabeth Krijgsman-Roueche for advice and assistance in the preparation of the 
manuscript. 
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Abstract 
 
In most clinical judgment analyses, the statistical process of multiple regression 
analysis is used to model judgment processes. However, this technique based on linear 
models is susceptible to a variety of difficulties and makes stringent and sometimes 
unrealistic assumptions about the structure of the data. The authors present JANNET 
(Judgment Analysis via Neural NETwork), which may be used when the assumptions 
underlying multiple regression analysis are not met. To illustrate this alternative 
approach, it was applied in order to gain insight into how a number of dental clinicians 
weight certain dental and radiotherapy conditions as important indications for 
prophylactic extraction of teeth in patients with head and neck cancer. The JANNET 
approach made it possible to recognize probabilistic "patterns" in "nonlinear" judgment 
policies and subsequently to group clinicians with related policies together. The authors 
conclude that this neural network approach to judgment analysis is promising and should 
be further tested and applied. 
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Introduction 
 
Judgment and decision-making are both cardinal elements of the clinical process.  
Clinical judgment is based on the weighting and combining of information so as to arrive 
at conclusions that can serve as a basis for clinical decision-making. The latter process 
involves selecting courses of clinical action in order to achieve optimum outcomes. 
Whereas the paradigm of clinical decision analysis and its underlying "expected utility 
theory" have become something of a growth industry(1) and have reached a "normative 
status," (2) clinical judgment analysis (CJA) has received far less attention in biomedical 
research.  A review by Wigton(3) summarized 24 reports on specific applications of 
clinical judgment analysis to biomedical problems. These reports appeared in 14 
different biomedical journal titles from 1964 through 1988. In the past decade, however, 
there has been little evidence of the application of clinical judgment analysis in the 
biomedical domain becoming more widespread. 
We first summarize some merits of the research on clinical judgment. After briefly 
reviewing the advantages of bringing judgment analysis into a constructive relationship 
with clinical decision analysis, we recall the assumptions underlying multiple regression 
techniques, which are typically used for this kind of research. We then propose a new 
approach, JANNET (Judgment Analysis via Neural NETwork), which may be used 
when the assumptions underlying multiple regression analysis are not met. 
There are reasons to believe that analysis of clinician judgments is important in order 
to enhance clinical decision-making. First, decision-makers often use "clinical wisdom" 
and a number of simplifying operations called "heuristics," which can lead to biases in 
judgments, predictions, and decisions.(4) Abundant evidence from judgment analysis 
research has revealed a gap between the judgments people make intuitively and the 
probabilities yielded by explicit calculation or empirical observations. As early as 1954, 
Meehl(5) stated that many clinical predictions could best be made by statistical rather 
than by intuitive means. Slovic et al. (1976)(6) concluded on the basis of diverse research 
findings that people systematically violate the principles of rational decision-making 
when judging probabilities, making predictions, or otherwise attempting to cope with 
probabilistic tasks. Clinical judgment analysis provides useful procedures for more 
clearly understanding these judgment processes.(7)  
The usefulness of clinical judgment analysis is also demonstrated when the 
methodology is applied to describe, aggregate, and compare clinicians' individual 
judgment policies. Policy clustering is the process of aggregating together clinicians 
having similar predictive policies.(7) It has proved a powerful method for revealing areas 
of divergence and consensus between individual judgment policies, especially when 
complex and interrelated clinical factors are investigated.(3) Not only are the results 
valuable in explaining these variations, they also provide cognitive feedback to clinicians 
for learning and teaching purposes. In 1980(8) and again in 1996,(9) Hammond 
emphasized the advantages of bringing clinical judgment analysis into a constructive 
relationship with the paradigm of clinical decision analysis. The present availability of 
literature on the application of clinical judgment analysis encourages this integration. 
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(For example, Cooksey has recently presented a comprehensive tutorial and the 
concomitant theoretical backgrounds).(7) 
In most judgment analysis studies, the statistical process of multiple regression 
analysis is used as a technique to model the judgment processes of individual judges. 
This statistical technique, which is based on the linear model, provides a powerful tool 
for studying clinical judgment making.(3) However, as explained by, among others, 
Cooksey(7) and Fox,(10) multiple regression analysis is susceptible to a variety of 
difficulties and makes stringent and sometimes unrealistic assumptions about the 
structure of the data.  
The four key assumptions associated with multiple regression analysis are(7) (see 
Tabachnick and Fidell(11) and Fox(10) for further discussion of regression assumptions and 
diagnostics): 
(1) "normality": the residuals, that is, the differences between obtained and predicted 
judgment scores, are normally distributed around the predicted judgment scores; 
(2) "linearity": judgments and predicted judgment scores are linearly related; 
(3) "homoscedasticity": the variance of the residuals around predicted judgments scores 
is the same for all predicted judgments; 
(4) "independence": the residuals associated with different judgments are uncorrelated. 
Although there is some disagreement in the statistical literature over how serious the 
violations of the regression assumptions can be before parameter estimates are distorted 
or biased,(12) it is claimed that multiple regression equations should routinely be 
checked.(13)  
Violation of multiple regression assumptions can be detected by means of statistical 
tests and by visual examination of typical patterns in plots, for example in a plot of 
standardized residuals versus standardized predicted values. Most statistical packages 
provide these plots in their regression programs. Several approaches are available to deal 
with regression violations, such as including more representative variables, increasing 
the number of cases and identifying outlying cases, mathematical transformation of 
variables, and bootstrapping and cross-validation.(7,11,13) Logistic regression analysis, 
which is more flexible and makes no assumptions about the distributions of predictor 
variables, has been used for analyzing dichotomous judgments.   
To the toolkit for the clinical judgment analyst, we propose the addition of JANNET, 
an alternative analytical technique employing neural network computing that can be used 
when the assumptions underlying multiple regression analysis are not met, especially 
under judgment conditions involving nonlinear cue relations or when clinicians' 
interpretation of the cue profiles exhibits strong nonlinear characteristics. The 
probabilistic neural network (PNN),(14) an outgrowth of the "Bayesian classifier," is used, 
which we believe has not previously been applied to clinical judgment analyses. This 
probability-based approach is nonparametric, that is, not dependent upon underlying 
distributions and assumptions. The PNN is particularly useful in classifying patterns or 
predicting outcomes, including judgments, from sparse or limited datasets.(14-16) Further, 
information weights are "grown" and revised in a nonlinear fashion through exposure of 
the model to successive judgment cases, a simple form of dynamic judgment modeling 
alluded to by Cooksey.(7)   
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The aim of the present study is to explore the application of the PNN, which may 
provide useful information for future CJA research. To illustrate this alternative 
approach, we applied it to gain insight into how dental clinicians weight certain "risk 
factors" as important indications for prophylactic extraction of teeth in patients with head 
and neck cancer, prior to radiotherapy.(17,18)  
The choice of the PNN as an analytical tool was based on the excellent mathematical 
credentials and performance of this type of artificial neural network.(15,19) Unlike neural 
network models using a feed-forward back-propagation (BP) learning algorithm,(20) the 
PNN learns from single-pass exposure to the training data, which makes it easier to train 
and many times faster than BP networks. It is also less subject to computational errors 
such as overfitting of data, as explained by Specht(15) and Specht and Shapiro.(21)  
Although so far there have been relatively few applications of PNN modeling in 
biomedical situations, all have performed well.(22) However, data sampling and coding 
remain critical issues when using a PNN application.(23) A full explanation of the PNN 
paradigm and its associated computer algorithms lies beyond the scope of this paper. 
Readers looking for detailed information on PNNs are referred to comprehensive 
introductory texts.(14-16,24) 
 
 
Material and methods 
 
The JANNET approach presented here incorporates three basic steps: 
1.  Aims, design, and execution of the judgment task 
2.  Modelling of conditional probabilities  
3.  Grouping of individual judgment policies 
 
Step 1: Aims, design, and execution of the judgment task 
The aim of the study was to establish the characteristics of individual judgment 
policies of dental clinicians with respect to the prophylactic extraction of teeth in patients 
with head and neck cancer, prior to radiotherapy.(17) A second aim was to form clusters 
of judges whose policies are most similar (judgment policy aggregation and typing).  
A judgment analysis questionnaire, part of a guidelines development study,(18) was 
mailed to 54 oral-maxillofacial surgeons and hospital-based dentists at a number of 
locations in North America, Australia, and Europe. Their names and addresses were 
obtained by contacting the secretaries of their professional organizations. The secretaries 
were asked to select those clinicians who were expected to be familiar with and 
experienced in the domain of dental screening of head and neck cancer patients. The 
clinicians were informed of the objectives of the survey and assured of its confidentiality 
and anonymity. They were queried concerning their professional qualifications and 
clinical posts and asked whether they were involved in the pre-radiation dental screening 
of patients with head and neck cancer. 
The questionnaire was constructed using the specific design considerations described 
by Cooksey(25) from 48 simulated paper cases in order to analyze the conditional 
importance of a number of clinical conditions, presented as "clinical cues." In addition to 
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"tooth function," two more attributes, "dental conditions" and "radiotherapy conditions," 
were included in the paper cases as clinical cues for judgment making. A fourth attribute 
concerning the location of a tooth (upper versus lower jaw) was not incorporated in the 
present analysis because an earlier analysis had showed that this particular cue did not 
contribute significantly to explaining clinician's judgment making.(18) A verbal format, 
incorporating the three aforementioned attributes, was used to present the paper cases to 
the clinicians. Clinicians were asked to choose the optimal option for dental intervention: 
"tooth extraction," "dental treatment," or "no action." An example of the questionnaire 
format and an explanation of how the verbal categories are related to the three clinical 
cues is given elsewhere(17) (see Chapter 3). We used a ratio of six cases (cue profiles to 
be judged) to each level of the three cues that were used to construct the judgment task. 
This 6 to 1 ratio exceeds the recommended minimum ratio 5 to 1 generally required in 
any study employing multiple regression techniques.(25) The paper cases were presented 
in a semi-randomized order to avoid response bias, e.g. clinicians' tendency to repeat the 
same score patterns.(26)  
 
Step 2: Modelling of conditional probabilities 
All completed questionnaires were analyzed at an individual level ("within judge" 
analysis). No attempt was made to compare the results originating from each 
international location. All three aforementioned cues and three response options were 
coded into independent and dependent variables, using a dummy coding scheme.(27) We 
first analyzed each data matrix using descriptive statistics and multiple regression 
procedures.(11) Regression diagnostics were performed through visual inspection of 
standardized residual/predicted judgment scatterplots and histograms depicting 
standardized residuals. A personal computer and a software package for statistical 
analysis (SPSS 9.0 with Advanced Statistic option, SPSS Inc, Chicago, IL) were used  
for these procedures. 
 
Model vectors 
The next phase of the analysis was the neural-network modeling. Preprocessing of 
variables is a vital step in neural-network computing.(22) We assume that the judgment 
task subjected to analysis can be modeled with so-called "model vectors." The model 
vectors represent the paper cases with input (independent) and output (dependent) 
variables. General formulation of the model vector {mv} may be written as: 
 
{mv}N  =  input{cue_1, cue_2; cue_3;…cue_M.}N output{response_1;….response_L}N 
 
where M represents the number of cues, L the number of response options, and N the 
number of model vectors. A judgment task characterized with N model vectors {mv}N  
(these model vectors are also called "judgment profiles") may be written in matrix form 
as shown in Fig 4.1. 
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model 
vector 
= input 
cue_1 
input 
cue_2 
... input 
cue_M 
output  
response_1 
output  
response_2 
mv1 = m_value11 m_value12 ... m_value1M m_value1,M+1 m_value1,M+2 
mv2 = m_value21 m_value22 ... m_value2M m_value2,M+1 m_value2,M+2 
. . . .  . . . 
. . . .  . . . 
mvN = m_valueN1 m_valueN2 ... m_valueNM m_valueN,M+1 m_valueN,M+2 
 
pv1 = m_valueN+1,
1 
m_valueN+1,
2 
... m_valueN+1,
M 
p_value1,M+1 p_value1,M+2 
pv2 = m_valueN+2,
1 
m_valueN+2,
2 
... m_valueN+2,
M 
p_value2,M+1 p_value2,M+2 
pv3 = m_valueN+3,
1 
m_valueN+3,
2 
... m_valueN+3,
M 
p_value3,M+1 p_value3,M+2 
 
Figure 4.1. An example of a judgment task, which is completely described with N model vectors; 
each model vector (MV) has M input variables and two output variables (M+1, M+2).  The MVs with 
known input and output values are used for the prediction of missing p_values (values of output 
variables-- see dark gray cells) for three new prediction vectors (PV). These PVs have known values 
of input variables only. The PNN predicts these unknown p_values of output variables of the PVs on 
the basis of all MVs. (Adapted with permission from the author, from Krajnc, 1997 (31,32) ) 
 
 
The PNN modelling was performed using the "aiNet" software (aiNet for Windows, 
version 1.25, aiNet, Celje, Slovenia).1  Its operation and performance were first 
successfully tested by analyzing two benchmark problems from the Proben database.(28) 
The first benchmark problem came from Proben's "heartc" dataset (source, Robert 
Detrano, MD PhD, Cleveland Clinic Foundation CA, 1989).(29) The second problem came 
from Proben's "breast cancer" dataset (source, William H.Wolberg, MD, University of 
Winconsin Hospital, Madison, WI, 1990).(30) 
 
 
Conditional probabilities 
We used the PNN(14) to model clinicians' responses as conditional probabilities 
(Baysian posterior probabilities). To compute these conditional probabilities, first the 
model vectors were fed into the network using aiNet's graphical user interface, which is 
designed like a spreadsheet application (Fig 4.2).  
 
 
 
 
 
 
 
 
 
                                               
1 A full working version of aiNet is available for FTP-download from the Internet at:  
http://www.ainet-sp.si/NNdownload.htm or at http://www.mexsys.net 
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Figure 4.2.  aiNet's Model Vectors View 
 
 
Using aiNet's "Verification Tool,"(31,32) the value of each output variable for each 
model vector is predicted on the basis of all other model vectors in the model vector 
spreadsheet that functions as a database. Each model vector under consideration is 
therefore temporarily removed from database. By means of aiNet's nonparametric 
mathematical algorithm, this "leave-one-out" procedure(24) generates a global error 
estimate, which in turn depends on an underlying probability density function 
(PDF).(14,32) Next, the PDF is applied for the prediction of unknown outcome values, 
which are the conditional probabilities. To accomplish this prediction procedure, a set of 
twelve prediction vectors was processed using aiNet's "Prediction Tool."(31,32) These 
twelve prediction vectors represent the two levels of the six input variables. This process 
results in the wanted conditional probabilities of all three response options (see columns 
labelled H , I, and J in Fig 4.3).  
For example, given that a strategic tooth (cue 1, level 2) with a dental condition 
considered as "medium risk" (cue 2, level 2) is within the planned radiation field of over 
55 Gray (cue 3, level 2) the conditional probabilities of the response options of a 
particular clinician are: 
 
P  [R1 | C1,2; C2,2; C3,2] = 0,128  (see cell  H:8 in Fig 4.3) 
P  [R2 | C1,2; C2,2; C3,2] = 0,747  (see cell  I:8  in  Fig 4.3) 
P  [R3 | C1,2; C2,2; C3,2] = 0,125  (see cell  J:8  in  Fig 4.3) 
 
where P  represents the conditional probability, Rn the response option, and CN,N a 
clinical cue. The | symbol means "conditional upon." Note that, while the three response 
options are mutually exclusive, the sum of the three conditional probabilities equals 1. 
As the main interest of the present survey was the effect that cue 1 ("tooth function") had 
on clinicians' judgments,(18) the conditional probabilities for this particular cue were 
devised for all three response options, as explained in BOX 1 (see page 65). 
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Figure 4.3   aiNet's Prediction View 
 
Next, the likelihood ratios of these conditional probabilities were computed. At this 
point, the Likelihood Ratio (LR) is defined as the ratio of the probability of a predicted 
response given that a tooth is "strategic" (cue1,1) to the probability of that response 
given that the tooth is "nonstrategic" (cue1,2), which is summarized in the following 
equation: 
 
Likelihood ratio (LR) =   
 
where P  represents the  conditional probability of a response, R# the response option, 
and C the clinical cue. BOX 1 (page 65) shows an example set of three likelihood ratios 
derived from the predicted responses depicted in Fig 4.3. The LR represents the cue 
weight for the attribute "tooth function". These cue weights are the standard expected 
outcomes for judgment analysis.  
 
Step 3: Grouping of individual judgment policies 
 After the characteristics of each individual's judgment process are established in 
step 2, the resulting profiles of judgmental characteristics across judges are analyzed in 
the search for groups sharing common characteristics. We used the "K-means cluster 
analysis" algorithm(33) to accomplish this. The measure for clustering was the "Euclidian 
distance." The goal of this procedure was to form clusters of judges whose LRs were 
most similar. We chose to cluster on basis of the LRs because they are very useful for 
characterizing clinical information.(34) We tested a range of three to five clusters in an 
iterative approach. In addition, One-way ANOVA and F-test statistics were performed in 
order to test the contribution of the Likelihood Ratios (independent variables) to the 
separation of the clusters (dependent variable: distances between final cluster centers).  
It should be noted that, when the goal of the analysis is directed only to the analysis of 
each individual judgment process, step 3 is not required.  
[ ]
[ ]2,1|
1,1|
#
#
CRP
CRP
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Results 
 
Forty-four clinicians returned the questionnaire (response rate of 81%) and provided 
usable data for analysis. The multiple regression analyses produced a total of 44 
individual regression models. As anticipated, inspection of the normal probability plots 
revealed major violations of the regression assumptions, indicating strong nonlinear 
relationships within the judgment data. Consequently, no further attempts were made to 
use these linear models for purposes of this clinical judgment analysis study.  
Modeling and prediction procedures of aiNet software were relatively simple and 
rapid. The performance testing of aiNet revealed that the overall predictive accuracy 
matched the results of other performance evaluations using the same benchmark 
problems.(29,30,35,36). All 44 data matrices deriving from the questionnaires were processed 
by the aiNet software without any difficulties. The procedures rendered 44 sets of 
predicted judgments, expressed as conditional probabilities. 
The K-means cluster analysis based on the LRs of response 1, 2 and 3 of each 
individual judge resulted in four clusters. A summary profile of the clusters is given in 
Table 4.1 and Fig 4.4. The F-tests revealed significance level p = 0.003 (df 3.40;  
F =5.342) for  the variable "LR  of response-1" ; significance level p = 0.0001 (df 3.40;  
F =269.395) for  variable "LR  of response 2," and significance level p = 0.885 (df 3.40;  
F = 0.216) for variable "LR of  response-3."  Thus, the "LR of response 3" ("no-action") 
failed to contribute significantly to the clustering of the judges, indicating that significant 
differences between the policies of the clustered judges exist only in cases in which a 
tooth should be extracted or treated.  
 
Table 4.1   Summary profile of the 4 clusters 
 Cluster 1 Cluster 2 Cluster 3 Cluster 4 
Number of clinicians 9 32 1 2 
Final cluster centers, based on 
Likelihood Ratios of responses 
(strategic vs. nonstrategic teeth) 
    
      Response 1 .602 1.019 .447 .670 
      Response 2 3.378 1.494 13.649 6.280 
      Response 3 .595 .517 .580 .650 
Distances between  
final cluster centers 
    
     Cluster 1  1.931 10.272 2.904 
     Cluster 2 1.931  12.169 4.801 
     Cluster 3 10.272 12.169  7.372 
     Cluster 4 2.904 4.801 7.372  
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Fig 4.4. Graphical depiction of all cluster members. Each number represents a clinician and the cluster 
number to which he/she belongs.  
     = center of Cluster 1;         = center of Cluster 2;         = center of Cluster 4 
 
 
Discussion 
 
A questionnaire comprising paper cases and a probabilistic neural network (PNN) 
application were used to examine the relevance of tooth functionality in the process of 
clinical judgment and decision-making in a dental domain. By means of this 
nonparametric ("free of assumptions") approach, we were able to identify four groups of 
dental clinicians on the basis of likelihood ratios (LRs) of responses concerning strategic 
teeth versus nonstrategic teeth.  
Assuming that judgments made on paper cases agree closely with judgments made 
on real patients,(37-39) the results of this survey indicate that the clinicians  from the four 
clusters differed with respect to how tooth functioning was weighted. However, this 
applies only to response 1 (tooth extraction) and response 2 (dental treatment), but not to 
response 3 (no-action). For example, the probability that clinicians belonging to cluster 2 
would carry out a dental treatment on a strategic tooth prior to radiation therapy is on 
average approximately 1.5 times higher then the probability of dental treatment on a 
nonstrategic tooth (weighted over all combinations of dental and radiotherapy 
conditions). The value of the center of cluster 2 (depicted with a gray square symbol in 
Fig 4.4) for response 2 is 1.494; i.e. mean value of "LR of response-2," which can be 
Likelihood ratio of response 1 (from PNN)
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read where the dotted drop line from the gray square symbol meets the y-axis in Fig 4.4 
(see also the values of cluster centers in Table 4.1) On the other hand, if the condition of 
a tooth requires extraction (response 1), clinicians in cluster 2 vary considerably with 
respect to the weighting of tooth function. This can be clearly seen in Fig 4.4 by the 
spread along the x-axis ("LR of Response-1") of cluster 2 clinicians (see the spread of the 
"2" numbers in Fig 4.4).  However, the clinician in cluster 3 (see number "3" in Fig 4.4) 
weights tooth function rather heavily ("LR of Response-2" = 13,649). This may be 
interpreted as follows: in the case of strategic teeth, this particular clinician is prepared to 
take the risk of a complication (should the dental treatment fail, or if the tooth develops 
new dental pathosis following radiation --see Chapter 5) in pursuit of a better patient 
outcome (maintaining strategic teeth contributes to oral functioning).(40) As discussed 
previously, such an insight into this particular area of nonlinear judgment and decision-
making could be helpful for development of evidence-based guidelines and for training 
of clinicians.(18) 
An important difference between this study and previous work on clinical judgment 
analyses is the use of a probabilistic neural network (PNN) that allows the use of 
nonlinear models.  Most judgment analysis studies use linear models as the statistical 
technique for analyzing clinician's judgments. By means of multivariate analysis of 
judgment data, these models represent judgment as the weighted sum of each clinical 
cue. The linear model of judgment, known as the "Lens Model," was proposed by Egon 
Brunswik in the 1950s, and was further developed and enhanced by Kenneth Hammond 
and others into the present paradigm for studying intuitive judgments. However, as 
mentioned earlier, the paradigm related to linear models is restricted in the validity of its 
underlying regression techniques. It is therefore not surprising that interest in deriving a 
form of judgment analysis that could cope with nonlinear judgments began to emerge. 
So far, as discussed by Cooksey (pp. 280-292)(7) these nonlinear approaches are a 
challenging issue for judgment analysis. 
The PNN application used for this study showed considerable power in capturing 
conditional probabilities deriving from judgments made on paper cases. The JANNET 
approach enabled us to recognize probabilistic "patterns" in "nonlinear" judgment 
policies and subsequently to group clinicians with related policies together. It revealed 
how the weighting of cues, expressed as likelihood ratios, dynamically evolves when 
clinical information (judgment data) varies. We therefore believe that this neural 
network approach to Judgment Analysis is promising and should be further tested and 
applied.  However, as the JANNET approach is conceptually different from most other 
Judgment Analysis studies using the "Lens Model," where cue weights are computed 
using multiple regression procedures and individual measures of consistency are also 
reported, it could impede the comparison of the results of two approaches.  
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Box 1: Composing of conditional probabilities 
 
The definition of conditional probability is the probability that an event (e.g. outcome "X") is true, given 
that another event (e.g. condition "Y") is true, formally defined by:  
 
 
 
 
Let the conditions and outcomes be given in a probability matrix (in spreadsheet syntaxes: A1:J12), 
where columns A:G represent  the conditions. "1" means condition is present (true), "0" means condition 
is absent (false), and H:J  represent the probabilities of 3 mutually exclusive outcomes, i.e. the predicted 
responses. As explained in the main text, the conditional probabilities of the outcomes were computed by 
the neural network on basis of the data from the questionnaire. Rows 1:12  (see also Fig 4.3)  
represent the cases for which these conditional probabilities were calculated (this was done for each 
participating clinician, n=44, resulting in 44 sets of predicted outcomes). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Using the formal definition of conditional probability, it can be shown that the conditional probability  
of outcome H, given that condition A= true and B=false is:2 
 
 
 
 
where P m is  the matrix probability (note that: 1 < P m < 12). 
The same method is applied to compute the conditional probability of outcome H, given A=false and 
B=true: 
 
 
 
 
The Likelihood Ratio (see text) is:   
 
 
2 We used spreadsheet syntaxes, whereas this calculation could also be easily performed with the use of 
matrix algebra. 
 
 A B C D E F G outcome 
H 
outcome 
I 
outcome 
J 
1 1 0 0 1 0 1 0 0.000 0.993 0.007 
2 1 0 0 1 0 0 1 0.004 0.872 0.124 
3 1 0 0 0 1 1 0 0.014 0.983 0.003 
4 1 0 0 0 1 0 1 0.798 0.202 0.000 
5 1 0 1 0 0 1 0 0.000 0.010 0.989 
6 1 0 1 0 0 0 1 0.381 0.429 0.190 
7 0 1 0 1 0 1 0 0.003 0.986 0.010 
8 0 1 0 1 0 0 1 0.128 0.747 0.125 
9 0 1 0 0 1 1 0 0.011 0.660 0.329 
10 0 1 0 0 1 0 1 0.905 0.093 0.001 
11 0 1 1 0 0 1 0 0.000 0.010 0.990 
12 0 1 1 0 0 0 1 0.019 0.012 0.970 
[ ] [ ][ ]YP
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[ ] [ ][ ]
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Abstract 
 
Objective 
This study was designed to investigate the association of tooth loss with patient's 
dental status (number of teeth present at baseline), dental risk factors (DRFs), and 
radiotherapy-related factors, respectively, in a sample of head and neck cancer patients. 
A further objective was to study the incidence of radiation caries and osteoradionecrosis. 
 
Study Design 
A retrospective and follow-up analysis was performed on 209 head and neck cancer 
patients in the Netherlands who had received a dental evaluation prior to radiotherapy for 
head and neck cancer. Patients were subsequently evaluated 1-5 years postradiation 
(median 3 years).  
 
Results 
Tooth loss was greater in the study population compared to data on tooth loss in the 
general population, and is significantly associated with dental status, DRF's, and 
radiotherapy-related factors. Radiation caries at the time of the follow-up evaluation was 
significantly associated with the number of DRFs at baseline. The incidence of 
osteoradionecrosis was relatively low (5 cases; 2.3%). 
 
Conclusions 
The survey supports the clinician's judgment to be uncompromising in preradiation 
treatment planning, especially in patients initially presenting with poor oral health. A 
survey study that would further define the relationship between a head and neck cancer 
patient's perception regarding the need for dental rehabilitation and his or her ability to 
comply with the advised dental treatment and oral hygiene measures is recommended. 
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Introduction 
 
It has long been known that head and neck cancer patients tend to have higher levels 
of dental pathosis compared to the general population.(1) In particular, elderly persons 
and those of lower socioeconomic status form a substantial proportion of patients with 
head and neck cancer.(2,3) The prevalence and incidence of dental disease in these groups 
are high and compliance with dental care is usually poor.(4-9)  
Numerous reports indicate that head and neck cancer therapies induce a wide 
spectrum of undesirable side effects, particularly affecting the mouth and jaws.(10) This is 
especially true if radiotherapy to the oral and maxillofacial structures is part of the 
overall treatment regimen.(11) It has been shown that these side effects seriously affect 
both the tolerance of treatment and the quality of life.(12,13) 
To reduce oral complications, extensive dental preventive and treatment measures 
before, during, and after cancer therapy are mandatory.(10,13,14) Implicit in the preventive 
approach is preradiation oral screening to identify and eliminate dental risk factors 
(DRFs). Preradiation dental decision-making has been described in previous 
publications.(15,16) The dental risk factors (DRFs) were found to be the most important 
factors in this process.(15) DRFs include caries, periodontal disease, periapical dental 
pathosis, impacted teeth, residual root tips, cysts, and other radiographic abnormalities. 
Table 5.1 summarizes the DRFs.  
 Elimination of DRFs is possible through dental treatment or tooth extraction. 
Criteria for the extraction of teeth before radiotherapy include the following:(14) 
• moderate to advanced periodontal disease, 
• extensive periapical lesions of the teeth, 
• extensive dental caries, 
• partially impacted or incompletely erupted teeth, 
• residual root tips not fully covered by  bone and/or showing  radiolucency to x-
rays. 
Pre-existing dental pathoses logically seem to be a risk factor for tooth loss. Patients 
with high levels of dental pathosis prior to radiotherapy need extensive dental 
intervention, frequently resulting in partial or even total loss of dentition.(17) In addition, 
patients with remaining teeth would also seem to be at risk for development of novel 
dental pathoses, such as radiation caries. Although this association has long been 
apparent,(1) its strength and functional form has not yet been clearly recognized in an 
evidence-based approach.(18,19)   
The objective of the present clinical survey was to investigate the association of pre 
and postradiation tooth loss with patient's dental status (number of teeth present at 
baseline), dental risk factors (DRFs), and radiotherapy-related factors, respectively, in a 
sample of patients with head and neck cancer. A further objective was to study the 
incidence of radiation caries and osteoradionecrosis. For these purposes, a retrospective 
and follow-up evaluation was performed on 209 head and neck cancer patients in the 
Netherlands, who had received a dental evaluation prior to radiotherapy for head and 
neck cancer.  
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Table 5.1         Dental Conditions to assign Dental Risk Factor (DRF) Score 
Clinical and Radiographic Findings (CRF)a Weighting  
Periodontal disease   
Probing depth / Proximal bone loss:b     3 to 6 mm Medium  
Probing depth / Proximal bone loss:      > 6mm  High 
Gingival recession:                                3 to 6 mm Medium  
Gingival recession:                                > 6 mm  High 
Bleeding upon probing Medium  
Spontaneous gingival bleeding  High 
Furcation involvement / Bone loss in furcation area  High 
Mobility       1-2 mm side to side Medium  
Mobility   > 2 mm side to side and/or 1 mm vertical  High 
PULPAL DISEASE AND PERIAPICAL LESIONS   
Abnormal response to tests,c  no previous endodontic treatment,  no rarefying osteitisd Medium  
Abnormal response to tests, no previous endodontic treatment, rarefying osteitis  High 
Swellings and/or sinus tracts  High 
Rarefying osteitis, O < 3mm, with adequate root canal filling,e without  (percussion) pain Low/Medium  
Rarefying osteitis, O < 3mm, with inadequate root canal filling,e with (percussion) pain  High 
Rarefying osteitis , O > 3 mm  High 
Condensing osteitisf/ hypercementosisg with normal reactions to tests Low  
Condensing osteitis with abnormal reactions to tests Medium  
Internal/external root resorption  High 
EXTENSIVE CARIES   
Primary caries < 2/3 of the clinical crown Medium  
Primary caries > 2/3 of the clinical crown/pulpal involvement  High 
Defective restorationh with secondary caries,i no pulpal involvement Medium  
Root caries  < 1/2 of root circumference, no pulpal involvement Medium  
Root caries  > 1/2 of root circumference  High 
NON FUNCTIONAL TEETH   
Partially impacted  (incompletely erupted) teeth or permucosal residual roots  High 
Residual root tips not fully covered by alveolar bone and /or showing periodontal ligament or 
radiolucency  High 
Fully impacted teeth, without follicle enlargement and fully covered by bone Low  
Fully impacted teeth, with follicle enlargement and/or not fully covered by bone,  High 
ORAL HYGIENE, DENTAL AWARENESS, CO-OPERATION   
Low level of oral hygiene, low dental awareness, lack of cooperation  High 
a Identified at tooth level, which means tooth-related.  
b Radiographic standard for interpretation of proximal bone loss is that the alveolar crestal bone must be greater than 3 mm from 
the CEJ. (20)  
c Pulp sensitivity: cold, heat, electric (EPT) and percussion tests. 
d Rarefying osteitis: radiolucent periapical bone destruction communicating with the periodontal ligament space via a 
discontinuity in the lamina dura.(21) 
 e Criteria for  assessment of root canal obturation: The prepared and filled canal should  contain the original canal and should be 
filled completely (0.5-2 mm from radiographic apex). No space between canal filling and canal wall should be seen. No canal 
space should be visible beyond the end point of the root canal filling. The whole canal system/ all roots should be obturated 
(Consensus Report European Society of Endodontology)(22) 
f Hypersclerotic bone trabeculi adjacent to the periapical region and communicating with the periodontal ligament space. (21) 
g Distortion of the apical third of the tooth root characterized by increased width while the periodontal ligament space and lamina 
dura remain unaltered. (21) 
h Restorations are defective if any of the following conditions are present: marginal discrepancies >0.5 mm, part of the restoration 
missing, bulk fracture, or marginal staining of composites suggesting leakage.(23) 
i True radiographic secondary (i.e., recurrent) caries and/or residual caries.(23) 
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Methods 
 
Subjects 
The subjects of this clinical survey, conducted in 1999, were patients who had 
undergone head and neck cancer therapy at the Department of Otorhinolaryngology and 
allied departments of the University Medical Center Utrecht, the Netherlands, between 
1993 and 1998.  Patients selected for inclusion in the clinical survey were required to 
satisfy the following conditions, they: 
(1) were in the regular oncology follow-up schedule;  
(2) had undergone primary cancer treatment, including radiotherapy, for squamous 
cell carcinoma in head and neck, one to five years previously;  
(3) were treated with the intention of curing the disease (patients receiving only 
palliative treatment or patients with active disease were not included for medico- 
ethical reasons);  
(4) had undergone preradiation dental screening;   
(5) were able to be examined postradiation. 
Informed consent was acquired from the patients who were found to meet the criteria for 
entry in the study protocol. 
 
Measures 
The data on patient characteristics (i.e. age, gender) and comprehensive information 
on the head and neck cancer were retrieved from the hospital's ONCDAT database 
(courtesy of Prof. Dr. G.J. Hordijk). Data on radiotherapy, such as doses and fields, were 
obtained from the appropriate records, simulation radiographs, and computerized 
treatment planning. Using a specially designed clinical assessment form (the 
SCREDENT form, see Appendix 2), data on dental health status and tooth loss were 
obtained from the clinical records and from intraoral and extraoral radiographs by one 
examiner, a hospital dentist (HHB). A number of clinical records were re-analyzed in 
order to be able to assure satisfactory levels of intra-examiner reliability. 
The clinical follow-up evaluation was carried out only on dentate patients and 
consisted of the same procedure as the preradiation oral screening. Patients' dental status 
was measured in terms of the number of teeth present (tooth retention). In addition, other 
essential findings of the clinical examination were recorded. DRFs that were measured 
according to the methods described earlier(16) are in outlined in Table 5.1. In this survey, 
radiation caries is defined as extensive, primary circumferential caries involving more 
then one third of  the crown and/or root circumference in patients who underwent high- 
dose radiotherapy in the head and neck region. Information on the incidence of 
osteoradionecrosis was retrieved from hospital records and the ONCDAT database. 
 
Analysis 
Initially, all data were transferred to a data matrix. The statistical analyses were done 
in SPSS 9.0 with the Advanced Statistic option (SPSS Inc. Chicago, Il) and S-PLUS 
2000 for Windows (MathSoft Inc., Cambridge, MA), using a personal computer. 
                                                                                                                                        CHAPTER 5 
74 
We first used descriptive statistics for the purpose of data screening and description of the 
sample of patients. We anticipated that tooth loss would not follow the normal distribution. A 
stem-and-leaf plot (Fig 5.1) indicated that tooth loss followed a Poisson distribution. 
Therefore, associations of tooth loss with age, gender, dental status, DRFs, and radiotherapy-
related factors, respectively, were analyzed by means of a Poisson regression analysis.(26) In 
addition, the Poisson regression analysis was done to test possible predictors for radiation 
caries at the time of the follow-up evaluation. In this survey, radiation caries is defined as 
extensive, primary root caries involving more then one third of root circumference. 
Statistically significance levels are designated as two-sided probability values, with p < 0.05. 
 
 
 
 
Frequency    Stem &  Leaf 
 
    52.00        0 .  000000000111122223333444 
    21.00        0 .  566667899 
    15.00        1 .  011234 
     6.00        1 .  579 
     3.00        2 .  & 
     1.00 Extremes    (>=24) 
 
Stem width: 10; Each leaf: 2 case(s);   
"&" denotes fractional leaves (only 1 case per leaf). 
 
     Figure 5.1  Stem and leaf plot of tooth loss in 98 patients, indicating a Poisson distribution. 
 
 
 
Results 
 
In total, 398 patients were initially selected for this clinical survey. Two hundred and 
nine patients (78.5 % male and 21.5 % female) fulfilled all inclusion criteria. The mean 
age was 60 years (median 60; range 33-84). The age distribution of males and females 
did not differ significantly (p > 0.05). The median of follow-up time was 36 months 
(range 12-60).  
The prevalence of head and neck cancer by site of occurrence for males and females 
is presented in Table 5.2.  
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            Table 5.2   Frequency of head and neck cancer by site 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
# International Classification of Diseases, Ninth Revision, Clinical Modification, as published by  
the U.S. Public Health Service and Health Care Financing Administration. M= male, F=female. 
 
    
It was found that 111 patients (53%) were edentulous, and 98 patients (47%) had a 
(reduced) natural dentition at the time of the preradiation oral screening (baseline). The 
total number of teeth present in 98 patients at baseline was 1,475 (mean number of teeth 
per patient: 15, range 31), of which 559 (37%) were situated in the upper jaw and 916 
(63 %) in the lower jaw. The total number of DRFs with high-risk level in the 98 dentate 
patients at baseline was 339 (mean number of high DRFs per patient: 3, range 15) 
 The incidence of total tooth loss in the 98 dentate patients was 602 (mean tooth loss 
per patient: 6, range 24). Prior to radiotherapy, 441 teeth (31 % of the total number of 
teeth at baseline) were lost, and 161 teeth (11%) were lost thereafter. Table 5.3 presents 
a cross-tabulation of tooth loss by time and arch. As a result of the preradiation tooth 
extractions, 33 patients became edentulous. Thus, a full mouth clearance prior to 
radiotherapy was performed in 34% of the dentulous patients. In addition, 7 patients 
(7%) became edentulous in the follow-up period after radiotherapy. 
 
 
 
Table 5.3   Cross-tabulation of total tooth loss by time and arch (in 98 patients) 
 
             
Sites of  
Squamous Cell Carcinoma (SCC) 
 
ICD -9-
CM# code 
Number 
of 
patients 
 
Frequency 
…% 
  M F M F 
  
 4 
  13 
  10 
  11 
  9 
    4 
  12 
    5 
 94  
3 
 
0 
6 
6 
3 
9 
0 
1 
2 
15 
2 
  
 1.9  
  6.2  
4.8  
5.2  
4.3  
  1.8   
5.7  
2.4  
44.8 
  1.4 
 
0.0 
2.9 
2.9 
1.4 
4.3 
0.0 
0.1 
1.4 
7.1 
1.4 
165 44 78.5 21.5 
Oral cavity 
  lips 
  tongue 
  floor of the mouth 
  unspecified 
Oropharynx 
Nasopharynx 
Hypopharynx 
Nasal cavities 
Larynx 
Unspecified head and neck 
 
Total 
 
140 
141 
144 
145 
146 
147 
148 
160 
161 
199 
209 100 
 Preradiation Tooth Loss Postradiation Tooth Loss Total Tooth Loss 
 in 98 
patients 
 
per patient 
in 65 
patients 
 
per patient 
in 98 
patients 
 
per patient 
 number mean  range number mean range number mean range 
Upper Arch 112  1.14 10 50 0.52 12 162 1.65 12 
Lower Arch 329 3.36 13 111 1.02 14 440 4.38 14 
Total 441 (73%) 4.50 24 161 (27%) 1.64 24 602 6.03 24 
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Review of the simulation radiographs and computer-based treatment planning 
revealed that 185 teeth (12%) present at baseline in 35 patients would be in the planned 
field of radiation (dose > 55 Gy). Using the same radiation planning information, we 
estimated that the major salivary glands (parotid and/or submandibular glands) of 165 
patients (79 %) were bilaterally, partially (at least for 50%), or totally in these radiation 
fields of 55 Gy or more. After preradiation dental extractions, 125 teeth (8% of the teeth 
present at baseline) in only 24 patients (24%) were actually in the field of radiation and 
received a dose of > 55 Gy.  
At the time of the follow-up evaluation, 25 of the 56 dentate patients (45%) had one 
or more teeth affected by radiation caries that required extensive dental treatment or 
tooth extraction. This treatment need would of course further increase total tooth loss. 
The Poisson regression analysis showed that association of tooth loss with dental 
status, the number of high DRFs, and the number of teeth in the high-dose field of 
radiation, are statistically significant, p < 0.001.  The estimated association between 
expected tooth loss and dental status is shown in Fig 5.2. There was no statistically 
significant association between age and gender respectively, and total tooth loss. In 
addition, the Poisson regression analysis revealed that patients' number of teeth with 
radiation caries at the time of the follow-up evaluation was statistically significantly 
associated with the number of high DRFs at baseline with; p < 0.001). 
The incidence of osteoradionecrosis (ORN) was 2.3%, i.e. 5 cases in the lower jaws 
of 1 edentulous and 4 dentate patients. These documented cases of osteoradionecrosis 
were successfully treated according to accepted protocols.(27)  
 
   
Discussion 
 
This clinical survey involved a retrospective and follow-up evaluation of 209 
patients treated for cancer of the head and neck. The main objective was to investigate 
the association of tooth loss with dental status, dental risk factors (DRFs), and 
radiotherapy-related factors, respectively. 
 Analysis of patient-related and cancer-related characteristics revealed that the 
sample in the main compared with epidemiological data on age and gender of head and 
neck cancer patients.(12) At baseline, 53% of the patients were edentulous. This 
proportion is rather large compared to other countries. For example, in the United States, 
Marcus et al.(28) and Hunt et al.(29) found a proportion of about 24-29% in similar age 
groups, i.e. older white males and females. However, patients included in this study did 
not differ significantly from the population in the Netherlands within the same age 
groups.(30)  
Total tooth loss in all patients was 602 (mean per patient: 6, range 24), which can be 
considered quite high. For example, in comparable age groups in the United States, the 
mean tooth loss among older white adults in an 18-month period was 0.4.(29) From the 
present study, it may be concluded that tooth loss in the head and neck cancer patients in  
this sample is considerably higher than the amount of tooth loss described in 
epidemiological studies concerning the general population. (4,6,28-30,32-44)   
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Figure 5.2  The estimated association of tooth loss with dental status. Each black circle 
represents a patient. Those on the diagonal represent patients who became edentulous as the 
result of pre- and/or postradiation tooth extractions. The dome-shaped line represents the fitted 
Poisson regression line, with covariate values: gender = male, and age = 60. 
 
 
Logically, we may conclude that this substantial tooth loss is initiated by the 
circumstance that these patients underwent radiotherapy for a head and neck malignancy. 
Dental intervention in these cancer patients is important because dental pathology is a 
potentially significant problem.(17) There is a strong need for dental treatment including 
tooth extractions, which is usually not perceived by the patients themselves,(45) in order 
to prevent oral sequelae of radiotherapy.(10) 
The results of the Poisson regression analysis indicate that tooth loss was statistically 
significantly associated primarily with dental status at baseline and the number of high 
DRFs, and secondarily with factors concerning radiotherapy. This finding compares to 
our earlier conclusion that the decision policies of dental clinicians seem to be based 
primarily on dental factors, and to a lesser extent on factors concerning radiotherapy.(18) 
It was noted that the association between dental status and tooth loss has a shallow 
dome-shape function form (see Fig 5.2). Thus, the amount of tooth loss increases when 
the number of retained teeth increases. However, the amount of tooth loss gradually 
decreases in patients who have more than 15 teeth, although these patients have more 
teeth that are "at risk" for potential tooth loss. It is plausible that patients who did not 
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experience substantial tooth loss in the past have better levels of dental health(46) and 
therefore required less dental treatment, including tooth extraction, prior to radiotherapy. 
The incidence of postradiation tooth loss (161 teeth, which is 27% of total tooth loss) 
and amount of radiation caries requiring extensive dental treatment including tooth 
extractions at the time of the follow-up evaluations was rather high. Possible expla-
nations for postradiation tooth loss are that for practical considerations, tooth extraction 
of teeth not within the high-dose radiation field was postponed until after radiotherapy. 
In addition, poor patient compliance could have resulted in failure to adhere to dental 
treatment and oral hygiene recommendations.  This may also explain the rather high 
levels of radiation caries at the time of the follow-up evaluation. 
Patterns of non-compliance for dental treatment in head and neck cancer patients 
have been reported by several investigators.(4-9) A review of the medical and dental 
literature by Ainamo & Ainamo(47) shows that patients with chronic illness tend to 
comply poorly, especially when the treatment time is lengthy or the complexity high.  
Typical reasons for non-compliance are, among others, stressful life events,(48) 
depression,(49) and alcoholism.(50) In addition, the lack of social network and social 
support, low interest in oral health, and "external locus of control" have been suggested 
as reasons for non-compliance. (9,51,52) Whereas "internal locus of control" means that a 
person takes charge of his or her own health-care situation, an "external locus of control" 
is determined by the individual's perception that various environmental factors are 
beyond his/her control. It has been shown that patients with head and neck cancer tend 
more toward external locus of control.(9) Non-compliance with dental care and oral 
hygiene is an important issue that deserves further attention.  
The findings of this clinical survey also indicate that when a head and neck cancer 
patient presents with reduced dentition and/or with poor dental health at the preradiation 
oral screening, substantial tooth loss may result. Moreover, patients who have remaining 
teeth during irradiation are at risk of developing new dental pathosis, such as radiation 
caries. Subsequent to the radiation, a patient who presented initially with poor dental 
health may again need extensive dental treatment, including tooth extractions. 
Consequently, the preradiation treatment plan, enhanced by dental decision-making, 
should include this anticipation. Uncompromising preradiation dental intervention is 
therefore warranted. However, we believe that our findings justify undertaking a survey 
study that would further define the relationship between a head and neck cancer patient's 
perceptions regarding the need for dental rehabilitation and his or her ability to comply 
with the recommended dental treatment and oral hygiene measures. This could result in 
better-targeted recommendations, leading to optimization of dental and oral-hygiene care 
regimens in patients with head and neck cancer. 
 
The authors wish to thank the anonymous reviewers, and Elizabeth Krijgsman-Roueche, language editor, 
for their valuable comments on the manuscript. 
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Abstract 
 
Objectives 
To construct and test a computer-based system for dental decision support in patients 
with head and neck cancer. 
 
Methods 
Findings from our previous studies concerning pretherapy dental decision-making in 
patients with head and neck cancer were used to develop and test SCREDENT, a 
decision support system. Dental health status, radiotherapy conditions, and tooth loss in a 
sample of 209 patients were modeled in an iterative approach, using the aiNet-software, 
a probabilistic neural network application. ROC curve analysis, measures of accuracy, 
and logistic regression analysis were used to assess SCREDENT's performance in 
predicting tooth loss/ tooth extraction. 
 
Results 
Modelling and prediction procedures of the aiNet software were relatively simple 
and rapid. In all training, testing, and validation sequences, SCREDENT was able to 
reach a solution. Altogether, approximately 1660 vectors (representing teeth under 
examination) were processed. The results show that in almost 95% of the cases, 
SCREDENT's predictions for tooth extraction (conditional probability cut-off value: 0.5) 
agree with the actual tooth extractions carried out as part of the preradiation oral 
screening. 
 
Conclusions 
SCREDENT accurately predicts whether tooth extraction is the most favorable 
option for preradiation intervention. By means of feeding all appropriate decisions made 
on the basis of SCREDENT's predictions back into the training set, this system offers a 
framework for continuous updating and adjusting of the decisions process and therefore 
not only allows evidence-based decision-making, but also may be a component of a 
quality control system. A further attractive feature of SCREDENT may be its use for 
training inexperienced clinicians. 
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Introduction 
 
High-dose radiotherapy to the head and neck, which includes oral and maxillofacial 
structures and salivary glands, may result in serious side effects. The short-term effects 
are mucositis, loss of taste and smell, secondary or "opportunistic" infections, and 
reduced salivary function. The long-term effects include persistence of reduced salivary 
function, radiation caries (Fig 6.1), progression of pre-existing periodontal disease 
activity, limited mouth opening (trismus), soft-tissue breakdown and failure to heal, and 
radiation bone injury, which in its severest form develops as osteoradionecrosis. As a 
secondary effect, patients with head and neck cancer experience significant tooth loss, 
prior to and following radiotherapy.(1,2) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1 Orthopantomogram showing massive radiation caries, two years after radiotherapy for an 
oropharyngeal squamous cell carcinoma. Note the circumferential spread of the lesions, which resulted in 
amputation of clinical crowns. 
 
 
 
To reduce oral sequelae of head and neck cancer therapy, extensive dental preventive 
and treatment measures before, during, and after cancer therapy are mandatory. (1,3-5) 
Implicit in the preventive approach is pretherapy oral screening to identify and eliminate 
dental risk factors for oral complications.(4) The current standards for dental care before 
radiation therapy include extraction of those teeth with significant bone loss, extensive 
caries, and/or extensive periapical lesions. In addition, partially impacted or 
incompletely erupted teeth and residual root tips not fully covered by bone and/or 
showing radiolucency to x-rays should be removed.(2,4,6-8)  
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Important factors in the dental management include, among others, the following 
considerations.(2,5,9)  
(1) anticipated radiation field and dose;  
(2) pretherapy dental status, dental hygiene, and retention of teeth that will be exposed 
to high-dose irradiation;  
(3) patient's motivation and ability to comply with preventive measures. 
Although several studies strongly support the efficacy of the pretherapy oral 
screening,(6,10,11) evidence-based clinical guidelines(12-14) to aid clinicians in deciding 
which options for dental intervention suit these patients best are not yet widely available. 
In view of the risk that results from high-dose irradiation, special attention to 
preradiation dental planning appears critical.(2,5) Each case must be managed 
individually; a single-formula approach for all patients is contra-indicated.(2) The key to 
control may be the implementation of a dental decision support system, derived from an 
evidence-based approach. 
Evidence-based medicine is an approach to clinical judgment and decision-making 
in which the clinician uses the best evidence available to decide upon the intervention 
that suits an individual patient best.(15) This approach involves the rigorous evaluation of 
the effectiveness of health-care interventions, dissemination of the results of evaluation, 
and application of these findings toward improvement of clinical practice.(16) Good 
clinicians use both individual clinical expertise and the best available external evidence, 
and neither alone is enough. External clinical evidence can inform but can never replace 
individual expertise. Evidence-based medicine is therefore not an obligatory "cookbook" 
approach.(17)  
This survey forms part of an international research project on dental decision support 
in patients with head and neck cancer.(5,9,18) The aim of the current survey was to 
construct and test a system to support dental decision-making, prior to radiotherapy for 
head and neck cancer. We first summarize some characteristics of decision support 
systems. We then propose "SCREDENT," a system for dental decision support in head 
and neck cancer patients. 
Decision support systems are interactive, computer-based systems that aid users in 
judgment and decision-making. They provide data storage and retrieval and support 
framing, modeling, and problem solving, as depicted in Fig 6.2. Decision support 
systems are especially valuable in situations in which confidence and reliability are of 
importance.  There are several types of decision support system, such as belief networks, 
influence diagrams, probabilistic expert systems, and artificial neural network 
applications.(19) We used a software package to emulate a neural network(20) as formal 
constructional technique for SCREDENT. 
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Figure 6.2  Diagram of SCREDENT, a computer-based decision-support system. The gray box 
represents the part of SCREDENT that is modeled using the probabilistic neural network (aiNet 
software). The predictions from SCREDENT are conditional probabilities for tooth loss/ tooth extraction. 
All decisions for tooth extraction that proved to be appropriate should be re-entered into SCREDENT's 
training set, assuring an evidence-based approach. 
 
 
The potential benefits of neural-network software seem obvious to those who design 
them but are often less clear to the end user.(21) Many clinicians are suspicious of these 
network applications and look upon them as "black boxes". The benefits of analyses 
using neural networks over more conventional methods, especially for analysis of 
complex and noisy data, must therefore be clearly demonstrated. In addition, according 
to Cross et al.,(21) useful software applications must be, among others things, robust and 
easy to use. While the quality and reliability of decision support systems are important, 
the most crucial aspect is their user interface. Systems with cumbersome or unclear user-
interfaces are rarely useful.  
Artificial neural networks have been extensively studied and applied.(20,22-25) This has 
resulted in numerous research reports in this area. The most common neural-network 
learning algorithm in biomedical applications is "back-propagation" in "multilayer 
perceptrons."(26) We used a type of neural network with a different architecture, the 
Probabilistic Neural Network (PNN). This type of neural network acts as a classifier or 
predictor that overcomes many of the problems of back-propagation. It has self-
organizing properties(27) and trains virtually instantaneously. At present, although there 
have been relatively few applications of PNN modelling in biomedical situations, all 
have performed well.(28) Readers looking for more information on neural networks are 
referred to comprehensive introductory texts.(20,21,29-37) 
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Evidence 
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Materials and methods 
 
The subjects came from a previous clinical study, conducted in 1999.(18) These 
patients (n=209) had undergone head and neck cancer therapy at the Otorhino-
laryngology department and allied departments of University Medical Center Utrecht, 
The Netherlands, between 1993 and 1998.  Patients selected for inclusion in that clinical 
survey were required to satisfy the following conditions: they (1) were in the regular 
cancer follow-up schedule; (2) had undergone primary cancer treatment, including 
radiation therapy, for squamous cell carcinoma in head and neck, one to five years 
previously; (3) were treated with the intention of curing the disease (patients receiving 
only palliative treatment or patients with active disease were not included for ethical 
reasons); and (4) had undergone preradiation dental screening. A second, more recent 
patient sample was analyzed in order to further validate SCREDENT. This sample 
consisted of 30 patients who were treated in the University Medical Center Utrecht in the 
year 2000. Informed consent was acquired from the patients who were found to meet the 
criteria for inclusion in the study protocol. 
Data on dental health status and tooth loss were obtained via pretherapy oral 
screening. We used a specially designed dentition assessment form- the SCREDENT 
form- that together with comprehensive instructions and a "getting started" document, is 
available for download from the Internet.1  The "SCREDENT, getting started" document 
also presents an example of a clinical case, illustrating how the findings from the 
preradiation oral screening should be recoded and entered into SCREDENT in order to 
make predictions for tooth extraction. 
The SCREDENT data collection form was designed and tested using the results from 
our previous studies. Among other variables, such as type, location, and stage of head 
and neck tumor, the following, fully described in the SCREDENT instruction document, 
were recorded:  
Input variables:  
(1) "dmftot": the number of teeth retained 
(2) "drftot": the total number of high Dental Risk Factors(5) 
(3) "upper" / "lower": the location of the tooth 
(4): "molar" / "bicusp" / "cusp" / "incis": the type of tooth 
(5) "gland": major salivary glands in high-dose irradiation field 
(6) "trx": tooth in high-dose radiation field  
(7) "patfact": patient's dental IQ  
Output variable:  
(8) "tloss" : tooth extraction/ tooth loss 
Using these eight variables, the decision problem analyzed in this paper was 
modeled graphically, as depicted in Fig 6.3. The solid arrows indicate the correlations 
between variables which were the scope of the present study. The dotted arrows indicate 
correlations that are present but were not further specified. 
                                                     
1 Available for download at the Internet at http://www.mexsys.net. (See also Appendices 2,3.) 
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Figure 6.3  Schematic representation of the variables involved in the decision problem. The solid arrows 
indicate the correlations between the variables that are modeled using aiNet software.  
(ICD code: International Classification of Diseases, Ninth Revision, Clinical Modification, as published 
by the U.S. Public Health Service and Health Care Financing Administration) 
 
 
The next phase of the analysis was the neural-network computing. We used the aiNet 
software package (aiNet for Windows, version 1.25, aiNet, Celje, Slovenia) to run the 
PNN on a personal computer.2 All sets of eight variables, including the known output 
variables ("tloss") were recoded into 2 discrete and 11 binary variables. This process 
resulted in sets of 13 variables, the so-called "training vectors." aiNet has a spreadsheet-
type interface, depicted in Fig 6.4, to enter and store the "training set." The procedure of 
modeling, data encoding, and data entering is thoroughly described and illustrated with 
examples in aiNet's manual and in the "SCREDENT, getting started" document. 
Interested readers are invited to download the SCREDENT files in order to try out the 
system. 
 
 
 
 
 
                                                     
2 A full working version of aiNet  (version 1.25), including online help files, examples, and a 
comprehensive manual in Microsoft Word  format (Microsoft Corporation, Redmond, Washington, WA), 
can be obtained through download from the Internet. (http://www.ainet-sp.si/NNdownload.htm).   
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Figure 6.4  aiNet's model vector view illustrating the first 20 model vectors of SCREDENT's 
training set (approximately 1660 model vectors). 
 
 
To test SCREDENT's performance, six separate samples of 60 training vectors (test 
sets) were randomly retracted from the training set and used to make predictions. The 
values of the known output variable ("tloss") were deleted, so these samples consisted of 
only the 12 input variables. Each row comprising the 12 input variables with the missing 
output variable is called a "test vector." Running aiNet's prediction option, the missing 
output variable ("tloss") of each test vector was predicted on the basis of the data in the 
training set. The prediction is given as the conditional probability that the tooth under 
examination should be extracted or will be lost. The value of this conditional probability 
lies between 0 (no tooth extraction) and 1 (tooth extraction). Next, these predictions were 
compared to the actual output variables, the tooth extractions that were or were not 
carried out as part of the pretherapy dental screening. Receiver Operating Characteristic 
(ROC) curve analysis, described in detail elsewhere,(38-40) was used to assess 
SCREDENT's performance. In addition, true-positive, true-negative, false-positive, and 
false negative values and  "overall accuracy" were computed. Overall accuracy is 
defined as true positives plus true negatives divided by total sample size. In addition, we 
compared SCREDENT's performance to logistic regression analysis, using the 
aggregation of test sample 1-6. This aggregated sample is designated "test sample 7" (see 
Table 6.1). 
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To further validate the model, a validation set consisting of the second patient 
sample was used to repeat SCREDENT's predictive accuracy. Again, a ROC analysis 
was carried out and accuracy was assessed.   
      
 
Results 
 
Modeling and prediction procedures of the aiNet software were relatively simple and 
rapid. In all training, testing, and validation sequences, SCREDENT was able to arrive at 
a solution. Altogether, approximately 1600 vectors (representing teeth under examina-
tion) were processed.  
 
        Table  6.1  Summary of SCREDENT test samples 
         1 Area under the ROC curves: asymptotic significance level, p <0.001 
 
 
The results show that in almost 95% of the cases, SCREDENT's predictions for tooth 
extraction (conditional probability cut-off value: 0.5) agree with the actual tooth 
extractions carried out as part of the preradiation oral screening. True-positive, true-
negative, false-positive, and false negative values are shown in Table 6.1, along with 
sensitivity and specificity values. Fig 6.5 displays ROC curves. The areas under the ROC 
curves of the test samples ranged from 0.941 to 0.987 (mean 0.964), which also 
 
SCREDENT 
Sample 
 
True 
pos. 
 
False 
pos. 
 
True 
neg. 
 
False 
neg. 
 
 
Sensitivity 
 
 
Specificity 
Area under 
the ROC 
Curve1 
 
Accuracy 
(%) 
test 1 9 1 47 3 0.75  0.97 0.967 93 
test 2 17 3 39 1 0.89  0.98  0.979 93 
test 3 17 5 36 2 0.89 0.87  0.945 88 
test 4 17 4 34 5 0.77  0.89  0.941 85 
test 5 13 0 45 2 0.86 1.00  0.987 97 
test 6 21 2 34 3 0.87 0.94 0.970 92 
Validation 
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   Validation sample 
………   Test samples 1-4 
    Test sample 7 
demonstrates a very high predictive accuracy. The area under the ROC curve of the 
validation sample was 0.987, which was the second highest of all ROC curves. It should 
be noted here that SCREDENT's specificity is slightly better than its sensitivity. This 
means that SCREDENT predictions are more accurate when a tooth should not be 
extracted or will not be lost than when a tooth requires extraction. 
                Figure 6.5   Receiver Operating Characteristics (ROC) curves. 
 
 
SCREDENT predictions revealed that the patient factor "patfact" has a major 
influence on the prediction values. A hypothetical prediction example is depicted in Fig 
6.6. The output values (conditional probabilities) in the column "tloss" were predicted on 
the basis of the model vectors in the training set with known outputs. Rows 1-6 represent 
teeth (together with dental health status and radiotherapy conditions) of a patient with a 
high 'dental IQ' (patfact=1). The overall 'mean' conditional probability for tooth loss 
(dental extraction) is 0,148. Rows 7-12 represent the same teeth, but now for a patient 
with unfavorable "dental IQ" (patfact=0). The overall "mean" conditional probability for 
tooth loss is now 0.626, that is 4.2 times higher, which shows that the mean probability 
of tooth loss (column "tloss") in patients with "patfact" = 1 (high dental IQ), in rows 1-6, 
is 4.2 times higher than in cases with "patfact" = 0  (average/low dental IQ), in rows 7-
12.  
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Figure  6.6  SCREDENT's prediction view of a hypothetical sample, further explained in text 
 
 
 
 Discussion 
 
Many clinical decisions are based primarily on values or beliefs and on various 
resources: opinion-based decision-making. At present, more and more attention is being 
given to evidence derived from research: evidence-based decision-making.(15,17) As 
stated before, good clinicians use both individual clinical expertise and the best available 
external evidence. In this paper, we propose SCREDENT, a system to support dental 
decision-making in patients with head and neck cancer. The rationale for constructing 
SCREDENT came from the understanding that decision-making in this area is often 
critical while evidence-based guidelines were not yet available.(5,9) 
SCREDENT incorporates a patient factor, describing patient's "dental-mindedness" 
or "dental IQ,"(41) that significantly influences the outcome of the prediction. The patient 
factor stresses the importance of the patient's overall dental health at the time of the 
pretherapy dental screening, as noted in our previous study.(18) We have found that, when 
a head and neck cancer patient presents with poor dental health at the pretherapy oral 
screening, there will be substantial preradiation tooth loss. Moreover, if these patients 
have remaining teeth during irradiation, they are more likely to continue to develop 
dental pathosis following radiotherapy than are patients who present with satisfactory 
dental health.(42) Subsequent to the radiation, they will need extensive dental treatment, 
including tooth extractions. Consequently, the initial treatment planning, enhanced by 
SCREDENT, should include the anticipation that the remaining dentition of patients 
presenting with poor dental health may continue to deteriorate. In these cases, 
SCREDENT accurately predicts whether tooth extraction is the most favorable option 
for preradiation intervention. 
Comparing SCREDENT's performance to the logistic regression model shows that 
SCREDENT performs slightly better (accuracy 92%, versus 90% for the logistic 
0,148 
0,626 
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regression model). However, unlike the logistic regression model, SCREDENT can 
handle missing or inaccurate data,(22) and the explicit form of the relationships between 
the input variables and the output does not have to be specified in neural network 
models.(43) 
A very important issue is to verify whether the predictions are applicable to the 
patient under examination. Additional considerations, such as the lack of clinical or 
financial resources, may require adjustment of the overall treatment plan.  In addition, 
timing considerations are very important. If the interval between the preradiation oral 
screening and the start of the radiotherapy is limited, dental intervention involving 
extensive dental treatments is usually not possible. On the other hand, teeth requiring 
extraction, as indicated by SCREDENT, can be left in place until later if they are NOT in 
the high-dose radiation field. This demonstrates that a decision support system is not 
prescriptive. SCREDENT can inform, but it can never replace individual expertise. 
The fact that the validation sample produced the second highest accuracy result may 
reveal a form of bias. Developing SCREDENT obviously provided feedback to the 
decision-making authors. Analysis of the decision problem yielded additional 
knowledge. In effect, it may have influenced the decision-makers' opinion and degree of 
belief in the appropriateness of the dental intervention decisions, leading to decisions 
that were more congruent with SCREDENT's predictions. This also illustrates the 
dynamic property of decision support systems.(27,32,44) By means of feeding all 
appropriate decisions made on the basis of SCREDENT's predictions back into the 
training set, a framework is created for continuous updating and adjusting of the decision 
process. This not only allows evidence-based decision-making but also may be a 
component of a quality control system. A further attractive feature of SCREDENT may 
be its use for training inexperienced clinicians. 
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Summary and general discussion  
 
This thesis presents a series of studies that investigated preradiation dental decision-
making in patients with head and neck cancer. In Chapter 1, it is ascertained that in view 
of the risk for oral sequelae resulting from high-dose radiotherapy, special attention to 
preradiation dental planning appears critical. Each case must be managed individually on 
the basis of the patient's needs, the status of the tumor, and the risks for dental health in 
irradiated tissues; a single-formula approach for all patients is contra-indicated.(1)  
In accordance with the evidence-based approach that forms the basis of the health-
care paradigm of this new millennium,(2,3) the main subject of this thesis is to develop 
and to test a decision support system, in order to enhance dental decision-making in 
patients with head and neck cancer. More specifically, studies were conducted to: 
(1)  Identify the decision dilemma and perform a clinical decision analysis; 
(2) Analyze the decision policies of clinicians familiar with and experienced in 
preradiation dental screening in order to describe how dental- and radiotherapy-related 
risk factors influence their decision-making; 
(3) Propose a method for judgment analysis, in order to identify the characteristics of 
individual judgment policies of dental clinicians with respect to the prophylactic 
extraction of teeth;  
(4) Develop and test "SCREDENT," a system for dental decision support in patients with 
head and neck cancer. 
 
 
In the studies underlying this thesis, three different approaches to analyzing 
judgment and decision-making were used: normative, descriptive, and contextual. These 
approaches to analyzing judgment and decision-making relate to two of the four decision 
strategies introduced in Chapter 1, which were applied in this thesis. This is summarized 
in a simple matrix. 
 
 
 
 
 
 
 
 
 
DECISION STRATEGY (see Chapter 1) 
STUDY  
APPROACH 
NORMATIVE  (Chapter 2) 
CONTEXTUAL (Chapter 6) 
COMPUTATIONAL JUDGMENTAL 
DESCRIPTIVE  
(Chapters 3,4,& 5) 
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Normative approach 
 
The normative approach attempts to answer the question, "How should decisions be 
made?" It seeks to identify the decision problem and separate it into manageable 
components that are usually better defined and understood. Studying a complex system 
built out of such components can subsequently be aided by a theoretically sound 
analyzing technique. The process of decomposing and formalizing a problem is called 
"modeling," which allows for exploring, explaining, and arguing about a decision 
problem. The normative approach is used to study a decision situation in which a 
computational strategy(4) should be adopted for decision-making. This applies if there is 
good insight into the decision problem and satisfactory levels of certainty on causation 
and outcome preferences. 
How should decisions be made? The answer is revealed by the formal technique of 
Clinical Decision Analysis,(5,6) which involves "a priori decomposition" of the decision 
process. It refers to separating the decision process into its components before the 
decision is made.(7) Such components include (a) the probabilities or likelihood of 
occurrence of each alternative considered and (b) the utility attached to each alternative. 
Construction of a decision tree prior to the decision is an easy way of simplifying the 
decision process because it forces clarification of all the bases for the decision. Only four 
types of information are needed in order to construct a decision tree: 
(1) What are the possible courses of action? 
(2) What are the events that might follow from those actions? 
(3) What is the probability of occurrence of each event? 
(4) What is the outcome value (utility) of each event? 
Generating this information makes possible the analysis of the decision problem in a 
much more organized and thoughtful way than would otherwise be the case.(5-8)  
 
 
Model for pretherapy decision support 
 
In Chapter 2, Clinical Decision Analysis was used to design and test a Model for 
Pretherapy Dental Decision Support (MDDS). The considerations that underlie the 
decision problem are outlined in detail. In order to construct the decision tree, the Dental 
Risk Factor (DRF), the Malignancy-Related Risk Factor (MRRF), and the Outcome 
Value (OV) are introduced. The major difficulty encountered in constructing the 
decision tree was assessment of probabilities and utilities. When results from evidence-
based research are available, reasonable probabilities can often be deduced. This was not 
the case with regard to the decision-making problem underlying this thesis, as explained 
in Chapter 2. Current clinical standards are descriptive in nature and do not involve 
straightforward probabilities. To compensate for the lack of these evidence-based 
probabilities, baseline estimates are used instead, resulting in what is therefore called a 
base-case analysis.(5) The estimates are than quantified through the use of direct ranking 
methods, using simple comparison scales. These hierarchical scales produce good levels 
of consistency and are very appropriate for making comparisons.(9-13) 
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However, the use of estimates implies a degree of uncertainty and susceptibility to 
biases.  For the purpose of testing the robustness and the coherence(14) of the MDDS, 
probabilistic sensitivity analyses were performed using second-order Monte Carlo 
simulations.(15) The sensitivity analyses show that in general, the decisions supported by 
the model are robust and the model is coherent (using 10,000 simulations, and a 95% 
confidence interval). The overall conclusion is that the MDDS is a useful tool for the 
development of evidence-based guidelines. 
The MDDS points out that in selected cases (favorable complementary decision 
factors, i.e. adequate clinical and financial resources, and satisfactory levels of patient 
compliance) and under certain risk conditions (especially, moderate risk conditions), it is 
worthwhile, with regard to better patient outcomes, to accept some degree of risk of an 
adverse outcome. Here, the model reveals the area in which further clinical research may 
be most valuable: how would clinicians use or "weight" the components of the decision 
tree in making pretherapy dental decisions? Do they accept some risk or do they avoid 
risky choices? These questions were solved using a descriptive approach. 
 
 
Descriptive approach 
 
The second approach in this thesis to analyzing Judgment and Decision-Making 
(JDM) is descriptive. The descriptive approach to JDM attempts to answer the question, 
"How do people make decisions?" It recognizes that people do not always follow 
normative rules and therefore tries to characterize their actual behavior and beliefs.(16-18) 
This descriptive approach is used to study a decision situation in which a judgmental 
strategy(4) for decision-making should be adopted. 
How do clinicians make judgments and decisions? The answer may be revealed via 
Clinical Judgment Analysis (CJA),(14,19) which involves "a posteriori decomposition" of 
the judgment process.(7) If a priori decomposition implies decomposing the decision 
process prior to its occurrence, then a posteriori decomposition obviously implies that 
decomposition will take place after a series of judgments have been made. It is 
meaningful to recall the definitions of judgment and decision-making introduced in 
Chapter 4: clinical judgment is based on the weighting and combining of information so 
as to arrive at conclusions that can serve as a basis for clinical decision-making. The 
latter process involves selecting courses of clinical action in order to achieve optimum 
outcomes.  
As outlined in Chapter 3 and 4, the judgment policies of a group of clinicians 
("between-judges") and of individual judges ("within-judge") can be captured after 
judgments are made regarding paper cases; the results may then be used to set up a 
survey to analyze clinical cases (Chapter 5). 
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Judgment analysis survey 
 
The findings of the international survey using a consensus questionnaire (Chapter 3) 
support the assumption made in Chapter 2 that policies in this field seem to be based 
primarily on clinical experience and opinions rather than on evidence-based guidelines.  
Nonetheless, opinion-based and experience-based decision-making are essential compo-
nents of the clinical thought process,(3,7) as explained in Chapter 1. 
Findings from the survey show a high correlation between the aggregated policies of 
the clinicians and the MDDS (correlation coefficient: 0.85; p < 0.01), indicating that this 
model may be appropriate in further solving the decision problem. 
As a cue for decision-making, the Dental Risk Factor (DRF) was far more important 
than either the irradiation factor (RTX) or tooth functionality (STRAT). Yet, clinicians' 
degree of certainty in the appropriateness of their decisions is significantly influenced 
(R= 0.69; p<0.01) by only the radiation dose on teeth (RTX) and not by dental conditions 
(DRF) or by tooth functionality (STRAT). This finding may be explained as follows: the 
dental intervention decision prior to irradiation is triggered by the fact that a high 
radiation dose will be delivered to the oral structures. Clinicians are quite certain of the 
necessity and appropriateness of this dental intervention. Anticipating irradiation, they 
subsequently make their judgments and decisions based mainly on dental health 
characteristics. As explained in Chapter 5, a parallel applies for tooth loss in these 
patients. Tooth loss is initiated by irradiation but is primarily correlated to dental factors. 
The findings in Chapter 3 apply to the aggregated policies of all forty-four clinicians, 
which were analyzed at group level. It is important to note here that a simple aggregation 
and a "majority rule" were used prior to the statistical analysis, in order to combine the 
independent judgments of multiple clinicians. Mean levels of clinicians' consensus show 
great similarity in their policies. However, this similarity is lower in the case of moderate 
dental risk conditions. Moreover, tooth functionality was not an important factor in 
clinicians' extraction decisions. One explanation might be that, particularly in these 
patients, clinicians found it difficult to acknowledge the functional impact of missing 
teeth. In adults and older persons, it has been shown that oral function problems increase 
when the number of retained teeth decreases.(20-25) In head and neck cancer patients, oral 
function problems relate primarily to the type and extent of tumor therapy.(26-30) The 
functional impact of the dental status is therefore most likely an additional factor and of 
less concern to a majority of, or perhaps to all, clinicians. 
The low importance of tooth function as a cue for preradiation dental decision-
making may also be related to "risk aversion." Many decision theorists have described 
individual differences in attitudes toward risk. It has been shown that one's willingness to 
accept risk (or willingness to gamble) is dependent on specific outcome dimen-
sions(9,31,32)  (in the problem domain of this thesis: oral complications, oral functioning), 
and on personal experiences.(17) For example, a clinician familiar with one or more cases 
of osteoradionecrosis induced by post-irradiation dental extractions is more likely to 
reduce his level of risk-taking by extracting more teeth prior to irradiation. Accordingly, 
the decision-maker seems less prepared to consider the "expected utility" or benefit of 
retaining functional teeth.(33,34) However, as the judgment analysis in Chapter 3 was 
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carried out at group level, these individual differences in the perception of risks and 
anticipated benefits could not be detected by this method. 
Several authors note that an aggregation of independent judgments is more accurate 
than individual responses.(35-38) In fact, the accuracy of an aggregate is a function of the 
number of raters and the agreement between raters.(39,40) cited by (35) However, several 
experiments have shown that the quality of answers improves with increasing group size 
up to about 13, after which the law of diminishing returns takes over(41,42) and 
"regression to the mean" may become apparent.  This leads to another assumption, that 
analysis of individual judgment policies before they are compared and aggregated may 
reveal additional information. 
 
 
JANNET 
 
These assumptions concerning the need for analysis on an individual basis resulted 
in the development of JANNET (Chapter 4). JANNET, Judgment Analysis by Neural 
NETwork, was designed to be used when the assumptions underlying multiple 
regression analysis, the principle analysis method for Judgment Analysis,(14,19) are not 
met. For each individual clinician, JANNET produced the Likelihood Ratio (LR) of each 
type of dental intervention for strategic teeth versus non-strategic teeth. Hence, the 
JANNET approach made possible the recognition of probabilistic "patterns" in 
individual judgment policies. Using the K-means cluster analysis based on the LR  of 
each response option resulted in 4 clusters. A summary profile of the clusters is given in 
Chapter 4 (Table 2 and Figure 5). In contrast to the LR's response options "tooth 
extraction" and "dental treatment," the LR of response 3 ("no-action") failed to 
contribute significantly to the clustering of the judges.  
Using the results from the clustering allows the judgment making of the clinicians to 
be analyzed more precisely than is allowed by the between-judge analysis in Chapter 3. 
As discussed previously, such an improved insight into this particular area of "nonlinear" 
judgment and decision-making could be helpful for the development of evidence-based 
guidelines and for training of clinicians.(43) For example, it has revealed that certain 
clinicians tend to avoid risky choices, and that others are willing to take some risk by 
retaining teeth in the anticipation of better outcomes in terms of oral function.(44) 
 
 
Cohort study 
  
The cohort study (45,46) described in Chapter 5 involved a retrospective and follow-up 
evaluation of 209 patients treated with radiation for cancer of the head and neck. This 
study was designed to investigate the association of tooth loss with dental status (number 
of retained teeth), dental risk factors (DRFs), and radiotherapy-related factors 
respectively. A further objective was to study the incidence of radiation caries and 
osteoradionecrosis. 
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 The results of the analyses indicate that the level of tooth loss was statistically 
significantly associated with dental status and the number of high DRFs at baseline, and 
also with radiotherapy factors (number of teeth and/or the major salivary glands in the 
high-dose radiation field). These findings compare to the conclusions made in Chapter 3 
that the decision policies of clinicians seem to be primarily based on dental factors, 
including patients' overall dental health, and also on factors concerning radiotherapy.  
The findings of this clinical survey indicate that when a head and neck cancer patient 
presents with reduced dentition and/or with poor dental health at the preradiation oral 
screening, substantial tooth loss may result. It is concluded that tooth loss in the patients 
in this sample is considerably higher than the amount of tooth loss described in 
epidemiological studies concerning the general population. (47-64) Moreover, patients who 
have remaining teeth during irradiation are at risk of developing new dental pathosis, 
such as radiation caries, following radiotherapy. Subsequent to the radiation, a patient 
who presented initially with poor dental health may again need extensive dental 
treatment, including tooth extractions. Consequently, the preradiation treatment plan, 
enhanced by dental decision-making, should include this anticipation. Uncompromising 
preradiation dental intervention is therefore warranted. A survey study that would further 
define the relationship between a head and neck cancer patient's perception regarding the 
need for dental rehabilitation and his or her ability to comply with the advised dental 
treatment and oral hygiene measures is recommended. 
 
 
Contextual approach 
 
The third and final approach to analyzing judgment and decision-making is 
contextual. Occasionally, the term "prescriptive" is used to outline how we can help 
clinicians make better decisions.  "Prescriptive" implies a degree of obligation and 
inflexibility. As explained in Chapter 1, good clinicians use both individual clinical 
expertise and the best available external evidence. External clinical evidence can inform, 
but can never replace individual expertise. Since evidence-based medicine is therefore 
not an obligatory 'cookbook' approach,(65) in this thesis the term "contextual" is 
introduced. This term should be interpreted as: "within the context of the decision 
problem," but also as: "from the context or approach of evidence-based decision 
making." The former interpretation implies that the decision maker not only understands 
but also takes into account all components of the decision-making process. The latter 
interpretation of the term "contextual" relates to the paradigm of evidence-based 
decision-making. As explained by Muir Gray, an evidence-based approach initiates 
strategies to increase the good-to-harm ratio of therapies, resulting in an increase in the 
effectiveness of healthcare.(3)  
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SCREDENT 
 
In Chapter 6, SCREDENT, a computer-based system for dental decision support in 
patients with head and neck cancer, is presented. Using methods of probability and 
decision theory, this system is capable of modeling dental decision problems. It allows 
for combining expert opinions with observational data and processes the information to 
support decision-making. SCREDENT is especially valuable in situations in which 
confidence and reliability are of primary importance. 
The findings from the first four studies in this thesis reveal that dental factors, 
radiation conditions, and patient's dental IQ are the most important variables in the 
decision process. The outcome value in terms of oral functioning seems of secondary 
importance in the decision process and has therefore not been included.  
SCREDENT was easy to train, and making predictions using the spreadsheet type 
"prediction view" is a straightforward procedure.  The software allows data to be added 
or deleted from the training set without lengthy retraining. As with human experience, 
artificial neural network learning is often a continuous process.(66) Additional input data 
collected during operation can improve the performance because it can be fed back into 
SCREDENT without difficulties. 
Testing of SCREDENT revealed high levels of accuracy, indicating that the system 
is capable of modeling preradiation dental extraction decisions in patients with head and 
neck cancer.  However, what is the advantage of SCREDENT, if any, over the decision-
tree model, the MDDS?  
 
 
Decision-tree model (MDDS) versus SCREDENT 
 
Clinicians often weight  (parts of) clinical data in a nonlinear fashion.(14) In general, 
nonlinear phenomena are pervasive in the medical domain.(67) The association between 
dental status and tooth loss, outlined in Chapter 5 and depicted in Fig 5.2 on page 77 is a 
good example of such a nonlinear phenomenon. Another simple example may illustrate 
these nonlinear phenomena. As shown in Chapter 3, the periodontal condition of a tooth, 
assessed by measuring the depth of a periodontal pocket using a special probe, is a 
significant cue for dental extraction prior to radiation therapy.  If we plot the risk level or  
"level of concern" against the pocket depth we can clearly identify the sigmoidal shape 
of the curve (nonlinear equation), see Fig 7.1. Thus, the difference in pocket depth of 1 
mm has major implications only when the pocket depths are in the interval of 4-7 mm. If 
a pocket depth is 11 mm instead of 8 mm, in this interval, the difference of 1 mm has 
virtually no consequences for the decision.  
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                             Figure 7.1    
 
 
Calculating expected values (EVs) by means of "folding back and averaging out" a 
decision tree (Chapter 2) is in fact a linear process with a limited number of outcomes. 
For example, the decision tree presented in Chapter 2 has 23 branches and 2 outcome 
variables, resulting in sixteen different Expected Values (Evs). Instead, the probabilistic 
neural network application not only easily handles a large number of conditions but also 
models nonlinear phenomena. The same applies to the neural network approach to 
clinical judgment analysis outlined in Chapter 4. The JANNET method enabled analysis 
of individual judgment policies when the technique of multiple regression analysis could 
not be applied because the linearity and normality assumptions underlying this technique 
were not met. 
Moreover, missing data of one or more decision-tree components (e.g. missing nodes 
or missing probabilities) fully corrupt the process of "folding back and averaging out." 
SCREDENT, however, can handle missing data very well. The system is capable of 
generalization: similar inputs produce similar predictions despite small deviations in the 
input data. Generalization in neural networks may be viewed as multidimensional   inter-
polation.(66,68) 
 Another important advantage of using SCREDENT over the decision-tree model is 
that the former is self-organizing and is capable of learning the most complicated 
relationships between the training vectors ("training vectors" are further explained in 
Chapters 4 and 6, and in Appendix 3) and their correct classification.(66,69-72) Here, one of 
SCREDENT's major potentials becomes clear: by feeding all appropriate decisions made 
on the basis of SCREDENT's predictions back into the "knowledge domain" comprising 
the training vectors, this system allows for continuous updating and adjusting of the 
decisions process and therefore not only permits evidence-based decision-making, but 
also may be a component of a quality control system in this problem domain. 
  
 
level of 
concern 
8 10 12 6 4 2 
periodontal pocket depth 
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Conclusions 
 
(1) The Model for Pretherapy Dental Decision Support (MDDS) in patients with head 
and neck cancer identifies and structures dental decision problems, and appears a useful 
tool for the development of evidence-based guidelines in this domain. 
 
(2) The preradiation dental decision policies of a group of experienced oral-maxillofacial 
surgeons and hospital dentists seem to be based primarily on clinical experience and 
opinions rather than on evidence-based guidelines; the policies are mainly determined by 
dental risk factors; the certainty concerning the appropriateness of the decisions depends 
only on irradiation factors. 
 
(3) The JANNET approach, which looks promising and should be further tested, makes 
possible the recognition of probabilistic "patterns" in nonlinear judgment policies and the 
subsequent grouping of clinicians with related decision policies together. 
 
(4) A majority of the clinicians participating in the international survey do not use tooth 
functioning as a significant factor in the preradiation decision making process; instead, 
they appear to avoid possible adverse outcomes by extracting teeth prior to irradiation, 
which may be interpreted as "risk aversion." 
 
(5) Tooth loss in patients with head and neck cancer is statistically significantly 
associated with preradiation dental-health status, the number of high dental risk factors, 
and radiotherapy-related factors; the incidence of radiation caries following radiotherapy 
is associated with the number of high dental risk factors at the time of the preradiation 
dental screening.   
 
(6) The initial dental treatment planning in patients with head and neck cancer, enhanced 
by clinical decision-making, should include the anticipation that the patient's oral health 
may deteriorate following radiotherapy, especially in cases initially presenting with poor 
dental health; therefore, uncompromising preradiation dental intervention is warranted. 
 
(7)  SCREDENT, a computer-based system for preradiation dental decision support in 
patients with head and neck cancer, is accurate in predicting tooth loss (i.e. dental 
extractions); the system can learn from those of its predictions that turned out to be 
appropriate, and may therefore be useful as tool for the continuous updating of evidence-
based clinical guidelines and for quality control in this domain. 
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Samenvatting  
 
Hoofdstuk 1 is de algemene inleiding van dit proefschrift. Hierin worden de 
probleemstelling, de doelstellingen en de opbouw gepresenteerd. Eerst komen een aantal 
aspecten van hoofd-halstumoren aan de orde. Vervolgens wordt ingegaan op de orale 
gevolgen van radiotherapie in het hoofd-halsgebied. Om deze complicaties zoveel 
mogelijk te beperken zijn preventieve en curatieve tandheelkundige maatregelen 
voorafgaand, tijdens en na de tumorbehandeling onontbeerlijk.  Met de tandheelkundige 
screening die aan de tumorbehandeling vooraf gaat worden tandheelkundige risico-
factoren opgespoord. Een op het individu toegesneden behandelplanning, waarbij sterk 
rekening wordt gehouden met de medische en psychosociale componenten dient hierbij 
centraal te staan. Het blijkt  niet mogelijk om voor het tandheelkundige beleid standaard-
procedures toe te passen.  
Dit proefschrift zoekt naar een oplossing met behulp van klinische besliskunde. 
Hierbij worden vier verschillende beslissingsstrategieën geïntroduceerd: (1) de 
rekenkundige strategie, (2) de beoordelingsstrategie, (3) de compromisstrategie en (4) de 
gokstrategie. De rekenkundige strategie en de beoordelingsstrategie worden uitgewerkt 
en toegepast in het proefschrift.  
De doelstelling van dit proefschrift is het ontwikkelen en testen van een systeem 
voor het ondersteunen van tandheelkundige beslissingen voorafgaand aan radiotherapie 
bij patiënten met een hoofd-halstumor. Dit wordt gerealiseerd door: 
(1) Een analyse van de tandheelkundige beslissingen die voorafgaand aan radiotherapie 
worden genomen;  
(2) Een analyse van de besluitvorming van op dit gebied ervaren kaakchirurgen en 
ziekenhuistandartsen met als doel te beschrijven hoe de tandheelkundige en de aan 
radiotherapie verbonden risicofactoren hun besluitvorming beïnvloedt;  
(3) Het presenteren van een nieuwe methode om te analyseren welke individuele 
afwegingen kaakchirurgen en tandartsen maken bij de beslissing om gebitselementen 
voorafgaand aan radiotherapie te extraheren;  
(4) Het nagaan in hoeverre gebitsverlies bij patiënten met een hoofd-halstumor 
verbonden is met de gebitsstatus en de aanwezige tandheelkundige en 
radiotherapeutische risicofactoren;  
(5) Het ontwikkelen en testen van  SCREDENT, een systeem dat ondersteuning biedt bij 
het nemen van tandheelkundige beslissingen bij patiënten met een hoofd-halstumor. 
In Hoofdstuk 2 wordt een klinische beslissingsanalyse beschreven die uit vier 
stappen bestaat: 
(1) Inventariseren en analyseren van de dilemma’s bij het nemen van beslissingen, 
gevolgd door het opstellen van een beslisboom; 
(2)  Bepalen van kansen en uitrekenen van de beslisboom; 
(3)  Afwegen van de optimale beslissingen; 
(4)  Sensitiviteitsanalyse waarbij gebruik wordt gemaakt van tweede orde "Monte Carlo"  
simulaties. 
                                                                                                                                        CHAPTER 8 
113 
Deze stappen resulteren in een beslissingsmodel (Model for Dental Decision Support 
--MDDS) voor optimalisatie van tandheelkundige beslissingen. De resultaten van de 
sensitiviteitsanalyse tonen aan dat het model voldoende robuust is. Het model lijkt 
daarom geschikt om richtlijnen te ontwikkelen die op wetenschappelijk onderzoek  zijn 
gefundeerd (Eng. evidence-based guidelines). De conclusie is dat verdere beoordeling 
van de validiteit van het model nodig is voordat praktische toepassing mogelijk is.  
In Hoofdstuk 3 wordt een internationaal onderzoek beschreven. Het werd uitgevoerd 
om inzicht te krijgen in de besluitvorming van kaakchirurgen en ziekenhuistandartsen 
die ruime ervaring hebben met de tandheelkundige screening. Aan in totaal 54 kaak-
chirurgen en ziekenhuistandartsen in diverse landen werd een vragenlijst toegezonden. 
Vierenveertig kaakchirurgen en ziekenhuistandartsen retourneerden de vragenlijst (een 
respons van 81%). Door een zogenoemde "klinische beoordelings-analyse" (Eng. 
clinical judgment analysis) toe te passen op de verzamelde antwoorden van de gehele 
groep is er sprake van een inter-beoordelaarsanalyse (Eng. between-judges analysis).  
De resultaten van de beoordelingsanalyse tonen aan dat 88% van de genomen 
beslissingen en 49% van de daarbij ervaren zekerheid kan worden verklaard door de 
tandheelkundige en radiotherapeutische risicofactoren. Bovendien blijkt de besluit-
vorming van de kaakchirurgen en de ziekenhuistandartsen in hoge mate gecorreleerd 
(correlatiecoëfficiënt = 0.85) met het beslisboom-model (MDDS). Slechts 9 van de 44 
deelnemers (20%) gebruikten schriftelijke richtlijnen bij de tandheelkundige screening 
voorafgaand aan de radiotherapie. Dit bevestigt de veronderstelling dat de besluit-
vorming vooral gebaseerd is op ervaring en persoonlijke standpunten in plaats van op 
richtlijnen die op wetenschappelijk onderzoek zijn gefundeerd. Geconcludeerd wordt dat 
het beslismodel (MDDS) een goede basis is voor verder onderzoek. Ook kan het model 
voor onderwijsdoelen worden gebruikt. 
In Hoofdstuk 4 wordt JANNET (Judgment Analysis via Neural NETwork) 
gepresenteerd. Deze nieuwe analysetechniek voor klinische beoordelingsanalyse (Eng. 
clinical judgment analysis) maakt gebruik van een artificieel neuraal netwerk en 
verschilt daardoor van de meeste klinische beoordelingsanalysen waarbij de 
analysetechniek gebaseerd is op multiple regressieanalyse. JANNET kan worden 
toegepast wanneer de aannamen voor multipele regressie analyse ongeldig zijn. 
Ter beoordeling van de bruikbaarheid van de analysetechniek wordt JANNET 
toegepast op de besluitvorming van de kaakchirurgen en ziekenhuistandartsen uit het 
internationale onderzoek dat in Hoofdstuk 3 wordt gepresenteerd. Omdat JANNET 
wordt uitgevoerd op individueel niveau en niet op groepsniveau, is er sprake van een  
intrabeoordelaars-analyse (Eng. within-judges analysis).  
Er wordt aangetoond dat met behulp van JANNET bepaalde patronen in de besluit-
vorming te herkennen zijn. Zo blijkt dat de clinici onderling sterk verschillen in de mate 
waarin ze de functie van gebitselementen wegen. Geconcludeerd wordt dat deze nieuwe 
techniek het verdient om verder te worden getest en toegepast. 
In Hoofdstuk 5 wordt een onderzoek beschreven bij 209 patiënten die vanwege een 
hoofd-halstumor met radiotherapie zijn behandeld. Onderzocht wordt de relatie tussen de 
mate van gebitsverlies en de gebitsstatus alsmede de tandheelkundige en  
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radiotherapeutische risicofactoren.  Een nevendoel is om het aantal gevallen van radiatie-
cariës en osteoradionecrose te bestuderen.  
Het totale gebitsverlies in een periode van 1 tot 5 jaar (mediaan: 3 jaar) was in de 
onderzoekspopulatie veel hoger dan voor de algemene populatie volwassenen is 
beschreven. De relatie tussen gebitsverlies en de gebitsstatus alsmede de tandheel-
kundige en radiotherapeutische risicofactoren wordt aangetoond. Tevens wordt vast-
gesteld dat radiatiecariës optrad bij 45% van de patiënten die tijdens de bestraling een 
natuurlijke (rest)dentitie hebben. Osteoradionecrose bleef beperkt tot 5 gevallen. 
De uitkomsten van het onderzoek ondersteunen de conclusie uit Hoofdstuk 4 dat de 
besluitvorming van kaakchirurgen en ziekenhuistandartsen op dit gebied voornamelijk 
wordt bepaald door tandheelkundige factoren. De uitkomsten vormen een belangrijke 
richtlijn voor tandheelkundige screening. Indien voorafgaand aan de radiotherapie bij 
een patiënt met een hoofd-halstumor een slechte gebitstoestand wordt aangetroffen, is 
het waarschijnlijk dat er na de radiotherapie opnieuw omvangrijke gebitspathologie 
ontstaat. Daardoor zullen er bij radiotherapie vaak uitgebreide tandheelkundige 
behandelingen, met inbegrip van gebitsextracties, nodig zijn. In het geval van een slechte 
begintoestand van het gebit is een grondige tandheelkundige sanering noodzakelijk. 
Hiermee dient bij het opstellen van het tandheelkundig behandelplan grondig rekening te 
worden gehouden.  
In Hoofdstuk 6  wordt  SCREDENT beschreven. Dit is een computerprogramma 
voor beslissingsondersteuning dat gebruik maakt van een artificieel neuraal netwerk. 
SCREDENT werd ontworpen aan de hand van de resultaten van het onderzoek dat in 
Hoofdstuk 5 beschreven werd.  ROC-curve analyse, predictieve waarde (Eng. accuracy) 
en logistische regressieanalyse werden gebruikt om SCREDENT te testen. De resultaten 
tonen aan dat SCREDENT in bijna 95 % van de gevallen een juiste voorspelling geeft 
voor gebitsextractie als beste optie voor tandheelkundige interventie (predicatieve 
waarde 0.94). Door de mogelijkheid om voorspellingen van SCREDENT die bij 
evaluatie juist blijken, vervolgens weer naar het kennisdomein (Eng. knowledge domain) 
van het systeem terug te koppelen, wordt het systeem "zelflerend" gemaakt.  
Hoofdstuk 7 bevat een samenvatting en een algemene discussie. Ook worden de 
conclusies van dit proefschrift gepresenteerd.  
De wetenschappelijke aanpak in dit proefschrift wordt in dit hoofdstuk geplaatst in 
het perspectief van een aantal benaderingen voor het analyseren van klinische 
beoordelingen en beslissingen (Eng. judgment and decision making): de normatieve, de 
beschrijvende en de contextuele benadering.  
De normatieve benadering beoogt de volgende vraag te beantwoorden: "hoe dienen 
beslissingen te worden genomen?" Het antwoord wordt in dit proefschrift  verkregen met 
behulp van de in Hoofdstuk 2 uitgewerkte rekenkundige strategie voor het nemen van 
klinische beslissingen. Met deze strategie wordt een beslisproces van tevoren 
gestructureerd en geanalyseerd. Door het gebruik van de normatieve benadering ontstond 
het  beslismodel (Model for Dental Decision Support --MDDS) voor optimalisatie van 
tandheelkundige beslissingen. Het construeren en het testen van dit model riep 
vervolgens nieuwe onderzoeksvragen op. Hoe wegen ervaren kaakchirurgen en 
ziekenhuistandartsen de factoren bij het tandheelkundige beslissingsproces dat aan 
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radiotherapie in het hoofd-halsgebied vooraf gaat? Zijn ze bereid om daarbij enig risico 
te nemen of proberen ze elk risico te vermijden?  
Deze vragen worden in de Hoofdstukken 3 en 4 beantwoord met behulp van de 
beschrijvende benadering. Deze benadering beoogt de volgende vraag te beatwoorden: 
"hoe worden beslissingen genomen?" De beschrijvende benadering maakt gebruik van 
de in Hoofdstuk 1 geïntroduceerde beoordelingsstrategie voor het nemen van klinische 
beslissingen.  
Met de beschrijvende benadering wordt aangetoond dat de meerderheid van de tand-
artsen en kaakchirurgen risicovolle beslissingen uit de weg gaat en dat "gebitsfunctie" 
meestal geen belangrijke factor is bij hun besluitvorming. De meest waarschijnlijke 
verklaring is dat deze clinici moeite hebben met het inschatten van de gevolgen van 
gebitsverlies op de orale functie bij dit type patiënten. Maar ook is het mogelijk dat de 
orale functie door hen ondergeschikt wordt gemaakt aan het vermijden van orale risico's 
bij hoofd-halsbestraling 
De beschrijvende benadering wordt ook toegepast bij het in Hoofdstuk 5 
gepresenteerde onderzoek van 209 patiënten die met radiotherapie behandeld zijn 
vanwege een hoofd-halstumor. 
De derde en laatste benadering in dit proefschrift bij de bestudering van  klinische 
beoordelingen en beslissingen is contextueel. Deze term verwijst naar het belang om 
zoveel mogelijk aspecten bij de besluitvorming te betrekken. De contextuele benadering 
wordt gebruikt om het in Hoofdstuk 6 beschreven SCREDENT systeem te ontwikkelen 
en te testen. Net als het beslisboom-model is ook SCREDENT gebaseerd op de reken-
kundige strategie 
De voordelen die het gebruik van SCREDENT heeft ten opzichte van het 
beslisboom-model (MDDS) worden ook in Hoofdstuk 7 besproken. In vergelijking tot 
het beslisboom-model kan SCREDENT een groot aantal condities verwerken en kan 
tevens niet-lineaire verbanden modelleren. Bovendien kan SCREDENT incomplete 
gegevens verwerken, en kan tevens generaliseren en gecompliceerde verbanden in het 
kennisdomein interpreteren. Het grootste voordeel van SCREDENT komt echter voort 
uit de 'zelflerende' eigenschappen van het systeem. Door terugkoppeling van de 
resultaten kunnen beslissingen voortdurend worden geoptimaliseerd. Daardoor is 
SCREDENT een systeem voor het nemen van "evidence-based" beslissingen en 
verschaft tevens een raamwerk voor kwaliteitscontrole.  
Het doel van Appendix 1 is een voorbeeld te geven van het theorema van Thomas 
Bayes, een dominee en wiskundige uit de 18e eeuw. Het voorbeeld laat zien dat er een 
verschil bestaat tussen de waarden van voorwaardelijke kansen die mensen intuïtief 
bepalen en de waarden die met behulp van een rekenkundig methode bepaald worden en 
hoe het theorema van Bayes deze verschillen kan verkleinen. 
Appendix 2 bevat het SCREDENT onderzoeksformulier en de richtlijnen voor het 
gebruik er van. 
Appendix 3 bestaat uit het  "SCREDENT getting started" document een handleiding 
voor de installatie en het gebruik van het SCREDENT computerprogramma. 
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Conclusies 
 
(1) Met het model voor tandheelkundige beslissingsondersteuning (MDDS) kunnen 
tandheelkundige risicofactoren bij patiënten met een hoofd-halstumor  geïdentificeerd en 
gestructureerd worden. Het model blijkt bruikbaar als instrument voor het ontwikkelen 
van "evidence-based" richtlijnen op dit gebied. 
(2)  De tandheelkundige beslissingen die  voorafgaand aan radiotherapie van patiënten 
met een hoofd-halstumor worden genomen, zijn voornamelijk gebaseerd op klinische 
ervaring en persoonlijke standpunten in plaats van op wetenschappelijk onderzoek 
gebaseerde  richtlijnen. De besluitvorming wordt vooral bepaald door aanwezige 
tandheelkundige risicofactoren. De mate van zekerheid hierbij wordt echter primair 
bepaald door aan de radiotherapie verbonden risicofactoren. 
(3) De JANNET methode lijkt veelbelovend en dient verder toegepast en getest te 
worden. Het biedt de mogelijkheid om kansvoorwaardelijke patronen te herkennen in de 
besluitvorming van tandartsen en kaakchirurgen. Hierdoor kunnen clinici met 
overeenkomstig beleid gegroepeerd worden.   
(4) De meerderheid van de kaakchirurgen en ziekenhuistandartsen die deelnamen aan het 
internationale onderzoek gebruiken "gebitsfunctie" niet of nauwelijks als factor in hun 
besluitvorming.  Het blijkt dat ze eventuele complicaties trachten te beperken door ook 
functionele gebitselementen te extraheren voorafgaand aan radiotherapie in het hoofd-
halsgebied, hetgeen als risicovermijding aangemerkt kan worden. 
(5) Gebitsverlies bij patiënten met een hoofd-halstumor is statistisch significant 
geassocieerd met de gebitsstatus, de tandheelkundige risicofactoren en de aan 
radiotherapie verbonden risicofactoren. 
(6) In het tandheelkundige behandelplan dat voorafgaand aan radiotherapie in het hoofd-
halsgebied wordt opgesteld dient sterk rekening te worden gehouden met het feit dat bij 
patiënten waarbij een matige of slechte begintoestand van het gebit wordt vastgesteld, 
ook na de bestraling een grote kans bestaat op het ontstaan van gebitspathologie. Daarom 
is bij deze patiënten het noodzakelijk om het gebit voorafgaand aan de bestraling grondig 
te saneren.  
(7) SCREDENT, een geautomatiseerd systeem voor ondersteuning van tandheelkundige 
beslissingen voorafgaand aan radiotherapie in het hoofd-halsgebied, blijkt accuraat in het 
voorspellen van gebitsverlies. Het systeem is "zelflerend" en lijkt daarom uitermate 
geschikt als instrument voor het voortdurend optimaliseren van op wetenschappelijk 
onderzoek gebaseerde richtlijnen en voor kwaliteitscontrole in dit domein.  
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APPENDIX 1.     Bayes Theorem: an example 
 
 
Thomas Bayes was born in London in 1702 and died in 
Turnbridge Wells, Kent, England, in 1761. He was a clergyman 
and mathematician-in spirit.  He made important contributions to 
the theory of probability. His conclusions were accepted by 
Laplace, and remained unchallenged until Boole questioned them. 
Over the past decade the value of Baysian methods have become 
increasingly apparent and has resulted in a "blossoming" of these 
techniques for reasoning under uncertainty. However, some 
controversy still remains. 
Bayes set out his theory of probability in "Essay towards solving a problem in the 
doctrine of chances" published in the Philosophical Transactions of the Royal Society of 
London in 1764. The paper was sent to the Royal Society by Richard Price, a friend of 
Bayes, who wrote:  
"I now send you an essay which I have found among the papers of our 
deceased friend Mr Bayes, and which, in my opinion, has great merit... In 
an introduction which he has writ to this Essay, he says, that his design at 
first in thinking on the subject of it was, to find out a method by which we 
might judge concerning the probability that an event has to happen, in 
given circumstances, upon supposition that we know nothing concerning it 
but that, under the same circumstances, it has happened a certain number 
of times, and failed a certain other number of times." 
The paper described Bayes' statistical technique known as Bayes Theorem. It bases the 
probability of an event that has to happen in a given circumstance on a prior estimate of 
its probability under these circumstances. The aim of Appendix 1 is to give an example 
of Bayes' approach. 
 
Basic definitions of notation 
 
In this Appendix, we will follow the following definitions of probability:  
• ( )AP : probability of event A, which is a number between 0 and 1. 
• If A represents a certain event then ( )AP =1. 
• ( ) ( )APANOTP −= 1 : probability of non-event A.  
• ( )ABP : probability of simultaneous events A and B.  
• ( )BAP | : conditional probability: probability of event A given event B.  
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Bayes Theorem 
 
The foundation of probability theory follows from the following intuitive definition of 
conditional probability: 
• ( ) ( ) ( )BPBAPABP ∗= |  
In this definition events A and B are simultaneous and have no (explicit) temporal order. 
Therefore, we can write: 
• ( ) ( ) ( ) ( )APABPBAPABP ∗== |  
This leads us to a common form of Bayes Theorem, the equation:  
 
•  
 
 
which allows us to compute the probability of one event in terms of observations of 
another and knowledge of joint distributions.  
 
 
Example: the problem of base-rate neglect 
 
Assume that temporomandibular disorders (TMD) have a prevalence of 1/1000. Next, 
assume that a test to detect the disorder, for example a questionnaire to assess a person's 
signs and symptoms, has a false positive rate of 5%. This means that of all persons with 
a positive test result, 95% has the disorder and 5% has not. Assume that the test 
diagnoses correctly every person who has the disease (false negative rate 0%).  
What is the probability (? %) that a randomly selected person$ found to have a positive 
result actually has a temporomandibular disorder? 
 
A similar type of question involving heart disease was put to a number of students and 
staff at Harvard Medical School. Almost half gave the response 95 %. The average 
answer was 56%. The correct answer was given by less than 10% of the participants. 
 
 
 
 
 
 
 
The correct answer is given on the next page. 
 
 
 
 
$ Do not select a person from the Special Dental Care department's waiting room because the prevalence of 
temporomandibular disorders in this group is much higher! 
( ) ( ) ( )( )ABP
BPBAPAP
|
| ∗
=
What is your answer?     …% 
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The correct answer that a randomly chosen person (from the general population) found 
to have a positive test result, actually has the disorder is 2%! 
An informal way of explaining this result is to think of a population of 10,000 people. 
Given the prevalence of 1/1000, we would expect just 10 people in this population to 
have the disorder. If you test everybody in the population then the false positive rate 
means that, in addition to the 10 people who do have the disorder, another 500 will be 
wrongly diagnosed as having it. In other words, only about 2% (10/510 x 100%) of the 
people diagnosed positively actually have the disorder. 
When people give a high answer like 95%, they are ignoring the very low probability of 
having the disease (base-rate = 0.1%). In comparison, the probability of a false positive 
test is relatively high (5%). 
The formal way of explaining the result, using Bayes Theorem, is as follows: 
Let A be the event "person has the disorder." 
Let B be the event "positive test." 
We wish to calculate              , where A is "having a TMD disorder", and B is "a positive 
test result."  
In fact, it is easier to calculate ( )BANOTP | .  
Therefore, we note that:                                              
Using Bayes Theorem:  
 
 
 
 
Now, we know the following: 
( )AP = 0.001 
( ) ( )APANOTP −= 1  = 0.999 
( )ANOTBP |  = 0.05 
( )ABP |  = 1 (remember, the false negative rate of the test was 0%) 
Hence, 
 
 
Hence,                = 1- 0.09804 is approximately 0.02 (2%) 
 
 
Conclusions 
 
This example illustrates the gap between the judgments people make intuitively and the 
probabilities yielded by explicit calculation or empirical observations. As early as 1954, 
Meehl stated that many clinical predictions could best be made by statistical rather than 
by intuitive means. Slovic et al., (1976) concluded on the basis of diverse research 
findings that people systematically violate the principles of rational decision making 
when judging probabilities, making predictions, or otherwise attempting to cope with 
probabilistic tasks. As shown in this example, a Bayesian approach provides a 
mathematical rule that may enhance rational judgment and decision making. 
( ) ( )BANOTPBAP |1| −=
( )BAP |
( ) ( ) ( )( )
( )
( ) ( ) ( ) )(||
)(|||
ANOTpANOTBPAPABP
ANOTPANOTBP
BP
ANOTPANOTBPBANOTP
∗+∗
∗
=
∗
=
( ) 09804,0
999,005,0001,0
999,005,0| =
∗+
∗
=BANOTP
( )BAP |
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SCREDENT DENTITION ASSESSMENT FORM      (Bruins, Jolly &  Koole,  1999) 
                                                    Date of Birth                                  Gender               Date  of  Oral Screening 
Patient code number                 Day      Month     Year                    M = 1 F = 2           Day       Month     Year                        
                          
  
                                                                                   Location of tumor:      CTNM  stage1              AJCC Stage1 
Type of head & neck  tumor1                                 ICD code1                      T       N       M               (1,2,3 or 4) 
 
 
Tumor record                                   Goal of tumor therapy:          Type of tumor therapy:   (more than one entry possible)
               
 
Dentition Status  (Tooth numbering according FDI system) 
 
 
 
 
 
 
SCC Benign Salivary Gland    
Cure Palliation ? Surgery  Radiation  Chemo  ? 
   
Major salivary glands in radiation field? (Bilaterally, > 50%):       yes / no 
Patient's Dental IQ / Compliance:  high / average-low   (please check guidelines) 
Prosthetic Status 
 
Upper               Lower 
  
 
 
0 =  No  prosthesis  
1 =  Bridge 
2 =  More  than one bridge 
3 =  Partial denture 
4 =  Both bridge(s) /Part.dent. 
5 =  Full removable denture 
9 =  Not recorded 
16 
 
 
 
 
15 
 
 
 
 
18 
 
 
 
 
17 
 
 
 
 
12 
 
 
 
 
11 
 
 
 
 
14 
 
 
 
 
13 
 
 
 
 
23 
 
 
 
 
24 
 
 
 
 
21 
 
 
 
 
22 
 
 
 
 
17 
 
 
 
 
28 
 
 
 
 
25 
 
 
 
 
26 
 
 
 
 
46 
 
 
 
 
45 
 
 
 
 
48 
 
 
 
 
47 
 
 
 
 
42 
 
 
 
 
41 
 
 
 
 
44 
 
 
 
 
43 
 
 
 
 
33 
 
 
 
 
34 
 
 
 
 
31 
 
 
 
 
32 
 
 
 
 
37 
 
 
 
 
38 
 
 
 
 
35 
 
 
 
 
36 
 
 
 
 
STATUS 
DRF 
Reminder Dentition Status Codes1  
TRX 
TREATM. 
STATUS 
DRF 
TRX 
TREATM. 
First Second/ recurrence 
Tooth STATUS:   
 0 =   Sound                                     
 1 =   Decayed                                
 2 =   Filled, with decay                 
 3 =   Filled, no decay                    
 4 =   Missing  
 5 =   Dental implant                               
 6 =   Bridge abutment / crown / implant                     
 7 =   Bridge abutment/  crown, with decay                    
 8 =   Unerupted tooth / unexposed root 
 9=    Not Recorded       
  
DRF:  0 = medium or low, 1= High 
 
TRX:  0 = tooth not in radiation field  (>50Gy.) 
          1 = tooth in radiation field (>50Gy.) 
 
TREATM.:  0 = None, 1 = Dental treatment, 2 = Extraction 
1 see guidelines document 
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SCREDENT Dentition Assessment Form:  guidelines for dental 
clinicians 
 
The SCREDENT form for oral health assessment of patients with head and neck cancer 
is designed for collection of information to support pretherapy dental decision-making, 
by means of the SCREDENT system. The form is designed to facilitate computer 
processing of the findings.  How to recode and enter the data into the SCREDENT 
system is described in the "SCREDENT getting started" document (see Appendix 3). 
To minimize the number of errors, all entries must be clear and unambiguous. Please, fill 
in the boxes and/or mark/circle one or more of the printed response options within with a 
black pencil, e.g.: 
 
                    Gender               Goal of tumor therapy: 
 
 
The form includes the following sections: 
-  Patient identification information; 
-  Head and neck cancer information; 
-  Dentition status and treatment need; 
-  Prosthetic status. 
 
The following should be recorded: 
- Survey and patient identification information 
~ Patient code number: a string of figures and or letters to identify the patient, e.g. 
patient's hospital ID number:  "AB123456" 
~ Date of birth: format: day month year, e.g. "05 12 1953"  
~ Gender: male is coded  as "1", female as "2" 
~ Date of oral screening: format: day month year, e.g. "01 02 1999"  
 
- Head and neck cancer information 
~ Type of head & neck tumor: refers to the histopathology. Approximately 90% of all 
malignant neoplasm of the oral cavity, pharynx, and larynx are: SCC - Squamous 
Cell Carcinoma. If so, mark/circle "SCC" 
If it concerns a benign salivary gland tumor, e.g. a  pleomorphic adenoma: circle 
"Benign Salivary Gland". If it concerns a different type of malignant neoplasm, 
please enter its description in the blank box, e.g. "malignant melanoma" or 
"lymphoma" 
~ Location of tumor: Please enter ICD code (According to the International 
Classification of Diseases, Ninth Revision, Clinical Modification, as published by 
the U.S. Public Health Service and Health Care Financing Administration). A 
comprehensive code list can be found on: http://www.eicd.com/EClass/2htm  
~ CTNM stage: the TNM classification system to be used is that of the American Joint 
Committee for Cancer (AJCC)(1), see page 129,130. 
2 Cure Palliation ? 
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~ Tumor record: "First" has to be used for primary malignant neoplasm's. "Second/ 
recurrence" is for patients who have had prior surgery and/or radiation for a head 
and neck malignancy in the past 
~ Goal of tumor therapy:  record  "cure" if the intention is to cure the patient. Record 
"palliation" or the "?" (unknown) if this applies for the case judged. 
~ Type of tumor therapy: more than one entry possible, e.g. if the treatment regiment 
consists of a combination of surgery and radiation, record both "Surgery" and 
"Radiation" 
~ Major salivary glands in radiation field? Record "Yes" if the major salivary glands 
(parotid and submandibular gland) are both, bilaterally, for at least 50% in the 
radiation field of 50 Gy or more (see figure). To get this information, please check 
simulation radiographs/CT scans and/or consult with the radiotherapist. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- Patient's Dental IQ/Compliance:   
~ Record "High": if  
 *  patient's level of oral hygiene is satisfactory, and  
 *  he or she visits a dentist at least one a year, and  
 *  if the overall level of oral health is satisfactory (the total number of DRF's should 
not be higher than 4), and  
 *  if there are no financial limitations for comprehensive dental care.  
~ Record "average-low" if patient's dental IQ/Compliance does not meet the criteria  
of "High". 
 
- Dentition status  
~ tooth codes according to the system used by the International Dental Federation  
 
 
 
 
 
 
Parotid 
Submandibular 
salivary gland 
Example of  
radiation field  
(50 Gray portal) 
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~ Status:  refers to tooth status (modified from WHO, 1997)(2) 
* Code "0":  Condition = sound, if a tooth (crown and/or root) shows no evidence of 
treated or untreated caries (clinical and/or radiographic). The stages of caries that 
precede cavitation, such as white spots and/or stained pits or fissures, as well as other 
conditions similar to the early stages of caries, are excluded because they cannot be 
reliably diagnosed. 
* Code "1": Condition = decayed: when a lesion in a pit or fissure, or on a smooth 
tooth surface, has a unmistakable cavity, undermined enamel, or a detectable softened 
floor or wall, which feels soft or leathery to probing with a dental probe. 
* Code "2". Condition = filled with decay: when the tooth has one or more permanent 
restorations and one or more areas that are decayed. 
* Code "3". Condition = filled, with no decay: a tooth is considered filled, without 
decay, when one or more permanent restorations are present and there is no caries 
anywhere on the tooth. 
* Code "4". Condition = missing tooth: as result of caries or for any other reason. 
* Code "5". Condition = dental implant: when a missing tooth (otherwise coded as 
"4") has been replaced by a dental implant 
* Code "6". Condition: bridge abutment, special crown or veneer, with decay: when 
a tooth forms part of a fixed bridge, i.e. is a bridge abutment, or has a crown (e.g. 
gold/porcelain/acrylic crown), or veneer (laminate), covering the labial surface of a 
tooth and has one or more areas that are decayed. 
* Code "7". Condition: bridge abutment, special crown or veneer, with no decay: 
when a tooth forms part of a fixed bridge, i.e. is a bridge abutment, or has a crown 
(e.g. gold/porcelain/acrylic crown), or veneer (laminate), covering the labial surface of 
a tooth and there is no caries anywhere on the tooth. 
* Code "8". Condition = unerupted crown or unexposed root: used for a tooth space 
with an unerupted permanent tooth, or a root (fragment, 'radix relictae') not exposed 
(covered with mucosa and or bone). A decayed root with missing crown should be 
coded as "1". A root resulting from decapitation of a tooth (e.g. an abutment to 
support an "overdenture") should be coded as "1", "2", or "3", depending on its 
condition. 
* Code "9". Condition = not recorded: this code is used for any tooth or root that 
cannot be examined for any reason (e.g. because of orthodontic bands, severe 
hypoplasia etc.) 
~ DRF: refers to Dental Risk Factor, as defined by Bruins et al.1998(3) 
Table summarizes dental conditions and weightings to assign the DRF score:  
* Code "0". Condition = low/medium risk. This code should be used when a tooth 
has:  
  - one or more dental conditions (see table) with a "low" weighting, and/or 
  - one or two dental conditions with a 'medium' weighting, and 
  - no conditions with "high" weightings. 
* Code "1" Condition = high risk.  This code should be used when a tooth has: 
  - three or more dental conditions with a "medium" weighting, and/or 
  - one or more dental conditions with a 'high' weighting. 
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~ TRX: refers to wether or not the tooth judged is in the radiation field over 50 Gray 
and or is in a short distance to a radioactive source for brachytherapy. The latter is a 
method of radiation treatment in which sealed radioactive sources are used to deliver 
the dose by interstitial (direct insertion into tissue), intracavitary (placement within a 
cavity), or surface application.(8) 
* Code "0", if the tooth is not in the radiation field of 50 Gy or more. 
* Code "1", if the tooth judged is within the radiation field of 50 Gy or more.  
To obtain this information, please check the simulation radiographs/CT scans and/or 
consult with the radiotherapist. 
~ Treatment need: refers to the indicated treatment of a tooth. 
* Code "0". Criterion = no treatment: this code is recorded if it is decided that a tooth 
should not receive any treatment. 
* Code "1". Criterion =  treatment, no extraction: if a tooth need any form of dental 
treatment, including root planing, surgical periodontics, surgical endodontics etc. 
* Code "2". Criterion = extraction: if it is decided to extract a tooth, including 
surgical removal. (This code also applies if an erupted tooth or unexposed root -Status 
code "8"- should be surgically removed). 
 
- Staging for head and neck cancers 
The TNM classification staging system to be used for the SCREDENT form is that of 
the American Joint Committee for Cancer (AJCC) (1) See Blair & Callender, 1994(9) for 
additional information. 
The staging system is a clinical system, based on the best possible estimate of the 
tumor extent, before treatment. The assessment of the primary tumor is based on 
inspection and palpation when possible and by both indirect mirror examination and/or 
direct endoscopy. Information on tumor extent usually is obtained by consulting the 
oncologist and from patient's hospital records. 
-The T stage is an anatomic description of the extent of the primary tumor. The T-
stage varies according to site of origin (see Table 2a).  
-The N stage (see Table 2b) is based on extent of regional lymphatic metastasis 
(cervical lymph nodes)  
-The M stage (see Table 2c) represents presence or absence of distant metastasis.  
 
Stage groupings recommend by the AJCC are as follows: 
Stage 1: T1N0M0 
Stage 2: T2N0M0 
Stage 3: T3N0M0; T1, 2, or 3, N1, M0 
Stage 4: T4N0 or N1; any T, N2 or N3; any T, any N, with M1. 
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Table  1       Dental Conditions to assign Dental Risk Factor (DRF) Score 
Clinical and Radiographic Findingsa Weighting  
PERIODONTAL DISEASE   
Probing depth / Proximal bone loss: b    3 to 6 mm Medium  
Probing depth / Proximal bone loss:      > 6mm  High 
Gingival recession:                                3 to 6 mm Medium  
Gingival recession:                                > 6 mm  High 
Bleeding upon probing Medium  
Spontaneous gingival bleeding  High 
Furcation involvement / Bone loss in furcation area  High 
Mobility       1-2 mm side to side Medium  
Mobility    > 2 mm side to side and/or 1 mm vertical  High 
PULPAL DISEASE AND PERIAPICAL LESIONS   
Abnormal response to tests,c  no previous endodontic treatment,  no rarefying osteitisd Medium  
Abnormal response to tests, and no previous endodontic treatment, rarefying osteitis  High 
Swellings and/or sinus tracts  High 
Rarefying osteitis, O < 3mm, with adequate root canal fillinge, without  (percussion) pain Low  
Rarefying osteitis, O < 3mm, with inadequate root canal fillinge, with (percussion) pain  High 
Rarefying osteitis, O >3 mm  High 
Condensing osteitis f/hypercementosisg with normal reactions to tests Low  
Condensing osteitis with abnormal reactions to tests Medium  
Internal/external root resorption  High 
EXTENSIVE CARIES   
Primary caries < 2/3 of the clinical crown Medium  
Primary caries  > 2/3 of the clinical crown/pulpal involvement  High 
Defective restorationh with secondary cariesi, no pulpal involvement Medium  
Root caries  < 1/2 of root circumference, no pulpal involvement Medium  
Root caries  > 1/2 of root circumference  High 
NON FUNCTIONAL TEETH   
Partially impacted  (incompletely erupted) teeth or permucosal residual roots  High 
Residual root tips not fully covered by alveolar bone and /or   showing periodontal 
ligament or radiolucency  High 
Fully impacted teeth, without follicle enlargement and fully covered by bone Low  
Fully impacted teeth, with follicle enlargement and/or not fully covered by bone  High 
 
 
a Identified at tooth level, which means tooth-related.  
b The radiographic standard for interpretation of bone proximal bone loss is that the alveolar crestal bone must be greater than 3 
mm from the CEJ.(4) 
cPulp sensitivity: cold, heat, electric (EPT) and percussion tests. 
dRarefying osteitis: radiolucent periapical bone destruction communicating with the periodontal ligament space via a discontinuity in 
the lamina dura. (5) 
e Criteria for  assessment of root canal obturation: The prepared and filled canal should  contain the original canal and should be 
filled completely (0.5-2mm from radiographic apex). No space between canal filling and canal wall should be seen. No canal space 
should be visible beyond the end point of the root canal filling. The whole canal system/ all roots  should be obturated (6).43 
ffCondensing osteitis: hypersclerotic trabeculi in the bone adjacent to the periapical region and communicating with the periodontal 
ligament space.(5) 
9 Hypercementosis: distortion of the apical third of the tooth root characterized by increased width while the periodontal ligament 
space and lamina dura remain unaltered.(5) 
h Restorations are defective if any of the following conditions are present: marginal discrepancies >0.5 mm, part of the restoration 
missing, bulk fracture, or marginal staining of composites suggesting leakage.(7) 
I True radiographic secondary (i.e., recurrent) caries and/or residual caries.(7) 
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Table  2a      T staging of primary head and neck tumors 
Site Stage  
All sites   
 TX Primary cannot be assessed 
 T0 No evidence of primary tumor  
 Tis Carcinoma in situ 
Oral cavity   
 T1 Two cm less in greatest dimension 
 T2 More than 2 cm but not more than 4 cm in greatest dimension 
 T3 Tumor is greater than 4 cm in greatest dimension 
 T4 Tumor invades adjacent structures, such as cortical bone, muscle of 
tongue, skin, maxillary sinus 
Nasopharynx   
 T1 Tumor limited to one sub site of nasopharynx 
 T2 Tumor invades more than one sub site of nasopharynx 
 T3 Tumor invades nasal cavity and/or oropharynx 
 T4 Tumor invades skull and/or cranial nerves 
Hypopharynx   
 T1 Tumor confined to the site of origin 
 T2 Extension of tumor to adjacent site region, without fixation of the 
hemilarynx 
 T3 Extension of tumor to adjacent site region, with fixation of the 
hemilarynx 
 T4 Massive tumor invading cartilage, bone, or soft tissue of neck 
Larynx - supraglottis   
 T1 Confined to site of origin with normal vocal cord movement 
 T2 Involving adjacent supraglottic sites without glottic fixation 
 T3 Limited to the larynx with fixation or extension to postcricoid area, 
medial wall of piriform, or pre-epiglottic space 
 T4 Massive tumor extending beyond the larynx to involve oropharynx, 
soft tissues of the neck, or destruction of the thyroid cartilage 
Larynx - glottis   
 T1 Confined to the vocal cord(s) with normal mobility 
 T2 Supraglottic or subglottic extension with normal or impaired vocal cord 
mobility 
 T3 Confined to larynx with fixation of vocal cord 
 T4 Massive tumor with cartilage destruction and/or extension beyond the 
larynx or both 
Larynx - subglottis   
 T1 Confined to subglottic region 
 T2 Extended to the vocal cord(s) with notmal or impaired cord mobility 
 T3 Confined to the larynx with cord fixation 
 T4 Massive tumor with cartilage destruction and/or extension beyond the 
larynx or both 
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Table 2b  T staging  of primary head and neck tumors (regional lymph nodes) 
Stage  
NX Regional lymph nodes cannot be assessed 
N0 No regional lymph node metastasis 
N1 Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension  
N2 Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest 
dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or 
in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension  
N2a Metastasis in a single ipsilateral lymph node more than 3 cm but not more than 6 cm in greatest 
dimension 
N2b Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension 
N2c Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension 
N3 Metastasis in a lymph node more than 6 cm in greatest dimension 
 
Table 2c  M staging  of primary head and neck tumors (distant metastasis) 
Stage  
MX Presence of metastasis cannot be assessed 
M0 No distant metastasis 
M1 distant metastasis present 
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1. Preliminaries 
1.1. Introduction 
 
This "getting starting" document introduces how SCREDENT (Beta-1 version) may be used to 
predict tooth extraction/ tooth loss in patients with head and neck cancer. The SCREDENT 
application runs within aiNet, a software package that emulates a probabilistic neural network on a 
personal computer. Please, check the aiNet manual for comprehensive information on the program. 
After familiarization with aiNet and SCREDENT, predicting tooth loss will take only a few 
minutes. This enables chair-side decision support. We believe that in addition, SCREDENT's 
primary role may be to offer a framework for continuous updating and adjusting of the decisions 
process, as explained in Chapter 6, and therefore to allow evidence-based decision-making; it may 
thus be a component of a quality control system. 
After further testing, we will develop plans for a new version of SCREDENT that combines the 
SCREDENT dentition assessment form and the prediction function, by means of a specially 
designed interface with pop-up menus and database facilities to store the cases. In addition, 
SCREDENT will be extended to all other situations where dental screening of medically 
compromised patients is mandated. 
 
1.2. Where to get the aiNET software? 
From the MEXSYS website at http://www.mexsys.net  follow the link to the SCREDENT 
download page.   
1.3. Hardware and Software Requirements 
 
aiNet requires the following minimal configuration: 
• a PC with the 386 processor  
• a minimum of 4 MB of RAM  
• about 5 MB of hard disk space, 
• Microsoft Windows95, Windows NT or as a minimum, Microsoft Windows 3. 
• a VGA graphics card (aiNet does not support Hercules mono and EGA graphics, although 
Windows does). 
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1.3.1.    Installation 
 
aiNet is supplied in a compressed format: AINETXX.ZIP. This ZIP.file contains all of the 
documentation and software. Decompressing the AINETXX.ZIP will result in the following 
subdirectory structure: 
 
Correct aiNet sub-directory structure 
 
2. SCREDENT 
2.1. Downloading the scredent.ain file  
To be able to run the SCREDENT application (Beta-1 test version) in aiNet, you first have to 
download the scredent.ain file from the MEXSYS.NET website at http://www.mexsys.net. 
Store the file in a new directory, for example in:  C:\My documents\SCREDENT\scredent.ain 
2.2. Open the scredent.ain file 
• Start aiNet  and  Click on         in the aiNet's menu bar at the top of the screen to open the 
scredent.ain file (follow the path to the scredent.ain file, for example:  
C:\My documents\SCREDENT\scredent.ain). 
After opening the scredent.ain file, your screen should look like this: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
            
 
 
Figure A 3.1 
                                                                                                                APPENDIX 3 
133 
NOTE: the model vectors are 'de-normalized' and 'unlocked', indicating that model vectors can be 
changed, deleted, and/or entered. First, make a copy of the scredent.ain file. From the menu, select: 
File | Save as  and enter the name of the new scredent file name, for example: scredent1.ain.  
 
• Next, normalize and lock the model vectors. From the menu, select:      
     Model vectors | Normalize+lock 
 
 
 
 
 
 
                                                                   
                                                
 
                                  
                                                Figure A-3.2 
 
 
• Make sure that you use: Normalization settings…  normalization method: regular 
 
 
 
 
 
 
 
                                                            
                                                          
                                                                  Figure A-3.3 
     
NOTE: the result should look like this: 
 
                                             
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure A-3.4 
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• Next, open the prediction view:select: View | Prediction 
or, alternatively, click on the           icon 
  
 
 
 
 
NOTE: the result should look like this: 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                       
 
 
  
                                                                                                                     
 
 
 
 
 
 
 
Figure A-3.5 
 
NOTE: the Prediction view is a spreadsheet-type interface. Each row represents a 'prediction 
vector' and has 12 input variables and 1 output variable. Before you can make predictions for tooth 
extraction (tooth loss), you first have to enter the input variables. An example (case presentation) 
will be given in the next section. 
2.3. SCREDENT, prediction of tooth extraction: a case presentation 
The preradiation dental screening was performed according to accepted standards (see Bruins, 
Koole & Jolly, 1998). The SCREDENT dentition assessment form was used according to the 
guidelines described in the SCREDENT guidelines document. Please check this document for a 
comprehensive description of all clinical variables. The completed form is depicted on page 138  
(example data displayed in blue.) The orthopantomogram/Panorex is displayed on page 137. 
 
- Open the scredent1.ain file. Next, save the file using a new file name representing the patient's  
name or number, or alternatively, chose any other file name. 
- Open SCREDENT's Prediction View, as explained above (see Figure A-3.5). 
- Recode the data from the SCREDENT form and enter the data into the Prediction View 
spreadsheet. Each row in the Prediction View represents a tooth. Therefore, in this example, we 
need 12 Prediction Vectors (rows) in order to make predictions in the case of this particular 
patient. 
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- ROW 1 of the prediction view represents tooth # 17 (the input is displayed in blue): 
• dmftot = number of teeth present (retained teeth) = 12 
• drftot = number of high Dental Risk Factors(DRF=1) = 7 
• upper = upper arch (yes=1/no=0) = 1 
• lower = lower arch (yes=1/no=0) = 0 
• molar (yes=1/no=0) = 1 
• bicusp (yes=1/no=0) = 0 
• cusp (yes=1/no=0) = 0 
• incis (yes=1/no=0) = 0 
• gland (in high dose radiation field >50% = 1 / not in field > 50% = 0) = 1 
• trx (tooth in high dose radiation field =1 / not in field= 0) = 0 
• drf (high dental risk factor, yes=1/no=0) = 1 
• patfact (dental IQ, high=1 / average-low=0) = 0 
 
Thus, the first Prediction Vector is: {12,7,1,0,1,0,0,0,1,0,1,0,…} 
NOTE: The output value, the conditional probability of tooth extraction/tooth loss, must not be 
entered. As explained before, SCREDENT will make this prediction for you. 
NOTE: the first row should look like this:  
 
 
 
 
 
 
 
 
- Repeat the process for the other 11 teeth. Note that the variables 'dmftot', 'drftot', 'gland', and 
'patfact' are not tooth-bound, but patient-bound. Thus, the values of these 4 variables are the same 
for every tooth. The result of entering all 12 teeth in SCREDENT's Prediction View should look 
like this: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                   
 
 Figure A3-7 
Figure A-3.6 
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- Next, predictions for 'tloss' are made. To calculate these predictions, select the 
Prediction|Calculate Prediction command from the menu, or alternatively, press F5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTE: the 'tloss' column displays the predictions for tooth extraction / tooth loss. These values 
are conditional probabilities. 1.000 means that tooth loss is 100% certain; 0.000 means that tooth 
loss is 0 % certain (= tooth retention is 100% certain, follow-up period 3 years, see Chapter 5) 
 
NOTE: a closer look at the 'tloss' column reveals the following: 
 
Most conditional probabilities are higher than 0.9, indicating a high chance for 
tooth extraction/tooth loss. The blue arrows point at conditional probabilities that 
are medium or low, indicating that in these cases the chance for tooth loss is 
between 17.9 % - 53 %. Thus, 9 of the total of 12 teeth that are present are likely 
(probability > 90%) to be extracted. The other 3 teeth (#23, #43, #33) may be 
retained.  
HOW should we interpret these results?  Please note that this prediction from 
SCREDENT can inform, but can never replace individual expertise. Remember, 
evidence-based medicine is not an obligatory 'cookbook' approach. Additional 
decision factors, such as timing considerations, are very important. For example, 
the conditional probability for tooth extraction of tooth # 48 (prediction vector in 
row 7) is 0.913. Tooth #48 is the only tooth within the high dose radiation field. 
Therefore, it is important that this tooth is extracted before radiation starts, 
allowing an adequate healing time of at least 14 days. The other eight teeth with 
high conditional probabilities for tooth extraction are not in the high dose 
radiation field and can be left in situ until later. In addition, the dental treatment 
planning should include 'normal' dental considerations. For example, in this particular patient, a 
full mouth clearance could be opted for, or alternatively, the decision could be for an over-denture 
on teeth #33 and #43. However, because the dental IQ of this patient is poor and because 
xerostomia is anticipated (salivary glands in high dose radiation field), the conditional probability 
for tooth extraction/tooth loss for both cuspids in the lower jaw is 0.530 (rows 9 and 12), 
indicating a 50% change that these cuspids will be lost within 3 years following radiation therapy 
(see Chapter 5). 
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3. Example case OPG (the example SCREDENT form is depicted on page 138) 
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SCREDENT   DENTITION   ASSESSMENT   FORM                       (Bruins,  Jolly  &   Koole,   1999) 
                                          Date of Birth                     Gender        Date of Oral Screening 
Patient code number         Day  Month  Year            M= 1 F = 2      Day  Month  Year                        
                          
  
                                                               Location of tumor    CTNM  stage   AJCC Stage 
Type of head & neck  tumor                  ICD code1                   T   N    M          (1,2,3 or 4) 
 
 
Tumor record                            Goal of tumor therapy:         Type of tumor therapy:     
            
 
Dentition Status  (Tooth numbering according FDI system) 
 
 
 
 
 
 
 
TREATM. 
TRX 
DRF 
STATUS 
TREATM. 
TRX 
DRF 
STATUS 
SCC Benign Salivary Gland   161.1 2
Cure Palliation ? Surgery  Radiation  Chemo  ? 
123AA 17 07 1936 24 03 1999
2 00
1
Major salivary glands in radiation field? (Bilaterally, > 50%):       yes / no 
Patient's Dental IQ / Compliance:  high / average-low   (please check guidelines) 
Prosthetic Status 
 
Upper               Lower 
  
 
 
0 =  No  prosthesis  
1 =  Bridge 
2 =  More  than one bridge 
3 =  Partial denture 
4 =  Both bridge(s) /Part.dent. 
5 =  Full removable denture 
9 =  Not recorded 
3 3 
16 
4 
- 
- 
- 
15 
2 
1 
0 
? 
18 
4 
- 
- 
- 
17 
3 
1 
0 
? 
12 
2 
1 
0 
? 
11 
2 
1 
0 
? 
14 
4 
- 
- 
- 
13 
4 
- 
- 
- 
23 
3 
0 
0 
? 
24 
4 
- 
- 
- 
21 
4 
- 
- 
- 
22 
4 
- 
- 
- 
17 
3 
1 
0 
? 
28 
4 
- 
- 
- 
25 
4 
- 
- 
- 
26 
4 
- 
- 
- 
46 
4 
- 
- 
- 
45 
3 
0 
1 
? 
48 
3 
0 
1 
? 
47 
4 
- 
- 
- 
42 
2 
1 
0 
? 
41 
4 
- 
- 
- 
44 
4 
- 
- 
- 
43 
2 
0 
0 
? 
33 
2 
0 
0 
? 
34 
4 
- 
- 
- 
31 
4 
- 
- 
- 
32 
2 
1 
0 
? 
37 
4 
- 
- 
- 
38 
4 
- 
- 
- 
35 
4 
- 
- 
- 
36 
4 
- 
- 
- 
Reminder Dentition Status Codes (see guidelines) 
First Second/ recurrence 
Tooth STATUS:  
 0 =   Sound                                     
 1 =   Decayed                                
 2 =   Filled, with decay                 
 3 =   Filled, no decay                    
 4 =   Missing  
 5 =   Dental implant                               
 6 =   Bridge abutment / crown / implant                     
 7 =   Bridge abutment/  crown, with decay                    
 8 =   Unerupted tooth / unexposed root 
 9=    Not Recorded       
  
DRF:  0 = medium or low, 1= High 
 
TRX:  0 = tooth not in radiation field  (>50 Gy.) 
          1 = tooth in radiation field (>50 Gy.) 
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